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SUMMARY
This project involved the chemical modification 
of the 6 ,7-benzomorphan nucleus by introducing a 
second nitrogen pharmacophore at the benzylic 
position to give a series of 8-aminobenzomorphans 
with potential analgesic activity. Concise reviews 
of 6 ,7-benzomorphan, morphine and related analgesics, 
pertinent to this project together with background 
material are given in Part One of the thesis.
The introduction of oxygen at the benzylic 
carbon of the 6 ,7-benzomorphan in improved yields 
was achieved using dilute solution of chromium 
trioxide in acetic acid at room temperature.
Various other oxidising agents which are known 
to attack benzylic methylene groups were also 
investigated and are reported in Chapter Two.
The stereoselective synthesis of the 8-amino-
6 ,7-benzomorphan by reduction of the oxime is 
described. Catalytic hydrogenation of the oxime 
yielded 8«~aminobenzomorphan whereas LAH reduction 
gave/^-isomer. These reductions together with the 
various factors which influence the stereochemical 
course of reduction cure, discussed in Chapter Three. 
The relative configuration of 8-aminobenzomorphan 
was assigned on the basis of ^H NMR studies. The 
stereochemistry of the 8g-aminobenzomorphan was 
confirmed by its successful cyclization via 8&- 
chloroacetamido-6 ,7-benzomorphan to the 2 ,8-bridged
V
benzomorphan derivative. All attempts to cyclize 
the 8«;-chloroacetamide under similar conditions 
proved to be impossible as anticipated on steric 
grounds.
The 8^-cyanobenzomorphan obtained from 8-oxo- 
benzomorphan and tosylmethyl isocyanide was cataly- 
tically reduced to 8-aminomethyl-6 ,7-benzomorphan. 
Introduction of an aminomethyl group at the 8 position 
creates a second phenylethylamine moiety in the 
benzomorphan nucleus.
The stereochemistry of 8o^-cyanobenzomorphan 
was determined from the ^H NMR chemical shifts and 
coupling constant between and Cg protons. Attempts 
to prepare the 8J3-cyano compound by base-catalysed 
racémisation of the (%-isomer surprisingly gave 8- 
oxobenzomorphan. A possible mechanism for this 
transformation is discussed in Chapter Five.
The availability of the nitrogen non-bonding 
electrons in the aminobenzomorphans was modified 
by acylation and alkylation. An unusual acylation 
reaction was observed for the 8^-amine and cyclo- 
propanecarbonyl chloride in that it gave 8g-dicyclo- 
propionamidobenzomorphan instead of the expected 
monoacylated derivative. A possible mechanism for 
this reaction is discussed in Chapter Three.
Approach to the synthesis of 8-alkylaminobenzomorphan 
via reductive amination of 8-oxobenzomorphan was
VI
investigated and shown to be unsatisfactory.
^H and ^ N M R  data for a series of 6,7- 
benzomorphan derivatives prepared in this work is 
presented and discussed in Chapter Six. These data 
are not only of importance for identification and 
differentiation but also valuable in the evidence 
they provide of the configuration and conformation 
of the various derivatives.
The experimental details of the syntheses of 
the aminobenzomorphans and their derivatives are 
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A widely recognized medical need exists for an 
analgesic useful in the long-term treatment of chronic 
pain that is both safe and effective, with minimum 
respiratory depression and dependence properties.
The oldest and best known analgesic is opium. For 
centuries the latex from the seed capsule of the opium 
poppy has provided pain relief unsurpassed by any other 
drug. Morphine, a major opium alkaloid, is still, in many 
cases, a preferred, drug for pain relief. Its use, however, 
is restricted by its side effects, the most serious of 
which are respiratory depression, and development of 
tolerance and physiological and psychological dependence. 
In an attempt to overcome these side-effects, a consider­
able number of analogues of varying structure have been 
prepared, some of which have proved useful substitutes 
for morphine. Despite the substantial progress made, there 
remains a serious problem with analgesics in so far as 
analgesic, euphoric effects and dependence remain largely 
unseparated properties. Thus, the goal of an ideal analge­
sic still awaits achievement. Lack of knowledge of the 
fundamental physiology of pain and the subcellular 
mechanisms by which the analgesic drugs exert their 
pharmacological effects has hampered progress towards 
this goal. The pharmacological effects of opiates have 
been linked with interactions with the central nervous 
system neurotransmitters acetylcholine, dopamine,
noradrenaline, 5-hydroxytryptamine and substance P.
The discovery of the opioid peptides now provides a new 
concept in the study and design of analgesic agents.
1.0 Morphine and related analgesics
The extract of the latex from opium poppy seed 
capsule is amongst the oldest materials employed for 
medicinal purposes, and the study of the major alkaloid 
in this extract, morphine (1), is one of the oldest areas 
of biological research. The Sumerians are thought to 
have used crude opium as early as 4000 B.C. for its 
ability to relieve pain and evoke a general feeling of 
peace and well being.
Morphine (1) was isolated from poppy latex by a 
German pharmacist, Sertuner, in 1803; since then twenty 
four other alkaloids have been isolated. The chemical 
structure of morphine was not fully understood until 
1903 and was only confirmed in 1952 by synthesis^.
( 1 )
5.
Morphine produces a large variety of pharmacological 
responses, the most important of which are analgesia, 
euphoria, respiratory depression and dependence. It has 
a retarding action upon the digestive system and is an 
effective antidiarrhoeaL agent. Its effect on depressing 
the cough reflex has been clinically utilized. But its 
principal effect has been in decreasing awareness and 
reaction to pain. The euphoric effects, and a reduction 
in anxiety and fatigue which are caused by it, is of 
importance in the alleviation of pain^'^'*.
Unfortunately morphine use is accompanied by several 
serious side-effects which pose a major drawback to its 
exploitation. In particular the effect of morphine 
decreases with each successive dose; the presence of 
drug becomes more and more tolerated and progressively 
large doses are required for a given effect. After 
continued exposure to the drug, the body becomes depen­
dent upon it for normal function. If the administration 
of the drug is terminated at this stage, severe with­
drawal symptoms develop. The symptoms are generally 
opposite to the original effects of morphine and vary 
from stomach cramps, diarrhoea, sleeplessness, nervous 
excitation with dLJlated pupil, increase of respiratory 
rate to respiratory failure and ultimately death. The 
need for ever-increasing doses to maintain the analgesia
and prevent withdrawal symptoms also increases the degree
2of side-effects such as nausea and constipation .
The mechanism involved in tolerance and physical
6 .
dependence remains largely unknown, in spite of intense 
biochemical investigation^'^. The hypothesis that tole­
rance is due to a change in the number or affinity of
the receptors has been tested, but no such change was
55observed. Snyder has proposed a model, in the light 
of the discovery of opioid peptides, which involves 
adenylate cyclase in the mechanism of analgesia, tole­
rance and physical dependence.
Respiratory depression is another undesirable 
effect and this depressant effect is the prime cause 
of death with higher doses. Other side-effects of 
morphine administration at therapeutic levels include 
antidiuresis, hyperglycemia, miosis, hypermotility, 
vomitjr>g^ nausea, mental confusion and depression of 
spinal reflexes. It also induces the release of pitui­
tary hormone, prolactin and growth hormone. The ph­
armacology of morphine has been irevie-u/eoL>73 detail^
Morphine is promptly absorbed after parentcraL 
injection but absorbtion by the oral route is poor.
It rapidly leaves the blood stream and is concentrated 
in parenchymatous tissue. The major pathway for 
metabolism of morphine is conjugation with glucuronic 
acid.
Numerous modifications of the morphine skeleton 
have been undertaken in an attempt to produce analgesia 
without morphine's harmful side-effects. Many morphine 
derivatives have been introduced in medical practice, 
some of which are very potent but they are all accompanied
7.
8,9by side-effects similar to morphine . Codeine (2a),
the phenolic ether of morphine, retains a useful degree
of analgesic activity, and is widely used as an oral
analgesic and antitussive agent. The abuse potential
of codeine is lower than most other narcotic analgesics
The ethyl (2b), benzyl (2c) and 4-morpholinoethyl
(phol c odLinô-, 2d) ethers have a similar clinical
utility. Heroin, or diacetylmorphine (3), is more
potent and shorter acting than morphine, but has a
higher addiction liability. The pharmacological action
of heroin is attributed to its hydrolysis products





a) R = Me b) R = Et
c) R = CH^PH
d) R = CH^CH^-N O
8.
The chemical modification of ring C of morphine 
has led to several drugs that are clinically important^^. 
These include dihydromorphinone (4), d(hydromorphine (5) 
and Metopon (6 ). Metopon is about three times as potent 
as morphine and shows lower addiction liability but 
has not been promoted for general use. Pfiiomorphine (7) 
is a fast acting, powerful analgesic with little emetic 
or gastrointestinal effects. The 14-hydroxy-7,8-dihydro 
compounds, oxymorphone (8a) and oxycodovre (8b) are 
also marketed, and are very potent drugs. The 14-hydroxy 
derivatives. Naloxone (9a) and naltrexone (9b) are 
potent pure antagonists opposing the actions of morphine 
and are used for the treatment of narcotic analgesic 
overdose^ ̂ .
Many 6,14-endoethenotetrahydrothebaine derivatives
12 13(10) have extremely high potencies ' , Etorphine (10,
R=C^H^), for example, is 8600 times as active as morphine 
in guinea-pigs, and is used for immobilizing large 
animals for veterinary purposes and for game conserva­
tion. Diprenorphine (11, R^CH^) is a potent antagonist
with very little analgesic activity and is used for the
14reversal of etorphine actions. Buprenorphine (11, 
R=t-Bu) is a very potent mixed antagonist - agonist 
(0.6mg=15mg morphine) and has recently been introduced 
for a period of monitored clinical release in UK. It 
has a longer duration of action and produces a greater 



















a) R = H
b) R = CH
a) R = CH^CH = CH^
b) R = CPMr
10.
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Once the structure of morphine had been elucidated,
attempts to synthesize it began. Among the early attempts
at the total synthesis of morphine were those of the
German chemist Rudolph Grewe^^. From his investigations
have evolved the morphinans(12), a class of compounds
possessing the main structural skeleton of morphine (1 )
without 4,5-oxygen bridge. Schnider and Grussner^^ in 
1 71949 and Grewe soon after described racemorphan;
(+)-3-hydroxy-N-methyl-morphinan (12) vs an analgesic 
more potent than morphine with no greater harmful side- 
effects. The laevo enantiomorph (Levorphanol) which 
possesses same absolute configuration as natural 
morphine was the form responsible for the analgesic 
activity.
Literally hundreds of morphinans have been evaluated 
for analgetic activity and acute toxicity, and some for
11
addiction liability and cough suppression. A complete
1 8review of these data has been published . Although 
the side-effects in these compounds are not as severe 
as those found in morphine, all of them do show the 
deficiencies of the parent alkaloid (1) ie. its 
dependence liability and respiratory depressant proper­
ties .
Morphinan derivatives with 14-hydroxyl groups 
which cannot be obtained by the usual Grewe synthesis
1 9have been, recently, prepared by a novel procedure 
The N-cyclopropyl-and N-cyclobutyl/derivatives (13a and 
b) represent two of the more interesting compounds to 







± Racemorphan a) R = CPM
b) R = CBM = Ĉ clo tuty
12.
1.2 6 ,7-Benzomorphans.
The 6 ,7-benzomorphans are one of the most extensively
investigated morphine analogues, first prepared and
20studied in detail by May and Eddy . These compounds 
retain chemical features considered at one time essen­
tial for strong analgesic activity, namely an aromatic 
ring attached to a quaternary carbon atom and two
21carbon atoms removed from a tertiary amine function 
These compounds are essentially three ring segments 
of the morphine nucleus. The four possible diastereo- 
isomeric forms resulting from asymmetry at C-1, C-9, 
and C-5 are reduced to two due to the cis B-C ring 
fusion. These two pairs are the «- and ^-diastereo- 
isomers which differ in configuration at C-9; in 
Qç-isomers 5,9-dialkyl substituents are cis with 
respect to the hydroaromatic ring B (14) while in 









The stereochemistry of the 9-substituent was
22initially determined by the rate of quaternization
2 3 9 3and by nuclear magnetic resonance (NMR) studies '
The rates of quaternization of ot- are faster than those 
of g-isomers, the reaction in latter being hindered by 
the 9-alkyl group. The C-9 methyl in the o<: -isomer is 
upfield over 20 cycles from that of 3 and was inter­
preted in terms of a diamagnetic shielding of the oc 
but not the ^ C-9 methyl by the fused benzene ring.
The geometry of the 9 position has considerable influence 
upon the analgesic activity. Without exception,
^-diastereomers are substantially more potent than 
2 2 24 2 5the ^-forms ' ' in spite of their stereochemistry 
differing from that of morphine.
9 3May and his colleagues , using a modified Grewe 
synthesis, prepared a number of 5-monoalkyl- and 5,9- 
dialkyl substituted benzomorphans, many of which possessed 
moderate to strong analgesic activity and low or no 
physical dependence capacity in monkeys. The influence 
of alkyl chain length at C^ and C-9 upon activity differs 
somewhat in the diastereoisomers (Table 1). For example, 
the p-dipropyl derivative (16; R^=R2=Pr) is a potent 
analgesic whereas the corresponding ot-isomer is essen­
tially inactive.
The 3 derivatives with a C^ ethyl or propyl groups 
are particularly potent even when deficient of a phenolic 
hydroxyl function^^'^^,normally a prerequisite for high 
activity. Ommission of a 9-methyl group is detrimental
14
to activity, and this suggests it is an important
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Morphine = 2.90 ED^q , mg/Kg sc
Table 1
A thorough study of the effect of substitution at
the nitrogen in the benzomorphan series was made by
2 6Harris and Archer , They, more than any other group, 
developed and promoted the agonist-antagonist concept 
of antinociception, which is very prominent in present 
day analgesic research rationale. Pentazocine (17; 
R=CH2~CH=CMe2) is a moderately strong agonist with weak
15.
antagonist activity and is now in clinical use in a
wide range of pain situations. Full reviews on its use
3 27are available in Goodman and Gilman and Martindale
Cyclazocine (17; R=cyclopropylmethyl) is a powerful 
morphine antagonist in the D 'Amour-Smith assay 
(7 X nalorphine) with equally powerful pain relieving 
qualities (0.25mg=10mg morphine), and has proved to 
be a good research tool. It may yet find application 
as an analgesic. Phenazocine (17; R=CH2CH2Ph; ED^^,
0.25 mg/Kg sc, mice) is about 5-10 times more powerful 
than the parent metazocine (R=Me; ED^^, 3.0 mg/Kg sc.
22mice hot plate) as an analgesic
A series of N-fû -̂f L benzomorphans (17) show
interesting pharmacological profiles. The activity
profile of (17) may be varied by simple structural changes
2 8as shown in Table 2 . Compound (17a) is devoid of agonist
activity but is an antagonist about equal in potency to 
nalorphine. Compound (17d) is a pure agonist comparable 
to morphine, but it did not display straub tail charac­
teristics in mice nor did it substitute for morphine
29in dependent monkeys . Compounds (17b and 17c) have 
mixed agonist-antagonist activity.
In contrast to compound (17b), N-2"-tetrahydrofur^uKy(,-
benzomorphans (18a) are devoid of antagonist activity
29and are potent analgesics . All eight isomers of the 
derivative (18a) have been studied; 2"S compounds are 
superior to the 2"R diastereoisomer. Modifications of 
the N-tetrahydrofuv-^cAry [ group markedly affected the 
action profile and furnished compounds with highly diffe-
16.
30rentiated opioid properties . More potent isomers of 
(18a and 18b) were powerful non-morphine like analgesics 
with potencies of more than 100 times that of morphine. 
These potent compounds did not show a positive straub 
tail test in mice and failed to suppress the abstinence 
sign in dependent monkeys deprived of morphine, and 
hence are potential non-addicting analgesics.
NR
Me (17)
a . b. c . d.
-CH CH-CH )R= -CH-CH
Antagonist None
2Analgesic None + ++ +++
1. 50% suppression of morphine analgesia in mice






2 "a) R =
CH,
O
An interesting aspect of the benzomorphan compounds
is the study of the agonist-antagonist profiles of pairs
of optical isomers^^(Table 3). The laevo-isomers are
more potent than corresponding racemates and, like
racemates, would not support morphine-dependent monkeys.
Surprisingly, laevo-isomers, in some cases, showed
antagonistic action in precipitating the morphine
abstinence signs in these morphine-dependent animals.
The laevo-isomers of 5-propyl-9v-methyl-6 ,7-benzomorphan
(Table 3; 19d) is one fifth as potent as nalorphine as
an antagonist but stronger than morphine as an analgesic
Some dextro-isomers are also active and, surprisingly
shows some capacity-. to substitute for morphine. However
this phenomenon of separation of morphine-like effects
32in enantiomers is not general for this series . For 
instance both isomers of 5-methyl-9of-ethyl-6,7-benzo- 
morphan (Table 3; 19c) are active and neither shows 
the capacity to substitute for morphine, nor do they 
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Table 3 Analgesic activity, physical dependence capacity 
and antagonistic potency of some benzomorphan 
enantiomers.
19.
The synthesis, analgesic activity and physical 
dependence capacity of a large number of 5-phenyl 
benzomorphan derivatives has been reported by Clark 
et al Such compounds provide a structural link
between the benzomorphans and the 4-phenylpiperidines 
and diphenylpropylamine analgesics. The 9-methyl-5- 
phenyl derivative (20; R=Me) was obtained by an adaptation 
of the Grewe-type synthesis. Only one diastereoisomer
33resulted and, unexpectedly, this had a g-configuration
The laevo-isomer of 20 (R=Me) is twice as potent as
morphine as an analgesic, with nalorphine-like properties
in precipitating the morphine abstinence in non-withdrawn,
dependent monkeys. The laevo-isomers of the N-dimethyl-
allyl- and N-cyclobutylmethyl analogues of 20 are both
mixed agonist-antagonists but are less potent than the
corresponding 5,9-dialkyl-6,7-benzomorphan derivatives
either as analgesics or as antagonists. The N-propargyl
analogue ((-), 20;R=CH2C=CH) is a pure, long acting
34antagonist in the guinea pig ileum .
Most of dextro-isomers (20) with antagonist-like 
substituents are inactive or very weak as analgesics.
May et ^^2,35,79,82 prepared 2-methyl-6,7- 
benzomorphan and 2 ,9-dimethyl-6,7-benzomorphan to 
acertain the importance of the quaternary carbon in 
rigid structures. Compounds (Table 5) with H at position 
5, although somewhat reduced in potency from correspon­
ding 5-methyl relatives, are nevertheless moderately to 





R isomer ED^q , mg/Kg sc
Me (-) 0.18
Me ( + ) 3.40
CHgCHgPh (±) Inactive
Metazocine it) 0.44
Mice hot plate test. 
Table 4
as racemates show mixed agonist-antagonist action in
the morphine-dependent monkey, similar to laevo-isomers
in the 5-alkyl series. Recently the improved synthesis
of 9a- and 9g-methyl compounds (16c and 16f) has been
36reported by Gless and Rapport . Surprisingly, a secondary 
amine analogue of (16b; R=R^=H) without quaternary carbon 
is codeine-like in analgetic activity (ED^^, 10.2 mg/Kg




ED^q , mg/Kg sc
a. R=Me, R^=H
b . R=R^—H
c . R=Me, R^=9«-Me
d. R=H, R^=9«f-Me
e. R=CH2 ,R^=9g-Me









Determined hot plate method, in mice. 
Table 5
The effect of introduction of a 9-hydroxyl group 
(equivalent to the 14-hydroxyl of the morphine analogues; 
has been examined in the benzomorphan series^^. A 9- 
hydroxy substituent reduces the analgesic activity of 
metazocine (21; R=Me), the influence of the g-positioned 
group being more deterimental^T, Introduction of an 
9g-hydroxy group onto the benzomorphan bearing an allyl 
or cyclopropylmethyl group on nitrogen (21; R=CH2-CH= 
CHg, or R=CPM) increased antagonist activity but
22.
.•the.
decreased agonist activity. In^case of cyclazocine, 
a 9^-hydroxyl group raised the antagonist activity 
by ten fold, while agonist activity decreased by 
about 400 fold. On the other hand, introduction of 
an 9a-hydroxyl group had no influence on the antagonist 
action of pentazocine or cyclazocine^^.
Some potent analgesics with agonist-antagonist 
profiles have been derived from 5-allyl-9g-hydroxybenzo- 
morphan (22). The N-cyclopropylmethyl and N-cyclobutyl­
methyl derivatives of 2̂  were effective agonists in
the mice writhing text, both effectively antagonised
.-the.
the action of oxymorphone. In both respects,/N-cyclo-
3 8propylmethyl compound was more potent . An 9oç-methyl 
group abolished the analgesic properties of the 
N-cyclopropylmethyl derivative of 22 enhance.cL
its antagonist action, whereas it increased the potency 
of the N-cyclobutylmethyl derivative of 22̂  both as 











a. R=CPM b. R=CBM
Introduction of another methyl group at C-9 in
certain 5,9-dimethylbenzomorphan derivatives, as in
(23), gave a series of compounds which possessed
pharmacological profiles similar to the 9-monomethyl







a • R“Ph 
b , R=Me 
pentazocine




Mice, tail flick antagonist of morphine 
Table 6
24.
The structure-activity effects of altering the 
substituents at other positions on the ring system have
o cbeen studied. Ziering ^  ^  introduced methyl groups 
into the and 3 *-positions, and phenyl into the 
Supposition of the benzomorphan nucleus. The 8oc-phenyl- 
and 8oi-methylbenzomorphan derivatives (Table 6; 24a & b) 
















Direct introduction of oxygen in the benzylic carbon 
provided another subseries with mixed agonist-antagonist 
properties^^^ (Table 7). Introduction of an 8-keto group 
in certain benzomorphan antagonists invariably reduced 
antagonist activity without appreciably effecting agonist
25
activity. However, antagonist activity increases when 
such a change is made in norbase (25; R=H), The 8-oxo 
analogue (25; R=CPM) of cyclazocine possessed agonist 
activity similar to cyclazocine, and an antagonist 
activity similar to pentazocine. A few 8-hydroxy-6,7- 
benzomorphans^^*'^^^ have been reported, all of low 
potency either as agonists or antagonists. For example, 
the diastereomerically related 8o^ and 8g-hydroxy-
6 .7-benzomorphans (Table 8 , 26) are weak analgesics.
The 8j8-hydroxy isomer was more potent than the y- 
isomer. Surprisingly the N-methyl derivative of 2^ 
was inactive. This is unexpected on the basis of the, 
classical structure action-relationships of analgesic
6 .7-benzomorphans. The tertiary amine would be expected 
to au more potent analgesic than the secondary amine^^^.
NH
(26)
R^ R2 isomer ED^^, mg/Kg sc
OH H «  56.5
H OH g 13.7
2-methyl-8g-hydroxy-6 ,7-
benzomorphan__________________ Inactive_____
Mice hot plate 
Table 8
26.
A series of 3/5-dimethyl- and 4,5-dimethylbenzo-
40morphan derivatives were prepared by Parfitt and Walters 
The non-phenolic 4,5-dimethyl-6,7-benzomorphan (27) 
showed significant analgesic activity and was more 
active than 3,5-(28) or 5,9-positional isomers (mice 
hot plate). The N-cyclopropylmethyl derivative of 2^ 
was about half as potent as morphine and the most 
active compound of the series. Surprisingly, the N- 
cyclopropylmethyl analogue of the more active 27̂  
proved to be inactive. The N-phenethyl derivatives of 








ED50» 4.2 mg/Kg sc ED^^, 11.9 mg/Kg sc
(Mice hot plate)
As a hybrid of both the benzomorphan and piperidine
analgesics May prepared 2-methy1-5-carboethoxybenzomorphan 
4 1(29a) . The analgesic activity of 29a is comparable
to meperidine, and it did not support morphine dependence 
in monkeys. The benzomorphan-prodine hybrid ( 2 9 b ) i s  
about one quarter as active as morphine, and does support 









Mice hot plate 
Table 9
It was anticipated that replacement of the 2'- 
hydroxyl group in benzomorphans by an amino group 
would give an analgesic less subject to metabolic 
inactivation, and thus render it longer acting.
The 2 '-amino analogue (30) of non-phenolic cyclazocine 
was found to be, a strong, active analgesic agonist with 
antagonist properties and had a favorable oral/parenteral
ratio'>3.44
45Michne et ^  have reported the synthesis and 
analgesic activity of a large number of 9-propanol-
6 ,7-benzomorphans (31). The structure-activity profile 
of 31 analogues differs from the structurally similar 
bridged oripavine derivatives. In general, these variants 
had weak analgesic properties but were potent antagonists 










a) acetylcholine writhing test
b) pentazocine antagonism.
Table 10
CH_)_) is five times as potent as nalorphine and 
(the.represents^most potent N-methyl antagonist reported 
4 6to date . A series of 9 - (3-oxoalkyl)-6 ,7-benzomorphans 
4 7(32) , where the alkyl group was a straight chain or
terminally branched chains containing from one to six 
carbon atoms, were synthesized. Several compounds 
(32; C^Hg, CHgCH (0 ^2 )2 , (CH2̂) 2CH (CH^) 2) displayed
activity up to 100 times that of morphine. Compound 3_2 
containing five or six carbon atoms in the alkyl chain 
exhibited antagonist activity.
Various skeletal modification of the benzomorphan 
ring have been reported. These include C-ring expansion 
to form the homobenzomorphan, introduction of a second
29.
nitrogen, contraction of B or C ring and synthesis of 
the basic skeleton with nitrogen in different positions.
A notable example are homobenzomorphans of type (33), 
prepared by variant of the tetralone route*^. These 
compounds have significant agonist and antagonist activity 
depending upon the nature of the N-substituent. The £- 
isomers withjfantagonist N-substituent (33; R=CPM or 
CH2CH=C(CH^)2) may be classified as 'pure' antagonist 

















There are several structural features common to 
narcotic analgesic drugs^^. Many strong analgesics contain 
an aromatic ring bonded to a saturated two- or three- 
carbon chains terminating with an amine nitrogen.
Other additional features are associated with strong 
analgesic activity^^'^^. In morphine analogues, the 
presence of a phenolic hydroxyl, tertiary nitrogen, 
and quaternary benzylic carbon all enhance analgesic 
activity.
It is generally agreed that an essential feature
of an analgesic drug is its basic nitrogen, which
either forms part of an alicyclic ring structure or
an acyclic chain. In most examples, the base is tertiary,
51 52but there are number of secondary amines ' with 
analgesic properties. The low analgesic potencies of 
nor-analogues is considered to be due to distribution 
factors and not to the failure of such derivatives 
to associate at the receptors^^.
The cationic (protonated) form of the drug is 
generally accepted to be the active species and to 
interact with the receptor via ionic association^^ . 
Belleau et , however, recently proposed that the
nitrogen lone pair orientation is a key factor gover­
ning association of an opiate drug with its receptor, 
and ruled out the protonated form as the active species^^.
This was postulated after comparision of the X-ray
Çf\or
structure of N-methyl-D-porphinan salt (34), which is
31 .
devoid of analgesic or antagonist activity, with that 
of the morphinan salt (35). Belleau et a^ pointed that 
the protonated nitrogen lone-electron pair of the D-nor- 
morphinan (34) is directed towards the aromatic feature 
of the molecule, whereas the same feature points away 
from aryl in morphinan or benzomorphan salts. An objection 
to these views is the fact that morphine metho-salts 
(in which the lone-pair is not available and nitrogen 
atom carries a full positive charge) are similar in 




Opiate receptors are stereoselective towards a 
variety of narcotic analgesics and in all cases activity 
is distributed unevenly in enantiomeric forms. Beckett 
and Casy^^, in 1954, formulated a receptor model on 
the basis of stereochemical evidence and structural 
features common to analgesics and their antagonists 
known at that time. It was postulated that the receptor 
possessed a flat surface, a cavity and an anionic site 
which were thought to accommodate an aromatic ring.
32e






A number of proposals that update Beckett's receptor
model have been made in the light of new information.
1 2Bentley and Lewis proposed an extension of the receptor
(Figure 2) to include a lipophilic site which would
accommodate the very potent 6,14-endoethenotetrahydro-
thebaine and oripavine series. An alternative proposal,
attempting to account for stereochemical anomalies among
certain compounds where both members of an enantiomeric
pair show significant pharmacological activity, for
example 5-phenyl-6 ,7-benzomorphan (19> has been advanced 
5 8by Galt . He proposed an extension of the planar 
binding area (A), as shown in Figure 3. Any molecule, 
according to Galt, which has, or can project, a planar 
surface and cationic centre in the same juxtaposition 
in space as the model, could have opiate properties.
Thus, both enantiomeric forms of 5-phenyl-6,7-benzomorphan 
provides features required to fit the model; the nitrogen
33.
atom and phenolic hydroxyl superimpose, but the aromatic 
rings do not overlap.
Lipophilic site
Extended A
Figure 2 Figure 3
55Snyder et ^  proposed a model attempting to explain 
the structure-activity relationships of opiate agonists 
and antagonists, and the importance of sodium. They 
suggest the receptor exists in two conformations 
allosterically modulated by sodium ions, the agonist 
and antagonist (Figure 4). Two sites, one of lipophilic 
and one of anionic character that interact with the 
aromatic ring and amine nitrogen respectively, are 
available in both conformations. In addition, the recep­
tor has a specific agonist site (F), which is not avail­
able to the antagonist molecule, and binding of agonists 
to this site stabilizes the agonist conformation. 
Antagonist also have a specific binding site capable 
of interaction with antagonist substituents and its 
occupancy stabilizes the antagonist conformation.
Normally, the receptor is in the antagonist conformation 
because of the prevailing brain sodium ion concentration.
34.
The enhanced potency of econitasene, phenazocine, 
fentanyl and the bridged thebaines is attributed to 
the fact that such molecules have aromatic features 
capable of binding to both A and F sites. Mixed agonist- 
antagonists are considered to interact with both agonist 
and antagonist conformations. The failure to design 
narcotic antagonists based on phenylmorphans by 
linking the basic centre to groups such as allyl and, the,
cyclopropylmethyl is suggested to be due to^aromatic 
rings of such compounds interacting with specific agonist 








In this model agonist and antagonist activities
are associated with axial and equatorial N-substituents
respectively and the effect of the C^^-OH group in
enhancing antagonist activity is explained by assuming
its presence is responsible for a shift from axial to
equatorial N-substituent. Quantum chemical studies
59carried out by Loew et a3̂  do not support this
35.
hypothesis. They found no correlation between agonist- 
antagonist potency variation and calculated axial- 
equatorial N-substituent characteristics. Loew et al 
suggest that agonist-antagonist activity is regulated 
by two different low energy equatorial N-substituent 
conformers, and the C,^^-OH and N-substituent interact 
indirectly through a common anionic site^^. Alternatively, 
Casy proposed that the hydroxyl group may exert its 
influence electronically by inducing an electron drift 
towards the RN^H feature via an N^H— OH hydrogen bonding 
mechanism^^.
A variant of the Snyder model in which only one
conformation of the receptor is needed for both agonist
6 2and antagonist molecules was proposed by Vera Kolb 
There are two different spacially fixed amine binding 
sites : one agonist and one antagonist. The opiate undergoes 
binding to its amine binding site via the lone-pair 
electrons on nitrogen. It is suggested that the primary 
action of antagonists at the receptor is through the 
interaction of the antagonist N-lone pair and its amine- 
site, and not through some lipophilic association of 
the N-allyl chain with a specific antagonist binding 
site. The main role of the N-allyl chain is to force 
the N-lone pair lobe of an antagonist molecule in the 
direction of its amine binding site^^.
Each of the proposed models can account for some 
of the experimental observations but none is satisfac­
tory. The concept of a single receptor at which all
64
36.
ligands associate by mechanisms that are essentially 
alike, appears improbable. Binding interactions of so 
restricted a character are incompatible with present 
stereochemical and structure-activity data.
Portoghese, in 1965, introduced a new concept on
the mode of interaction of ligands with opiate receptors
He proposed multiple modes of interaction which arise
from association of different ligands with different
recognition loci on either a single or a group of
related receptors. A method of determining similarities
or differences in molecular binding modes by comparing
the variation of activity in different series of compounds
when identical changes in the N-substituent are made,
was proposed. Comparision of meperidine derivatives
with identically substituted benzomorphans showed no
64parallel relationship , and thus implies dissimilar 
modes of binding.
The loss of activity upon introduction of a meta 
phenolic OH in allylprodine (36), which is in marked 
contrast to the enhancement of agonist potency conferred 
by this group in morphine, is attributed to divergent 
binding modes. Portoghese 2Ë Êi postulated that this 
difference arises from the recognition of the aromatic 
groups of morphine and allylprodine by different aromatic-
binding subsites of the receptor. These subsites are
jt̂ hichsuggested to be identical with thoseyrecognize the 
aromatic rings of the Tyr^ and Phe* of the enkephalins 
and endorphin (Figure 5)^^.
37
Binding site of aromatic
ring of allylprodine and4of Phe enkephalin
,,OCOEt
MeT binding site of
aromatic rings of 




Evidence of competitive kinetics and the fact that 
antagonist molecules like nalorphine block a wide range 
of analgesics support the view of a single receptor 
species. However, the differential pharmacological 
responses seen with various opiates, and the differential 
competitive displacement of various opiates by narcotic 
agents from the receptor suggests that there are multiple 
r e c e p t o r s ^ ^ ,
Martin et ^  postulated the existence in the brain 
of and jgr receptors on the basis of the different 
pharmacological responses observed with a variety of 
narcotic analgesics in the non-dependent chronic spinal 
dog. Morphine is the prototype agonist of t h e ^  receptor, 
Ketocyclazocine for the X, and SKF-10047 (N-allyl analogue 
of normetazocine) for the crreceptor^^. The effects of 
these drugs are antagonized by naltrexone, indicating
38.
that they are agonists. Pentazocine is suggested to 
be a weak ^  receptor antagonist and a moderate t  and 
agonist. The antagonistic action of pentazocine at 
the ̂  receptor is the reason why pentazocine precipitates 
abstinence in persons dependent on morphine. Its agonistic 
action at the X  receptor accounts for its analgesic 
activity and for the induction of the nalorphine-type 
of physical dependence. Agonistic effects at receptors 
accounts for the psychotomimetic effects. Cyclazocine 
is suggested to have both ^  and cragonistic activity 
but no activity at the receptor.
The Martin et ^  hypothesis has been confirmed
6 8biochemically by demonstrating the presence in brain 
as well in isolated organs^^ of at least two kinds of 
sites for radio-labelled analogues of enkephalins. These 
compounds bind to a low affinity site where they are 
readily displaced by natural and synthetic opiates, 
and to a high affinity site which exhibits a high pre­
ference for the peptide structure. From a comparision 
of the binding properties and the pharmacological 
potency on isolated organs, the low affinity site has 
been related to the ^  receptors (or morphine receptors) 
of the guineau pig ileum and the high affinity site has 
been related to cr receptor (or enkephalin receptors) 
of the mouse vas deferens^^'^^. Several biochemical 
differences between the binding sites exist. Sodium 
selectively inhibits opiate agonist binding by abolishing 
high affinity, with minimum effects on the low affinity 
site^^. Structure-activity studies with selective
39.
enkephalin analogues have provided support for the 
hypothesis that analgesia is mediated by the A  receptor. 
The 2; receptors are considered to be involved with 
behavioral effects^^.
The actiLal structure and mechanism of action of
opiate receptors must await the isolation of receptor
material in a pure and viable state. Numerous attempts
to obtain an active solubilised receptor have so far
met with very limited success. Recently successful
solubilization of receptor in a state that reversibly
binds opiate ligands, using new types of detergent, has 
72been reported ; hopefully this will lead to further 
progress.
The concept of the analgesic receptor has been 
progressively modified with new experimental information. 
Casy, in 1978, concluded that the Portoghese hypothesis 
of multiple modes of ligand-receptor interaction, whether 
at a single receptor or a variety of linked receptor 
sites, was a reasonable one in the light of present 
day stereochemical and other structure-activity data^^.
40.
1.4 Chemistry of benzomorphanones
1.4.1 Nomenclature
There are two systems of nomenclature used for 
the benzomorphans. The Chemical Abstracts name for the 
parent ring system is 1,2,3,4,5,6-hexahydro-2,6-methano-
3-benzazocine (37), but is better known as 6 ,7-benzomorp- 
han (38) which is the original nomenclature. The number­







2 * 1 •
(38)
1.4.2 Synthetic routes to benzomorphanones.
The principal synthetic routes for constructing 
the ring system are shown schematically only (Figures 
8-16). The Grewe and tetralone routes, as well as 
modification of these methods, are by far the most 
important synthetic routes.
The first compound containing the benzomorphan
73nucleus was prepared by Baltrop in 1947. He synthesized 
the ethobromide salt of 2-ethyl-5-methyl-9-oxobenzomorphan 
from the ^-tetralone (39). May and Murphy^* prepared
41
2 ,5-dimethy1-6 ,7-benzomorphan (40) exploiting this
route (Figure 6 ) and ly a,longer synthesis starting
with hydratroponitrile (Figure 7). The g_-tetralone
75-77route has been widely used in the preparation
of various 5-alky Ibenzomorphans and also in the 






















































Mitsuhasi ^  al employed^tetralone route to
prepare the nonquaternary carbon compound, 2-methyl-
benzomorphan (Figure 8 > 42) which was previously
prepared by Kanematsu, Parfitt et al by an alternative 
79route (Figure 9). Mitsuhasi's approach to the 
preparation of the tetralone precursor (41) involved 
a Beckmann rearrangement of 4-phenylcyclohexanone 
oxime followed by hydrolysis, N-methylation, and 
cyclization. This was converted in the usual manner un­
to 2-methylbenzomorphan (42).
Kanematsu, Parfitt et ^  prepared. 2-methyl-



























2 . H^, PtO^
Me
80The preparation of 5-phenyl-6,7-benzomorphan 
involved the base catalyzed cyclization of the amido 
tetralone (43), which was prepared by alkylation of 























R = H or Me
Figure 10
46
The preparation of 2,9^-dimethyl-6,7-benzomorphan 
(Figure 11; 46), unattainable by the usual Grewe 







2. H2 , Pd/C
cis, 80%















A modification of this synthesis, in which
8 2cyclization is effected by mercuric acetate oxidation , 
has been used to prepare the 9a-methylbenzomorphan 
(Figure 12? 50) from the corresponding trar^oc*tetra­
lone (47). The formation of the 2,9g-dimethyl derivative 
(49) was postulated to arise from inversion (by allylic 

































The ^-tetralone syntheses referred to above all 
suffer from low overall yield, and there are problems 
associated with cyclisation and demethobromination 
steps due to the formation of elimination products 




A novel synthesis to overcome these problems 
involves bromination and rearrangement of heterocyclic
Q Oenamines (Figure 13; 52). For example, Gerry Kavadias 
84et al synthezised 9-oxobenzomorphan with various 
substituents at the 2,2' and 5 positions in good yields 
by a modification of this process.
8-0XO-6,7-benzomorphan has been prepared by 
oxidation of previously prepared benzomorphans with 
chromic acid^^'^^'^^^. The most widely used approach 
to benzomorphan synthesis is based on the Grewe 
cyclization of tetrahydropyridines (Figure 23,





























1 .4.3 Reactions of benzomorphanones.
Benzomorphanones provide useful intermediates which 
have been used for the synthesis of a variety of
benzomorphan derivatives. Reduction of 9-oxobenzomorphan
9 6 9 7 98(52) with platinum oxide ' or sodium borohydride
yielded 9orhydroxybenzomorphan (53), whereas similar 

























98dequaternization, the 9g-hydroxybenzomorphan (54) 
Similar modes of addition occurred during Grignard 
or methyllithium^^' addition resulting in carbinol
(55) with hydroxyl cis to the C^-methyl, and carbinol
(56) with hydroxyl trans to the C^-methyl (Figure 14).
The mode of reaction was dependent on whether or
not nitrogen was cationic. When nitrogen was cationic,
I-the,
addition -to carbonyl occurred to yield/alcohol with
hydroxyl oriented towards nitrogen. With neutral 























Thionyl chloride dehydration of 5 6 gave the
7 79-methylene~6,7-benzomorphan (57) . Pyrolysis of
the 9-acety 1-9-methyl benzomorphan (58) also gave -the
9-methylene product (57). Hydrogenation of 9-methylene
benzomorphan was stereoselective depending again upon
9 9the condition of the nitrogen atom (Figure 15; 59a & 
59b). The 0^ and g-isomers of the 9-hydroxymethyl-6 #7- 
benzomorphan have been synthezised from the correspon­
ding 9-methylene-6 ,7-benzomorphan (57) by hydroboration 
under controlled c o n d i t i o n s ^ f o l l o w e d  by peroxide 
oxidation.
101Shiotani and Mitsuhasi converted the 9-oxo-
6 ,7-benzomorphan (60) into oxime (61), reduction of 
which demonstrated stereoselectivity (Figure 16). 
Hydrogenation of the oxime (61) in the presence of 
acetic acid and sulphuric acid gave 9g-acetamide (62) 











5-Allyl-9“Oxo-6,7-benzomorphan and its methiodide 
salt were stereoselectively reduced to the correspon­
ding 9^- and 90f-hydroxy compounds (64 ,65) respectively 
which in turn were transformed to a number of 2-substi- 
tuted-5-allyl-9-hydroxy-6,7-benzomorphans. A series of
102
3-hydroxy-8-oxaisomorphinans (66) and 3-hydroxy-8- 
oxamorphinans (67) were derived from^corresponding 
















8“0xobenzomorphans have provided a means of access
to 8-hydroxy-6 ,7-benzomorphans and thence the acetyl
derivatives. Catalytic reduction of the 8-oxo compound
(68) with palladium-charcoal or platinium oxide gave
74only one and the same diastereomer (69). Reduction 
of the ketone (68) with sodium borohydride also gave 
8g-hydroxy-6 ,7-benzomorphan (69) whereas similar 
reduction of its methiodide (70) gave the 8orhydroxy





















The diastereomerically related 8or and 8g-hydroxy-
6 ,7-benzomorphanS(77, 78) were prepared from 8-oxobenzo- 
104morphan (72). Reduction of 8-oxobenzomorphan (72) 
with sodium borohydride yielded only/2-methyl-8g-hydroxy 
diastereoisomer (73). The N-demethylated compound (74) 
was converted mko the 2-tosyl derivative, which upon 
reduction and detosylation afforded exclusively 8g- 
hydroxy-6 ,7-benzomorphan (77). Conversion of 2-tosyl- 
8p-hydroxybenzomorphan (75) iiito the 2-tosyl-8g-tosyl 
derivative (76), followed by aqueous solvolysis and 
detosylation of the latter gave 8oç-hydroxy-6 ,7-benzo­
morphan (Figure 19; 78).
Reaction of phenyllithium with the 2,5,9-trimethyl- 
8 - O X O - 6 ,7-benzomorphan (79) gave the 8 ,8-difunctionalized 
benzomorphan (80) which upon hydrogenolysis gave the 
8orphenyl derivative (Figure 20;81). Treatment of 7_9 
with methyllithium afforded carbinol (82) which 
dehydrates with acid to the 8-methylene compound (83). 
Catalytic reduction of ^  gave 8ormethyl-6 ,7- 
benzomorphan^^ (Figure 20; 84).
Catalytic hydrogenation of the N-demethylated 
compound (85) afforded 8^-hydroxy-6 , 7-benzomorphan”* 
(Figure 20; 86).
8-Oxobenzomorphan (72) was converted mto the oxime
which catalytically reduced in either acetic acid or
acetic acid and sulphuric acid to give only 8g^acetamido- 
101benzomorphan (Figure 21; 87); this is in contrast to 
similar reduction of the oxime of 9-oxo-6,7-benzomorphan 
















































































Treatment of the 2,5-dimethyl-8-oxo-6,7-benzomorphan 
(Figure 22; 88) with lithium-ethylacetate, followed by 
dehydration with thionyl chloride-pyridine gave the 
8-ethoxycarbonylmethylene compound (89). Catalytic 
hydrogenation of 82 gave the 8g-ethoxycarbonylmethyl 
isomer (90) which, after déméthylation, was cyclized 
to give the lactam (91). The lactam was reduced with 
LAH, and 0-demethylated to give the 2,8-bridged 
benzomorphan (92).
Treatment of ketone (93) with ethyl bromoacetate,
followed by reduction with sodium borohydride yielded
the diol (94), which was cyclized by treatment with
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CHAPTER TWO
SYNTHESIS AND REACTIONS OF BENZOMORPHANONES.
2.0 Introduction.
The substitution of a carbon-bonded hydrogen by 
a carbonyl oxygen atom is one of the more useful 
chemical reactions available for *functionalizing* a 
carbon atom thereby making it available for reaction 
with a variety of chemical reagents.Many agents are 
available for the oxidation of organic c o m p o u n d s ^ ^  
among the most commonly employed are derivatives of 
chromium or manganese.
74May et a^ have prepared 2,5-dimethyl-8-oxo-6,7-
benzomorphan (100) in about 5% yield from hydrotropa-
nitrile (Figure Iz, page 42). 8-0xo-6,7-benzomorphans
77 78have been prepared by other methods ' (figures 6
and 9). The direct introduction of oxygen at the
benzylic position in previously prepared benzomorphans
has been achieved by chromium trioxide oxidation in
either aqueous sulphuric acid or acetic anhydride.
Ziering et al oxidized 2-methoxy-2,5,9-trimethyl-
6 ,7-benzomorphan with chromium trioxide in sulphuric
acid to give the corresponding 8-ketone in good yields
2-Methyl-8-oxo-6,7-benzomorphan was prepared by Fauley 
104et al with chromium trioxide in acetic anhydride in 
70% yield.
The most effective method for performing the 
oxidation of/benzylic carbon of 6 ,7-benzomorphans is
63.
described in this chapter. The simple procedure 
involved the use of an excess of a stirred dilute 
solution of chromium trioxide in acetic acid at room 
temperature. Various other oxidising agents, which 
are known to attack benzylic methylene groups were 
also investigated (Section 2.1).
8-ÜXO-6,7-benzomorphans may be converted mto the
corresponding nitriles by reaction with tosylmethyl
108isocyanide (TOSMIC) in the presence of base 
TOSMIC adds one carbon to a ketone as in the cyanohydrin 
reaction but without the simultaneous formation of an 
a^hydroxy group. Clearly the nitrile is a useful 
synthetic intermediate which may by further exploited, 
for instance, by conversion into the carboxylic acid 
and derivatives. The oximes (117 & 119) of 8-oxobenzo- 
morphans were prepared in good yield by standard method.
A search of the literature revealed that no
compounds in the benzomorphan series possessing
halogen at C-8 have been reported. The halogénation
of benzomorphan is an attractive synthetic step
since the resulting halide may prove to be a useful
synthetic intermediate. Amines, for example, may be
prepared by the reaction between alkyl halide and
potassium phthalimide to give N-alkyl phthalimide
which may be cleaved to afford the corresponding
primary amine. The classical procedure for displace-
128 129ment of halogen by cyanide is well known ' . An
attempt was made therefore to synthesise, 2,5,9-trimethyl- 
8-bromo-6 ,7-benzomorphan.
64.
2.1 Synthesis of 2,5-dimethyl-6,7-benzomorphan and 
2 1 5 ,9-trimethyl-6,7-benzomorphan.
The Grewe synthesis of 6,7-benzomorphans involves 
an acid-catalyzed cyclization of appropriately substi­
tuted tetrahydropyridines. The Grignard reagent derived 
from benzyl chloride was reacted with 4-picoline 
methVocLide to give the unstable dihydropyridine (96) 
which was immediately reduced by sodium borohydride 
in almost quantitative yield. The tetrahydropyridine
(97) formed was cyclized with 48% hydrobromic acid













o n2.1.1 2,5,9-Trimethyl-6,7-benzomorphan (99) was
obtained in a similar manner from 3,4-lutidine. The
predominant ^-diastereoisomer was isolated as the
hydrochloride salt. In the «-isomer the C-9 methyl
has a higher proton magnetic resonance (PMR) chemical
shift than that of and this has been interpreted
in terms of a diamagnetic shielding of the «  C-9 methyl
93by the fused benzene ring
In the Grewe synthesis, the major product is
always that in which alkyl groups are cis with respect
to hydroaromatic ring B (Figure 24; 99). This is
expected if cyclization is viewed as a trans addition
to the double bond of the tetrahydropyridine (98) ;
109protonation occurs from the less hindered side 
(Figure 24).
Optical resolution of the enantiomeric pairs has
shown that the biological activity resides mainly in
the leavo isomer. Resolution can be effected by (+) -3
bromo-S-camphorsulpVionic acid^^ or with a combination
31 3 2of (+)- and (-)- mandelic acid ' . No separation of










2.2 Synthesis of 2,5-dimethyl-8-oxo-6,7-benzomorphan(100)
and 2,5,9-trimethyl-8-oxo-6,7-benzomorphan (115).
The 2,5“dimethyl“6 ,7-benzomorphan was oxidized 
with chromium trioxide in aqueous acetic acid to give 
2,5-dimethyl-8-oxo-6,7-benzomorphan (100). Chromic 
acid in 95% aqueous acetic acid was added dropwise 
to the solution of 6 ,7-benzomorphan in glacial acetic 
acid over a period of several hours. Efficient stirring 
was required for an optimum yield of the 8-oxobenzomorp- 
han (100). When addition was complete the reaction was 
stirred at room temperature for an additional 20 hours.
The solution was then poured into ice cold water, 












This procedure gave a mixture of products as
indicated by thin layer chromatography (silica, MeOH;
DCM:ACOH 12:4:1). The main product required was the
ketone (100) but some 2,5-dimethyl-3,4,8-trioxo-6,7-
benzomorphan (101) and unreacted starting material were
also isolated. The trioxo compound (101) was separated
from the resulting mixture through its lower solubility
in nonpolar solvents such as cyclohexane and petroleum
ether. The infra-red spectrum of the trioxo-6,7-
benzomorphan (101) exhibits absorption at 1690cm ^
-1and 1730cm due to carbonyl functionalities. The PMR 
spectrum shows nine aliphatic protons (1.8-4.0 ppm).
The C-5 methyl appears as a singlet at 1.84 ppm while 
the N-methyl resonates at 3.1 ppm as expected. The 
remainder of the aliphatic protons, and C^, 
resonate at 3.98 ppm (t) and 2.67 ppm (d) respectively. 
The molecular ion observed at M/Z 243 by mass spectro­
metry supports structure (101).
Purification of 8-oxobenzomorphan (100) was achieved 
by passing the crude material through a silica column 
(12:4:1 , MeOH;DCM:ACOH). It may also be purified via 
the bisulphite addition compound (102) or the oxime 
derivative (117).
^1 ^ W  HO“or H"*" ^1





Absorption at 1680 cm in^infra-red spectrum
of the product (100) suggested a conjugated carbonyl 
group. The melting point and spectral data confirmed 
the structure of the 8-oxo-6 ,7-benzomorphan (100),
It is interesting that no dioxo compounds (103 or 
104) were detected. This suggests that attack at 
carbon 3 and 4 occurs almost simultaneously. Oxidation 
at one of the methylene positions probably increases 





The relative rates of oxidation of primary, 
secondary and tertiary hydrogens are 1:110:7000^^^.
With 6,7-benzomorphans reaction at the tertiary C-H 
bond at the bridgehead is suppressed because of the 
increase in strain associated with a change in 
hybridization at that position. The methylene bridge 
is not attacked, presumably because of the increase 
in strain resulting from a change in hybridization.
The yield of 8-oxobenzomorphan (100) was optimised 
by varying the concentration of the reactants employed.
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the reaction time and reaction temperature. At elevated 
temperatures it was found to give higher yields of the 
trioxobenzomorphan (101). The time course of this 
oxidation which was followed by thin layer chromato­
graphy showed an initial rapid phase, followed by a 
slowing and finally cessation of reaction with oxidizing 
agent still remaining. The decrease in the rate of 
reaction with increasing time is possibly due to the
production of acetate ion during the reaction. Acetate
113is known to retard oxidation reactions • Chromic
acid oxidation at the benzylic position in aqueous
acetic acid is accelerated by increasing the concentra-
111tion of mineral acid
The mechanism of the chromic acid oxidation has
107been extensively studied . The observation of a
kinetic isotope effect demonstrates that the cleavage
of the carbon-hydrogen bond occurs in the rate-
determining step. Oxidation of aromatic side chains
is believed to be initiated by attack at a benzylic 
112C-H bond . A possible mechanism for chromic acid
oxidations is outlined in Scheme 1. The initial step
involves either a hydride ion (two electron transfer)
or a hydrogen atom abstraction (one electron transfer,
112as illustrated). Rocek has proposed that the 
transition state for hydrogen transfer is a resonance 
hybrid (105), in which the carbon atom has both radical 
and carbonium ion character. This then reacts with the 
chromium derivative to form the chromium (IV) ester
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(106) which is generally regarded as the reaction
intermediate which leads to the observed products.
The benzylic type radical, the initial species
involved in the oxidation of 6 ,7-benzomorphans,
is expected to form only slowly due to difficulty in
2its stabilisation through overlap of the Sp hybridi­
sed C-8 's p-orbital with the aromatic ring, a conclu­
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Oxidation by chromium trioxide varies with/nature 
of chromium (IV) species employed but solvent also has 
a marked effect on the rate and the type of reaction 
which occurs. The use of chromium acetate for such reac­
tions was first reported by Thiele and W i n t e r T h e y
71 .
found that the oxidation of several substituted toluenes 
with chromium trioxide in acetic anhydride in the presen­
ce of a strong acid gave good yields of the benzal 
diacetates (eg. 108).
The oxidation of 6,7-benzomorphans with chromyl
acetate was examined in some detail. Chromyl acetate
solution was prepared by adding the chromium trioxide
to the acetic anhydride slowly with cooling and
stirring. The benzomorphan (40) was dissolved in acetic
anhydride at O^C and concentrated sulphuric acid was
added slowly. When the mixture had cooled to O^C chromyl
acetate solution was added at such a rate that the
temperature did not exceed 6^C and stirring was continued
at this temperature for several hours. The brownish oil
isolated was identified as diacetate derivative (Figure
26? 107). An absorption peak at V  ̂ 1685 cm  ̂ ( ^C=0 ),max /
( ^C=0) and 1230 cm  ̂ ( -8- 0-1740 cm ) C ) in the infra­
red spectrum, together with PMR spectrum support struc­
ture (107) as the product. The diacetate was then 
hydrolysed with sulphuric acid in 50% ethanol to give 











Chromyl acetate is generally quite satisfactory 
for converting toluene derivatives to the corresponding 
aldehyde. The success of this procedure has been attri­
buted to the formation of the diacetate (eg. 108) which 
is resistant to further oxidation. The reaction of 
aromatic aldehydes with acetic anhydride in the presence 
of acid occurs much more rapidly than the oxidation
of the aldehyde. This then provides a route for the







114Carr has reported oxidation of 2,5-dimethyl-
6 ,7-benzomorphan (40) with acidic chromic acid solution. 
His procedure gave a lower yield of 8-0x0 compound (100) 
than the oxidation with chromium trioxide in acetic acid 
largely due to incomplete oxidation. A further disadvan­
tage of this method is that it required drastic conditions 
which included refluxing the solution of benzomorphan 
in acidic chromic acid.
Other oxidizing agents which are known to oxidise 
benzylic methylene groups were also investigated. 
Hydrogen-transfer reactions between phenols and high-
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potential quinones can lead to a wide variety of 
115products . The process may be controlled to allow
selective benzylic oxidation of suitable phenols by
116the use of alcoholic solvents (Figure 27). Quinone
methides (eg. 110) formed by dehydrogenation are
thought to be intermediates in these reactions, and
stable forms of these species have been isolated as
the end products of suitable blocked and hindered 
117phenols . Benzylic oxidation of phenols by 2,5- 
dichloro-5,6-dicyanobenzoquinone (109) does not require 
protection of the phenolic hydroxyl group, whereas 
chromic acid oxidation of aromatic compounds of this 









Oxidation of 2 '-hydroxy-2,5-dimethyl-6,7-benzomorphan 
(Figure 28; 111) with 2.0 equivalents of dichlorodicyano- 
quinone in methanol gaVa o. two component mixture, one of 
which was unreacted starting material. The minor component
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was identified as 8a-methoxy-6,7-benzomorphan (113) 
from its spectral properties. No trace of the 
corresponding 8-OXO- 6 ,7-benzomorphan (114) was 
detected. An IR spectrum did not show the carbonyl 
bond. The PMR spectrum obtained for product (113) 
showed a singlet at 3.4 7 ppm due to methoxy and the 
normal benzylic protons signal a t *^3.2 ppm was absent.
A new downfield singlet was evident at 4.75 ppm due 
to the 8£ benzylic proton. Mass spectral evidence 
supported the proposed structure for (113). The 
formation of 8a-methoxy-6,7-benzomorphan is rationa­
lized by the mechanism outlined in Figure 28. It is 
proposed that this product arises by addition of 
alcohol to the reactive quinone methide intermediate


















Several attempts were made to oxidize 111 with 
dichlorodicyanoquinone by varying the concentration 
of the reactants employed, temperature and the reaction 
time. In most cases, low yields of 8-methoxy derivative
(113) were, obtained.
118The use of cerium (IV) ammonium nitrate or
119silver nitrate ammonium persulphate to oxidize
2,5-dimethyl-6,7-benzomorphan (40) wo.s ineffective 
and unreacted starting material was recovered in each 
case. Ethyl benzene and tetralin are known to give 
acetophenone and 1-tetralone respectively in 76-78% 
yield when treated with eerie ammonium nitrate in 
3.5 M nitric acid.
2.2.2 Similarly 2,5,9-trimethyl-6,7-benzomorphan
(99) was oxidized by chromium trioxide in 95% aqueous 
acetic acid to the corresponding 8-oxo-6,7-benzomorphan 
(115) in good yields. Oxidation of this benzomorphan 
required careful, slow addition of chromium trioxide 










with 2,5“dimethy1-6,7-benzomorphan. The side product, 
trioxo compound (116), was formed in a larger quantity 
than in the case of 2,5-dimethyl-6,7-benzomorphan but 
no dioxo compounds were detected.
2.3 Synthesis of 2,5-dimethyl-8-oxo-6,7-benzomorphan 
oxime (117) and 2,5,9-trimethyl-8-oxo-6,7- 
benzomorphan oxime (120).
The oxime derivative (117) was prepared by
heating the 8-oxo-6,7-benzomorphan (100) and hydroxyl-
amine hydrochloride in boiling ethanol for 18 hours.
The hydroxylamine salt was neutralized by addition of
sodium acetate, which also provided a buffering action
■ for
near the optimum pH/condensation. Although this reaction 
is reversible the equilibrium favours condensation under 
the experimental condition employed. Since water is one 
of the products of the reaction, the use of anhydrous 
systems is advantageous. Removal of water from the 
reaction medium to force condensation was unnecessary.
OH




Carbonyl compounds usually react completely with 
free hydroxylamine (equation A) but the instability 
of free hydroxylamine due to air oxidation often 
discourages its use. On the other hand, although 
hydroxylamine hydrochloride is relatively stable, 
an equilibrium is involved in its reaction with 
carbonyl compound (equation B). The condensation of 
the 8 -OXO-6,7-benzomorphan and free hydroxylamine 
(NH^OH) was carried out by heating the reactants in 
methanol. A solution of free hydroxylamine was prepared 
from NHgOH.HCl and sodium acetate in methanol. After 
one hour, the mixture was filt^redL and the filtrate 
was treated with 8-oxo-6,7-benzomorphan (100). This 
procedure was found to give an improved yield of oxime
(117).
\ \C = O + NH,OH ------> C = NOH + H^O (A)/ z / Â
\  ^ \C = O + NH-OH.HCl C = NOH + H^O + HCl (B)/  z / z
All ketones which have two different groups 
attached to the carbonyl carbon are capable of affording 
two isomeric oximes. However, as a rule, one of the 
isomers is formed in a great excess over the other.
NMR studies of solutions of semicarbazones and 
phenylhydrazones show that condensation gives rise 
exclusively to the isomer in which the bulky Z group 
attached to the imino nitrogen bears a syn relation-
ship to the smaller S group
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120
C = 0 + NH.Z C = N
syn
The condensation of the 8-oxo-6,7-benzomorphan
and hydroxylamine gave rise exclusively to the
ketoxime (117) isomer which bears a syn relationship
to the bridgehead carbon ( C^). This was deduced from
the deshielding effect experienced by the bridgehead
proton by the proximity of the hydroxyl group. The
chemical shift of that proton depends upon whether it
is syn or anti to the hydroxyl group; when syn it is 
1 on 19 1deshielded ' . The main deshielding effect is
regarded as arising from the proximity of the unshared
122pair of electrons on nitrogen , however Huitric 
123et al have presented evidence for the greater effect 
being due to the proximity of the hydroxyl oxygen non­
bonding electrons. The chemical difference in the
/the/
hydroxyl proton resonance of/oxime is also useful for
1 24assignment of configuration
The PMR spectrum obtained for the oxime (117) 
shows the bridgehead C^-proton resonates at 4.41 ppm (t) ; 
this is at a considerably lower field when compared with 
the corresponding 8-oxobenzomorphan ( 100,; \/'3.0 ppm,t) .
The formation and hydrolysis of oximes has been
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the subject of a number of investigations^  ̂ .
Reactions tend to exhibit general acid catalysis and 
it is established that in the formation reaction the 
addition step is rapid in comparison to the dehydration 
step. The acid catalysis of hydroxylamine condensation 
with a ketone in neutral solution involves catalysis 
of the dehydration step and not the facilitation of 
addition by conversion of the carbonyl compound into 
its conjugate acid.
The observation that the reactions show pH optima 
is mainly due to transitions in the rate determining 
stages with changing acidity of the reaction medium.
At pH 7 the addition step is fast and in this region 
the overall rate increases with increasing acidity, 
the acid-catalysed dehydration being now rate-determin­
ing. When the acidity is increased, the addition step 
becomes gradually slower owing to the conversion of 
the nitrogen base into its conjugate acid, and at 
sufficiently high acidities this will determine the 
overall rate. A possible mechanism for such condensa­
tion reactions is outlined in Scheme 2.
The dehydration of the carbinolamines and the 
addition of water to oximes are subject to both specific 
and general acid catalysis. The addition of hydroxyl­
amine to a carbonyl group also exhibits some specific 
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Beckmann rearrangement of the oxime (117) was
carried out by treating it with polyphosphoric acid
at ISO^C, This gave a single product whose IR and
PMR spectra suggested that, in agreement with
9 8previous literature reports , it had the acylanilide- 
type lactam structure (118) rather than the alternative 
benzamide-type lactam structure, and this confirmed 




In the Beckmann rearrangement, the group which
migrates is usually trans (ANTI) to the hydroxyl
function, and this is often used as method of determi-
127ning the configuration of the oxime , Concerted 
fission and rearrangement is necessary to explain the 
stereochemistry, and species (119) is generally assumed 

















oxime (120) was prepared from the corresponding 8-oxo-
6,7-benzomorphan (115). Only one ketoxime isomer was
isolated and this was found to bear a syn relationship
to the bridgehead carbon.. The PMR spectrum of the oxime 
.the. ‘
shows^C^-proton as doublet at 4.22 ppm. The C^-proton
is strongly deshielded apparently due to the proximity










29; 121) was prepared from/corresponding 8-oxo compound
108by reaction with tosylmethyl isocyanide (TOSMIC,122) 
Potassium tertiary butoxide was added at O^C to a 
solution of the 2,5-dimethyl-8-oxo-6,7-benzomorphan 
and 3 equivalents of TOSMIC in dimethyl sulphoxide 
containing some methanol. The mixture was stirred 
under for 1 hour at room temperature and then for 




(1 0 0 )
NMe
Me
(11 2 1 )
Figure 29
The reaction of TOSMIC is effectively a reductive
cyanation, and it allows the ketone into nitrile conver-
108Sion to be carried out in a single operation, . This 
is an attractive synthetic reaction as the resulting 
nitrile is an intermediate which can be exploited to 
generate potential pharmacophores, for instance, by 
conversion to amine, carboxylic acid and related
d e r i v a t i v e s T 2 8 , 1 2 9 ^
t-BUOK
T O SCH^N^ ------- >
R r .0N-C'


























The mechanism of this reaction is considered to
involve a base-catalyzed condensation of TOSMIC and
a ketone to give 4-tosyl-2-ox&zoline^^^(Scheme 4 ; 123a),
This intermediate has been shown to play a crucial role
in the reaction, and evidence for it was obtained by
the isolation of derivative (124) with sodium ethoxide
1 4in ethanol and by C labelling experiments. The role
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of the added methanol is to accelerate the final stage 
of the reaction, and is explained in part by its 





E t O ^ N
-O;
(124)
The reaction of TOSMIC with the 8-oxobenzomorphan
(100) afforded exclusively the 8«-cyanobenzomorphan (121). 
The large TOSMIC anion would be expected to attack the 
ketone from the less hindered ^-side to give tosyl- 
substituted oxazolines (123b).
The configurational assignment for/8-cyano compound 
(121) was made by ^H NMR spectroscopy. Dreiding models 
furnished approximate dihedral angles for the Cg-C^ 
segment, which assisted in relating the vicinal proton- 
proton coupling constant to structure. The ^H NMR spectrum 
of the cyano compound (121) exhibits a singlet at 4.13
f-the,
ppm with JH^,H^^2Hz, assignable toy 8_g-.proton. The 
vicinal coupling constant corresponds by the Karplus 
relationship^*^ to dihedral angle (*^90°), which is 
consistent with that derived from Dreiding models, 
establishing the 8o£-cyano stereochemistry. Furthermore, 
the bridgehead proton (H^) is oriented in the deshielding 
zone of the nitrile and would be subjected to a consider-
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able deshielding influence. The proton absorption 
occurred at a strongly deshielded position (3.42 ppm), 
thus confirming the stereochemical assignment.
Tosylmethyl isocyanide (TOSMIC) used in the reaction
was prepared by dehydration of the N-(p-tosylsulphonyl-
methyl)formamide, which was derived from sodium p-toTuene- 
1 30sulphite (Figure 30). TOSMIC has also been prepared
by reaction of p-tosylsulphonylfluoride with isocyano-
methyllithium or by irradiation of p-tosyIsulphonyl
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2.5 Attempted synthesis of 2,5,9-trimethyl-8-bromo-
6,7-benzomorphan.
Bromination of the benzylic carbon of 2,5,9- 
trimethyl-6,7-benzomorphan, in order to offer a 
valuable reaction synthetic intermediate, was attempted 
The most facile means of halogénation is by reactions 
involving free radical intermediates that effect the
87.
homolysis of the carbon-hydrogen bond.
N-bromosucciniYMicl6. normally highly selective in 
attacking only activated C-H bonds, was used along with 
benzoyl peroxide as a radical initiator. The reaction 
gave a complex mixture as shown by thin layer chromato­
graphy. The PMR spectrum of the crude reaction products 
was more complex than anticipated and showed no 
indication of the presence of the required bromo- 
benzomorphan. Attempts to separate the complex mixture, 
by passing the material through a silica column, and 
attempts to identify the components were, not successful.
Examination of Dreiding models of benzomorphans 
illustrated that most acidic protons are sterically 
hindered and it is likely that bromination on other 
carbon atoms may occur. Under the normal conditions 
of reaction, N-halogenation would appear to be unimpor­
tant relative to C-halogenation; however N-bromosuc-
ciniYYirde is reported to effect preferential N-bromir 
135nation . Thus the complex mixture of products results 
probably from the bromination of several carbon atoms 
and on nitrogen . Bromination may also be complicated 
by possible rearrangements and/or degradation.
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CHAPTER THREE
8"AMINO*6/7-BENZQMQRPHANS AND THEIR DERIVATIVES.
3.O Introduction.
The mechanism by which opiates elicit their 
biological response is poorly understood but is known 
to involve principally interactions with one or more 
opiate receptors in the central nervous system.
A necessary feature of an opiate molecule is its 
basic c e n t r e ^ I t  is believed that the opiate 
nitrogen interacts with a receptor either via its 
lone electron pair^^'^^ or in its protbnated formf^ . 
In either case/ the electron density on the nitrogen 
plays an important role in pharmacological activity.
The concept of a single receptor defined by a 
rigid morphine skeleton is incompatible with present- 
day stereochemical and structure-activity data. It is 
more likely that analgesics bind ionically with a 
relatively simple/ identical anionic centre which acts 
as a pivot around which a variety of modes of binding 
may occur^*'^^. It is noteworthy that simple amines 
like Jg-phenylethylamine/ 3-aminocyclohexene/ 2-amino- 
indane fulfil the simple requirements for receptor 
binding in terms of structure and spacial configuration; 
these amines have been reported to possess some 
analgesic activity^^^.
6/7-Benzomorphans/ which are semi-rigid/ afford 
the most versatile series of synthetic compounds for 
investigating the nature of opiate receptors. Chemical
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modifications by altering the substituents at several 
positions of/benzomorphan nucleus have been intensively 
s t u d i e d ^ 35,61,85,106^ these modifications have
led to the discovery of a considerable number of
compounds possessing interesting profiles with respect
to analgesic activity. Several workers have proposed
that the distance of the nitrogen atom relative to
137-40the aromatic ring is critical for the interaction 
The basic nitrogen atom of the benzomorphan is rather 
rigidly held about 1.5A^ above the plane of an aromatic 
ring and is displaced about 4,1A^ from the centre of 
that ring (Figure 31). However, an interesting compound 
(125) which exhibits extremely potent opiate analgesic 
activity is one in which nitrogen atom is attached 
directly to the carbon bearing the aromatic ring^*^.
It was thus of some interest to ascertain the effect 
on biological activity of placing a nitrogen atom at 
this apparently important position in the benzomorphan 




<----- 4.1AO  > (125)
Figure 31
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The introduction of a second nitrogen pharmacophore 
would affect pKa and electron density distribution of 
the benzomorphan, and thus should markedly influence 
opiate activity. It might also alter the fit between 
the opiate and its receptor(s), and thus may further 
define receptor requirements. Additionally the 
availability of the nitrogen non bonding electrons was 
modified by alkylation and acylation.
3.1 Stereoselective synthesis of the 8or- and SP-amino-
2,5-dimethyl-6,7-benzomorphan and 8&- and 8g- 
amino-2,5,9-trimethy1-6,7-benzomorphan.
The 8^- and 8or-amino-2,5-dimethyl-6,7-benzomorphans 
(126,127), key compounds in this study of amino substi­
tuted compounds, were obtained via reduction of the 
oxime (117) of 2,5-dimethyl-8-oxo-6,7-benzomorphan. 
Reduction of 117 with lithium aluminium hydride (LAH) 
gave exclusively the ^-amine (126). The oxime was added 
to a stirred solution of LAH in diethylether under
nitrogen and the mixture was stirred at room temperature
i»fovernight. Excess^hydride was destroyed with dilute 
aqueous sodium hydroxide and the resultant 8p-amino-
6,7-benzomorphan was purified as the hydrochloride _ 
salt from ethanol-ether.
The infra-red spectrum of the product (126) shows
- 1  —1absorption at 3475 cm and 3400 cm arising from
stretching vibrations of two N-H bonds. Additionally 
the spectrum exhibits the characteristic primary amine
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- 1  - 1absorption bonds at 1603 cm and 763 cm . The PMR
spectrum of the g-amine (126) shows the Cg benzylic 
proton as a doublet at 4.05 ppm with Hz. The
dihedral angle between proton (Hg^) and the vicinal 
proton (H^) is •^30^0 (Figure 32), and according to the 
Karplus relationship^*^ JHg^,H^ would be expected to kg, 






Lithium aluminium hydride in ether solution is 
postulated to exist largely as ionic aggregates of 
strongly solvated lithium ions and aluminohydride anions 
(AlH^ ). Most reduction reactions involve the displace­
ment of a strongly electronegative atom (oxygen, nitrogen 
or halogen) and the addition of a hydrogen atom to the 
electron deficient centre, usually a carbon atom.
Hydrogen is transferred from the reactive species, the 
aluminohydride ion, as a hydride ion in a molecular 
nucleophilic displacement type mechanism. The steric 
course of the reduction is governed by a combination
of steric interference, torsional strain and electro-
143-145static effects in the transition state
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Theoretically, the reduction of the oxime (117) 
with LAH was expected to yield both Of- and g-amine. 
However, experimentally it gave exclusively the 
g-amine (126). The approach of metal hydride to one 
side of the oxime function is clearly hindered by the 
iminoethane bridge between the carbon atoms and C^.
The product (126) formed is by addition of hydride ion 
from the less hindered of-side viz g-isomer.
H-AIH3 i \

















A possible mechanism for the reduction of oxime 
is outlined in Scheme 5. The first step is the reaction 
of the oxime with LAH to give intermediate (128), which
94.
is followed by LAH attack on the nitrogen-oxygen bond
145as illustrated in Scheme 5 . The corresponding
reaction of aluminium hydride, a reagent which we did
not investigate, involves the addition of AlH^ to the
carbon-nitrogen double bond^*^. This electrophilic
reducing agent (AlH^) has been utilized for the reduction
of oximes and is reported to give the least réarranger 
144ment products
In contrasty the reduction of oxime (117) by a nickel- 
aluminium alloy in alkaline solution gave predominately 
8aramino-6,7-benzomorphan (127). Raney alloy was added 
to a stirred solution of oxime in ethanol and 2N-aqueous 
sodium hydroxide (1:1). No external cooling was necessary 
and stirring was continued for 6 hours. The resultant 
amine was isolated by extraction of the mixture with 
dichloromethane. The action of sodium hydroxide on a 
nickel-aluminium provides a source of hydrogen ijn situ 
permitting direct hydrogenation. This procedure involved, 
at least in part, a catalytic hydrogenation in which 
the hydrogen liberated is adsorbed on the surface of 
the newly formed Raney-nickel.
The 8oramino-6,7-benzomorphan (127) was purified 
as the oxalate salt from ethanol. In contrast to the 
g-isomer (126), attempts to prepare a pure crystalline 
hydrochloride salt of of-amine (127) failed due to the 
hygroscopic nature. Although a single isomer was 
isolated, a trace of the g-isomer (127) was apparent 
in the PMR spectrum of/crude reaction product.
95.
Oxalate salts Wave been regarded as more toxic 
than corresponding hydrochlorides, however, Mazzocchi 
et recently obtained toxicity data (mice hot plate)
for the hydrochloride and oxalate salts of several 
^-norbenzomorphans(129) and found that, if anything, 
oxalates are less toxic than corresponding hydro­
chloride salts.
The base from a recrystallized salt of the amino 
isomer (127) exhibited a proton ^ to the amino group witk 
PMR absorption at 4.0 ppm as a singlet with JHgp,H^^l-2Hz. 
The dihedral angle between the Cg^-proton (Hg^) and the
proton (H^) is 80° and according to the Karplus 
142relationship ^^^Id be expected to be in the,






Absorption peaks at 3425 cm ^, 3350 cm ^, 1603 cm"^ 
and 760 cm in the infra-red spectrum of the #-amine 
(127) confirmed the presence of a primary amino group. 
Mass spectral data gave a molecular ion at M/Z 216 
corresponding to a molecular formula of 4^ 20^ 2 ’
96.
The mass spectra of the epimeric pairs of the amino-
6,7-benzomorphan were indistinguishable; the base
+ CHpeak in each spectrum being at M/Z 70. ĥ c = C - N ^
H H
The mechanism of catalytic hydrogenation is 
complex and remains controversial. Hydrogenation 
of the oxime proceeds stepwise via the hydroxylamine 
or imine. Imines are only rarely isolated as products. 
Hydrogenation of the oxime is considered to be similar 
to that of ojY\. olefin and the following Scheme 6 has 
been proposed in terms of the Horiuti-Polanyi mecha­
nism^











/ C-NH+2H ^0 0 0
\ (/ C=N-OH ^C-N0H+2H / 0 0 —  \ - N O H  / H  k
\ Ç-NOH+H 
^ H  H 0
-H,0 \
->■ ^Ç-NH2
0 = catalyst active site.
Scheme 6
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The usual assumption in predicb-i m g  the stereo­
chemical outcome of catalytic hydrogenation is that 
the substrate will adsorb on the catalyst in such
a way as to minimize steric interaction between
148-150substrate and catalyst . The adsorption is
thought to be followed by addition of hydrogen to 
the side of the molecule adsorbed on the catalyst^ 
This scheme does not account for the stereochemistry 
of the isolated or-amine (127). Hydrogenation of the 
oxime gives the product arising from addition of 
hydrogen from the more hindered side, and not as 




C A T A L Y S T  
Figure 33
A satisfactory mechanism must explain the observed 
amine formed. It is reasonable to assume that the 
oxime group will be adsorbed preferentially so as 
to minimize the steric interaction between the surface 
and the remainder of the molecule. The hydrogen then 
could be considered to add from the side of molecule 
opposite to the catalyst, as proposed by Rideal,
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resulting in the formation of the oc-isomer^ ̂ ^Fig. 33).
151According to Rideal only the substrate is
chemisorbed on the catalyst and that hydrogen
emanates from the reaction medium. Hydrogenation
proceeds with addition of hydrogen from the side
of the molecule opposite to the catalyst. Farina 
1 52et al have obtained stereochemical evidence which 
lends support to the Rideal mechanism.
Alternatively, this result may be interpreted
in terms of an interaction between the ring nitrogen
atom and the catalyst surface. It is possible that
the amino nitrogen may form a dative bond with the
1 53catalyst surface thus producing an anchor effect
which will favour the addition of hydrogen from the
hindered g-face of the molecule. In general, compounds
with an unshared pair of electrons on nitrogen are
more readily hydrogenated in acidic rather than in
basic solution. This has been ascribed to the ability
of the unshared nitrogen electrons to bind with the
active surface of the catalyst thus poisoning it.
The amino nitrogen has been demonstrated to be capable
of catalyst poisoning only when it has an unshared
1 54pair of electrons
It is interesting to note that the reduction of
the azabicyclodecanone (130), was reported to take
place in a markedly different manner with respect to
155stereochemical relations . In summary, catalytic 
hydrogenation yielded predominantly orisomer (131a),
99
a result which could be attributed to the approach 
of the molecule to catalyst surface from the less 
hindered g-side. Reduction with aluminium hydride, 
on the other hand, gave mainly the g-isomers due to 




a. ĉ , R^= OH
b. g_, R^= OH
Similarly the stereochemistry of reduction of 
9-OXO-6,7-benzomorphan (Figure 14;52) is known to be 
dependent on whether or not a free pair of electrons
95-99is available on nitrogen . Catalytic hydrogenation
or hydride reduction of the free base (52) affords 
the 90^01 isomer (53), whereas the 9g-ol (54) is
derived from the quaternary salt of (52) under similar
conditions. These results may be attributed to prior 
complexation of the amine function with the catalyst 
surface or to the assistance of hydride transfer by 
the direct participation of the amine function. The 
lone pair is not available in the quaternary salt 
where nitrogen carries a full positive charge.
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In an effort to assess the extent to which the 
anchor effect influences the stereochemistry of 
hydrogenation, reduction of the oxime (117) was 
carried out in an acidic media. As acid cannot be 
used in reductions over Raney nickel,platinum oxide 
was employed.
The platinuonn-catalyzed hydrogenation of oxime 
(117) in hydrochloric acid-ethanol at low pressure 
(3 atm.) and at room temperature gave, as a result of 
addition from the more hindered side, exclusively 
the ^-amino isomer (127). The presence of acid in the 
reaction system apparently had no influence on product 
stereochemistry. This suggests that the role of the 
amine nitrogen in directing the course of the reduction 
is of minor importance and that the product determining 
step is hydrogen transfer to the substrate and not 
adsorption of the substrate on the catalyst. However, 
any explanation of these stereochemical results must 
take into account the influence which solvent and 
catalyst can exert upon different modes of adsorption 
of the oxime group onto active sites of the catalyst.
In contrast, Shio-tani and Mitsuhashi^^^, report the 
opposite stereochemical result of an oxime reduction.
The oxime of 2-methyl-8-oxo-6,7-benzomorphan (Figure 21 ; 
72) gave only 8g-acetamide (82) when reduced with 
platinum oxide in either acetic acid or acetic acid- 
sulphuric acid. However, the oxime of 2,5-dimethyl- 
9-0X0-6,7-benzomorphan (Figure 16 ; 60) was found tc
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give the 9o^acetamide (62) when reduced in acetic acid- 
sulphuric acid and the g-isoroer (63) when reduced in 
acetic acid alone.
3.1.1 The reduction of 2,5,9-trimethyl-8-oxo-6,7- 
benzomorphan oxime (120) with nickel-aluminium alloy 
in sodium hydroxide-ethanol or with platinum oxide 
in hydrochloric acid-ethanol, as described for 2,5- 
dimethyl-8-oxo-6 ,7-benzomorphan oxime (117), proceeded 
selectively to give the 8w-amino-2 ,5,9-trimethyl-6 ,7- 
benzomorphan (Figure 34 ; 132). The stereochemistry of
the amine was determined from the PMR chemical shift
,-fche,
and coupling constant ofyCg proton. The proton 
signal was observed as singlet at 3.95 ppm in CDCl^ 
solution. The vicinal coupling constant (1-2Hz) between 
protons on the Cg-C^ unit correspond by the Karplus 
relationship to a dihedral angle of 80°, which is 
consistent with that derived from the examination of 
Dreiding models, thus establishing the 8ot amino 
stereochemistry.
Infra-red absorption bands indicating a primary
amino group occur at 3350 cm , 1603 cm and 765 cm
1 3The structure of 132 was supported further by C NMR, 
PMR and mass spectral data. The stereochemistry is 
consistent with that anticipated from the catalytic 
hydrogenation of the oxime (117) of 2 ,5-dimethyl-8-oxo-
6 ,7-benzomorphan.
It is of interest to note that catalytic reduction 
of the 2 ,5,9-trimethyl-8-methylene-6 ,7-benzomorphan 
(Figure 20; 83) with Pd-C has been reported to yield
102
as a result of attack from the more hindered side,
8 5the Bermethylbenzomorphan (84). In contrast, the N- 
demethylated 8-oxo-6 ,7-benzomorphan (Figure 20, 85) 
hydrogenation under similar conditions gave the 
corresponding 8g-hydroxybenzomorphan (86), which
could be attributed to approach of the molecule to 




















In contrast to the single 8g-amino isomer obtained 
from LAH reduction of oxime 117, the corresponding 
reduction of 2 ,5,9-trimethyl-8-oxo-6,7-benzomorphan 
oxime (Figure 34 j 120) afforded the mixture of 8oc- 
and 8g-amino isomers (132 & 133). ^H and ^ N M R
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data obtained for the product indicated a mixture of 
8^  and g-amine in a 40:60 ratio. Attempts to isolate 
pure g-amine (133) by fractional crystallization of 
the hydrochloride, hydrobromide and oxalate salts 
from various solvent mixtures (ethanol-ether, acetone, 
propan-2-ol etc.) was to no avail.
The isomeric amines (132 & 133) are readily 
distinguished by their PMR spectra. Protons on ,
C q , Cg-methyl and N-methyl are all influenced by the 
orientation of the amino substituent. The proton
signal of the ^-amine (132) was observed as singlet 
at 3.95 ppm with JHgp,H^— 1-2 Hz. The signal for the 
Cg^ proton of the g-amine (133) appeared as a doublet 
at 4.02 ppm with JHg^,H^— 6 Hz. The Cg methyl doublet 
in the «-amine (132) at 0.94 ppm was at slightly 
lower field relative to that seen in the g-amine (0.84 
ppm; 133). Differences between «- and g-amines were 
seen also in the shifts of the N-methyl and proton 
signals. In the ot-amine the singlet due to N-CHg 
appeared at 2.45 ppm, compared with 2.64 ppm for the 
g  - amine (133). The proton signal of the «-amine 
(132) appeared at 2.90 ppm a?om apparent doublet (J-4 Hz ; 
1-2 Hz), whereas in the g-amine the corresponding 
signal appeared as doublet of doublet centred at 
2.70 ppm (J=6 Hz; 4 Hz).
The mass spectral fragmentation pattern of both 
805- and 8g-amino isomers (132 & 133) exhibited a 
molecular ion peak at M/Z 230, loss of an amino group
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gave a radical ion peak at M/Z 213. The remaining 
fragmentation patterns were identical, with base peaks 
at M/Z 84.
The stereochemistry of LAH reduction may be 
explained in terms of the steric hindrance caused by 
the presence of a methyl function at position 9 of
the
120. The approach of metal hydride to/g-side of the 
oxime is hindered by the iminoethano bridge between 
the carbon atoms and C^. Inspection of molecular 
models of the oxime (120) demonstrates that a 9o<”niethyl 
group will hinder the approach of metal hydride from 
the more accessible «-side of the molecule, consequently 
there will be little difference in hindrance to attack 
by the reducing agent from either side of the molecule, 
thus leading to the formation of almost equal amounts 
of the epimeric amines.
Interestingly, addition of phenyl- or methyl-
lithium to 2,5,9-trimethyl-8-oxo-6 ,7-benzomorphan
has been reported to afford 8 ,8-difunctionalized
benzomorphans (Figure 20; 80 and 82) as result of
8 5substituent addition from the «-face only
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3.2 Reactions of 8-amino-6,7-benzomorphans.
3.2.1 Preparation of isomeric 8-acetamido-, 8- 
cyclopropionamido- and 8-phenylacetamido 
derivatives of 2 ,5-dimethyl-6,7-benzomorphan.
A primary amino function may be rendered non 
basic by simple conversion to an amide. Such a change 
could influence attack at an opiate receptor signifi­
cantly. Good yields of amides (134-138) were obtained 
by following established procedures for acylation of 
amines; reacting them with the required acid chloride 
in the presence of base. Thus the acetamido derivatives 
(134,135) were prepared by the addition of the acetyl 
chloride in a controlled manner to the amine dissolved 
in dichloromethane in the presence of a mole of tri- 
ethylamine. Attempts at acétylation with acetic 








The phenylacetamido derivatives (136 & 137) were 
obtained by the reaction of 8of- and 8g^amino-6,7- 
benzomorphan,respectively,with phenylacetyl chloride 
in the presence of potassium carbonate in aqueous 
methanol. The use of aqueous methanol is effective 
because of its slow rate of solvolysis of phenyl­
acetyl chloride. However, the addition of neat reagent 
(phenylacetyl chloride) to the amines was necessary to 
achieve acylation. When the reaction was attempted 
with phenylacetyl chloride in methanol as solvent, 
starting material was recovered fully. Thus no 
reaction had occurred, suggesting that the acid 
chloride may have undergone alcoholysis. Many workers, 
including Walters^®, have reported the preparation 






Reaction of the 8oramine (127) with cyclopropane- 
carbonyl chloride in the presence of triethylamine 
afforded 8ercyclopropionamido-2,5-dimethyl-6,7-benzo­
morphan (138) as expected. The infra-red spectrum of 
the product (138) exhibited typical amide absorption 
bands at 3295 cm  ̂ ( ^NH) and 1670 cm  ̂ ( ^ C O ) . The
PMR spectrum showed the Cg proton doublet at 5.2 ppm
with —  10-12 Hz. Deuter/um oxide exchange of
the amide proton at 6.6 ppm reduced the doublet to 
singlet. The four protons of the cyclopropyl group
.“Hie.
appeared in the 0.6-1.1 ppm region./w)lecular ion 
observed at M/Z 284 in/mass spectrum also supported 
this structure for the product (138).
However, treatment of 8^*-amine (126) with
cyclopropanecarbonyl chloride in the presence of
base did not give the expected 8g-cyclopropionamide
but gave 8g-dicyclopropionamide derivative (140).
The infra-red spectrum of the product (140) showed
_  1two strong carbonyl absorption bands at 1660 cm 
- 1and 1712 cm and the absence of NH stretching bands.
The PMR spectrum revealed a complex pattern for
the protons of the cyclopropyl group in the 0.8-1.4 ppm
region, which intergrated for 8H. The Cg benz^lic
proton signal was observed as doublet at 6.08 ppm
instead of expected doublet of doublets at 5.2 ppm.
The Cg proton was at lower field than its normal
position due to the inductive effect of an extra acyl 
/Tht
group . / wass spectral fragmentation pattern showed a
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molecular ion at M/Z 352, loss of a cyclopropyl 
carbonyl unit gave a monoacylated radical ion at M/Z 
283. The remaining fragmentation pattern was similar 
to that of the Bor^yclopropionamide (138). The base 
peak in both compounds occurred at M/Z 70 and was











Mechanisms for acylation reactions have been 
proposed by several workersT^G'159,160,161^ ^ feasible 
mechanism for the acylation reaction in the presence 
of triethylamine is shown in Scheme 7.
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Reversible addition of the carbonyl to both amines is 
followed by reaction of the adduct with triethylamine. 
The weaker basic amine is acylated and the stronger 
is converted to a salt. The role of triethylamine is 
not only as a base to remove hydrogen chloride, but 
because of its ability to form a reactive intermediate 
with acid chloride it may possibly function as a 
nucleophilic catalyst. The tertiary nitrogen in the 
aminobenzomorphans also act as a hydrogen chloride 
acceptor.
Et.N: RC-Cl R — C — Cl ^=±: R — C — NEt.Cl
ON 0 1 o ^
II - J  » ^  II +R - C — Cl R - C - ^ l  R — C — NH^R^Cl
NH^R^
O O
II IIR — C — NH^R-jCl+NEt^ ----» R^NHC-R+NEt^Cl
Scheme 7
Acylation of a primary amine usually affords no 
diacyl derivative. A second acyl group is not easily 
introduced due to the electron drain effect of the 
initial acyl function at the nitrogen atom. The 
formation of diacylamines is possible under vigorous
110
conditions or in the presence of suitable basic 
c a t a l y s t ^ P y r i d i n e  is resistant to C-acylation 








R* — C —  NH,
(141)
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The addition products of pyridine and acid chlor­
ides, the alkanoylpyridinium chlorides (Figure 35; 141), 
are able to acylate amides whereas the free acid 
chloride is ineffective. It has been suggested that 
this is due perhaps to a greater positivity of the 
acyl carbon on pyridine N in anhydrous organic 
solvents owing to a possible resonance contribution 
of the structure B, or possibly to an induction
111.
caused by electronegative oxygen and positively charged 
nitrogen atom in A, which renders the acyl carbon 
relatively more positive and thus capable of reacting 
more readily with a weakly negative nitrogen centre 
of the almost neutral amide^^^.
The relative ease of the diacyl amine (140) forma­
tion suggests that the requirements for acylation 
of the amide are already present in the aminobenzo- 
morphan (126) itself, ie. the additional basic 
tertiary nitrogen. A possible mechanism for the 
diacylation of the 8g-amine (126) is outlined in 
Figure 36. The formation of an unstable amine 
adduct (142) and the intermediate (143) are thought 
to be involved in intra-molecular acylation. Clearly, 
such a transition state (143) cannot exist with 8oc- 
cyclopropionamide or 8g-phenylacetamide, and thus 















It was possible to prepare the desired 8^-cyclo- 
propionamido-6,7-benzomorphan (139) in poor yields 
by adding exactly one equivalent acid chloride very 
slowly with rapid stirring to a cooled solution of 
the 8g-amine (126) in dichloromethane. Although the 
amide (139) was not obtained analytically pure, its 
structure was supported by IR and NMR data.
In initial attempts an excess of the acid 
chloride was employed as it was thought the 
formation of salt type adduct (144) by reaction of
j-tha.
acid chloride with/tertiary nitrogen of benzomorphan 
would effectively reduce the amount of acid chloride.
RCOCl + R^N --- > RgN^^CORjCl"
(144)
The infra-red spectrum of the amides (134-139) 
displayed characteristic amide carbonyl and NH 
stretching bands cet 1640-1650 cm  ̂ and ̂  3295 cm"^ 
respectively. PMR spectra of the oc- and g-acetamide
j tkt,
exhibited a singlet for/acetyl methyl at 1.9 and 
2.14 ppm respectively. The methylene singlet of 
phenylacetyl group in ^  and g-phenylacetylamide 
(136 & 137) appeared at 3.5 and 3.69 ppm respectively. 
The amide proton resonated as a broad doublet at 
—  5.9 ppm for the amides (134,136,138) and in the 
7.0-7.2 ppm region for the g-isomers (135,137,139).
In the «-isomers (134,136,138) Cg proton appeared 
as a doublet at 5.2 ppm with JHg,NH cc 10-12 Hz which
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on D^O exchange of the amide proton was reduced to
singlet. The signal for the Cg proton of the g-amides
(135,137,139) appeared as a doublet of doublet
centred at 5.18 ppm with JHg,H^— 6 Hz and JHgNH —
10-12 Hz. D^O exchange of the amide proton change!the
multiplicity of this absorption to the expected 
13doublet. C NMR and mass spectral data were consistent 
with the assigned structures of the amides.
3.2.2 Preparation of 8oc-acetamido-, 8orcyclopropion- 
cimido- and 8of-phenylacetamido-2,5,9-trimethyl-
6,7-benzomorphan.
The title compounds (145-147) were prepared from 
8or-amino-2,5,9-trimethyl-6,7-benzomorphan (132) 
essentially in the same manner as that described 
earlier (section 3.2.1) for 8-amino-2,5-dimethyl-
6,7-benzomorphans, namely by reacting the amine with 
the required acid chloride in the presence of base.
These amides (145-147) were identified by their 
NMR, mass and infra-red spectra. Infra-red spectra 
exhibited typical amide stretching absorption bands 
between 3400-3200 cm  ̂ and 1630-1670 cm ^. The Cg 
proton signal of the amides (145-147) was observed 
as a doublet at 5.24 ppm with JHq^,NH=10-12 Hz which 
on deuteration with D^O collapses to the singlet. The 
signal for the amide proton was found as a doublet in 
the 5.5-5.8 ppm region. Other PMR absorptions for the
114






145. R = COCHg
146. R = CO
147. R = CO-CH%
Most narcotic analgesics bear a nitrogen 
functionality of sufficient basicity to be predominant^ 
protonated at physiological pH, and the electron : 
density about nitrogen is important in opiate activity. 
The introduction of an acyl substituent ony8-amino 
group would change the electron density distribution 
throughout the molecule and affect the pKa of the 
drug. It may also distort the molecule and the 
distortions could cause a change in the fit between 
opiate and its receptor. Further, the acyl group may 
directly participate in binding to the receptor and 
thus may further define receptor requirements.
The importance of nitrogen basicity for pharma­
cological activity has been studied and it is reported
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162that reduced basicity results in a loss of activity 
This loss was ascribed to inefficient transport to 
relevant receptor sites of compounds resistant to 
protonation at the physiological pH. It is surprising 
that the N-carboxamide^^ (148) which lacks a basic 




3.2.3 Synthesis of 8oc- and 8g-(ethylamino)-2,5-
dimethyl-6 f 7~benzomorphan, 8oe- and 8p-(cyclo- 
propylmethylamino)-2,5-dimethyl-6,7-benzo- 
morphan, and 8ot~ and 8p-(phenylethylamino)-
2,5-dimethyl-6,7-benzomorphan.
The nitrogen substituents of the opiates play 
a complex role in effecting pharmacological responses, 
which range from potent agonism through mixed agonism- 
antagonism to pure potent antagonism^' Other 
structural modifications such as an axial C^^-OH group 
on the morphine, Cg-OH group in the benzomorphans and 
long chain tertiary carbinol substituents on in the
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oripavine series, effect the relative analgesic 
agonist-antagonist potencies for any given N-substi- 
tuent.
In the 6,7-benzomorphan series (eg. metazocine;
14) replacement of N-methyl by saturated alkyl moieties 
from ethyl to butyl causes reduction or loss of analge­
sic activity and concurrent gain in narcotic antagonist 
81 93activity ' . When a five or six carbon side chain
is introduced to form N-pentyl or N-hexyl compounds, 
the potent analgesia associated with the parent N- 
methyl compound is restored. An N-phenylethyl group 
gives a particularly enhanced analgesic activity, and 
phenazocine (17; R = CHgCHgPh) is in clinical use.
A similar replacement of N-methyl by N-phenylethyl 
groupr in non-phenolic benzomorphans may actually 
reduce activity.
A similar variation of analgesic potency is 
observed in homologous normorphine and morphinan 
series. Maximal analgesic potency is noted with 
N-methyl and N-pentyl, and a loss of analgesic 
potency occurs with N-ethyl and N-butyl derivatives^'^.
6,7-Benzomorphans unsubstituted on the nitrogen 
atom generally do not display antagonist behaviour in 
primates but have been shown to have a weak antagonist 
component by their action on the guinea pig ileum^^^. 
Conversion to partial antagonists has been effected 
by replacing N-methyl with allyl, propyl and cyclo- 
propylmethyl. Many mixed agonist /antagonists prepared 
in this manner are potent and some find clinical
117.
applications. Pentazocine (17; R = CHg-CH = CMeg), an 
analgesic with antagonist activity, is firmly 
established as an analgesic of value in a reasonably 
wide range of pain situations^' .
However, antagonist activity is not limited to
the above substituents or to tertiary amines; more
recently even N-methyl compounds have been reported
31 35to possess antagonist properties ' . It is suggested
that the only required structural feature for the 
production of antagonist activity is a certain degree 
of nitrogen crowding, above or below which agonist 
activity prevails. An alkyl substituent at a centre 
remote from the nitrogen is also known to change 
drastically the ratio of agonist to antagonist
activity12'164_
Reductive alkamination of 8-oxobenzomorphan (100) 
presents a synthetic route to 8-alkylamino-6,7- 
benzomorphahi required for pharmacological evaluation 
in this project. Work by Borch et demonstrated
the feasibility of employing the cyanohydridoborate 
anion (BH^CN ) as a selective reducing agent in a 
reductive amination. Reaction of 2,5-dimethy1-8-oxo-
6.7-benzomorphan (100) with anhydrous methylamine in
(■fche.HCl-methanol in/presence of sodium cyanohydridoborate 
furnished the corresponding 8p-methylamino-6,7-benzo- 
morphan (149) in poor yields, with the 8p-hydroxy -
6.7-benzomorphan (150) as a by-product. Separation of 
these products was achieved by passing the crude
118
material through a silica column, and they were 
characterised by their infra-red and NMR spectra.
Attempts to minimise undesired side reactions 
and to improve yields of the amine (149) by modifying 
reaction conditions 'yy)et with only limited success. 
Usually the reduction of ketones to alcohols with 
sodium cyanohydridoborate is much slower than 
reductive amination. Reduction of the imminium 
group ( ^C=NHR) with cyanohydridoborate anion is 








The stereochemistry of these compounds was 
assigned from their NMR spectra. The benzylic Cg 
proton in the PMR spectrum of 8g;-me thy lamine appears 
as a doublet (J=6 Hz) at 3.65 ppm. The coupling 
constant is identical of that of the 8p-amino-6,7- 
benzomorphan (126) and by analogy indicates that 
it is the 8g-isomer. The signals of the 8-NH proton 
and 8-N-methyl protons were seen as singlets at 
2.05 ppm and 2.60 ppm respectively. In the spectrum
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of 8^-hydroxybenzomorphan (150) the Cg proton 
appearsma downfield position at 4.70 ppm also as a 
doublet (J=6 Hz). The hydroxyl proton resonates as 
a broad singlet centred at 3.90 ppm.
Interestingly, the addition of hydrogen to both 
the imine and carbonyl groups is stereospecific; 
hydride transfer from sodium cyanohydridoborate 
occurring from the more accessible oe-face leading 
to the 8g-0H and NH-R isomers. This is consistent 
also with known methyl- and phenyl lithium additions 
of 8-oxobenzomorphans ( 79) or LAH reduction of oxime 
(117) which gave exclusively 8g-isomer (126). Catalytic 
reduction of oxime (117) gave the 8«-aminobenzomorphan 
(127), and hydrogenation of the imine under similar 
conditions may be expected to yield 8a-alkylamino-
6,7-benzomorphan.
The first steps in a reductive alkamination 
involve substitution! on nitrogen by the activated 
carbonyl compound to form a carbinolamine (151) which 
is followed by dehydration to give imine (Scheme 8;152) 
Imine formation is an equlibrium process and the 
removal of water produced is advantageous. The 
rate-determining step of the reaction is pH dependent. 
In neutral solution the rate-determining step is the 
dehydration of the carbinolamine intermediate. However, 
at low pH the dehydration becomes fast, and as result 
of the decrease in concentration of free amine, the 
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Scheme 8
Reductive alkylation is dependent to a large 
extent upon the reactivity of the carbonyl function.
It is well known that conjugated carbonyl compounds 
are less reactive with usual carbonyl reagents than 
are the saturated analogues, presumably because of 
the greater electron density at the carbonyl carbon 
in the former case. Hindered ketones eg. pinacolone 
are reported not to react with amine^^^. Examination 
of a Dreiding model of 8-oxobenzomorphan (100) showed 
the 8 position to be sterically hindered. Since the 
8 - O X O - 6 ,7-benzomorphan (100) itself is reduced with 
BHgCN , the poor yield of 8p-methylamino-6,7-benzomorphan 
may be due to difficulty of the imine formation step.
It was clear that difficulty of imine formation with 
bulky amines (eg. phenylethylamine) will be even more
121
acute, and consequently this synthetic route was aban-
93 168doned in favour of the usual procedures '
A fairly representative group of 8-alkylamino-
2,5-dimethyl-6,7-benzomorphans (153-158) was prepared 
following the established literature procedure for 
the acylation of amine and the subsequent reduction 
of the resultant amide. Thus 8^- and 8«-amino-6,7- 
benzomorphans (126 & 127) were treated with the 
appropiate acid chloride in the presence of a 
hydrogen acceptor to afford amides, as described in 
section 3.2.1. The intermediate amides were reduced 
with LAH in ether or tetrahydrofuran (THF) to yield 
the corresponding N-alkylated amino-6,7-benzomorphans 
(153-158) in fair to poor yields. That reduction had 
occurred was indicated by loss of a PMR signal for 
the amide proton and the absence of a carbonyl 
stretching band in the infra-red.
Lithium aluminium hydride reduction of 8-phenyl- 
acetamido derivatives (136,137) required drastic 
conditions which included heating in refluxing THF 
solution (65^) and a longer reaction time. These 
reaction conditions resulted in poor yields o| the, 
8-phenylethylamino-6,7-benzomorphans. It would appear 
that harsh conditions lead to decomposition of the 
amide and/or the amine formed. The slow rate of 
reaction observed for the phenylacetamido derivatives 
and especially for the g-isomer (158) was attributed 
to more stringent steric requirements and to the low 


















Reduction of 8g-dicyclopropionamido-6,7-benzo- 
morphan (140) with LAH did not give 8g-dicyclopropyl- 
methylamine but gave 8g-cyclopropylmethylamino-6,7- 
benzomorphan (156) identified by IR, PMR, NMR and
mass spectral data.
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The relative instability of amides to both basic 
and acidic conditions is well known. LAH is a very 
strong base in addition to being a powerful reducing 
agent. It may be that reduction of the diacylated 
compound (140) with basic LAH results in cleavage of 
one acyl fragment to form the 8g-cyclopropionamide 
(139), which is subsequently reduced to the 8jB-cyclo- 
propylmethylamino-6,7-benzomorphan (156). A possible 
mechanism would involve the nucleophilic displacement 
of the acyl fragment by aluminohydride.
NMR, infra-red and mass spectra were consistent 
with the assigned structures of the alkylamines. Infra­
red spectra exhibited a typical amine stretching 
absorption band at 3340 cm . PMR spectra of 8oc- and 
Üg^ethylamino derivatives (153 & 154) exhibited a 
triplet at:=1.2 ppm (J= 8-10 Hz) for the methyl of 
ethylamino group. Chemical shifts for these protons 
are influenced by the stereochemistry of the amino 
substituent; the signals of the ^-isomer (154) was 
at lower field relative to the oc-isomer (153). The 
spectra of 8«- and 8p-cyclopropylmethylamino-6,7- 
benzomorphans (155 & 156) exhibited a broad multiplet 
in the 0-1.2 ppm region for the cyclopropyl group.
A doublet at 2.68 ppm (Jc4 Hz) was assigned to the 
methylene ^  to the cyclopropyl group. The signal of 
the methylenes »  and g to the 2° amino nitrogen 
in the 8-phenylethylamino derivatives (157 & 158) 
were present as complex multiplet attz3.0 ppm.
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The stereochemical assignments for the isomeric 
amines has been deduced previously on the basis of 
NMR evidence (section 3.2). The Cg proton signal of 
the (X- and p-alkylamines were observed as a singlet o-'acL 
as CL doublet (Jrc6 Hz) a t ^ 3 . 8  ppm, respectively. The
coupling constants betweenjCg proton andyC^ proton 
were identical to those of their precursors.
3.2.4 Synthesis of 8a— ethylamino-2,5,9-trimethyl-
6,7-benzomorphan and Soc-cyclopropylmethyl- 
amino-2,5,9~trimethyl-6,7-benzomorphan.
The target compounds (159 & 160) were synthesized 
from 8aramino-2,5,9-trimethyl-6,7-benzomorphan by 
direct acylation of the amine followed by LAH reduction 
of the amide intermediate, in the same manner as that 









PMRfIR and mass spectral data for B&rethylamino- 
and 8#-cyclopropylmethylamino-6,7-benzomorphan were 
consistent with the structure assignments ( see 




SOME POTENTIAL LONG ACTING NARCOTIC ANALGESICS 
AND A NEW BRIDGED AMINOBENZOMORPHAN
127.
CHAPTER FOUR
Some potential long acting narcotic analgesic 
and a new bridged aminobenzomorphan.
4.0 Introduction.
The structure-activity effects of altering the 
substituents at several positions of 6,7-benzomorphan 
have been intensively studied, and these modifications 
have produced many compounds possessing interesting 
profiles with respect to narcotic antagonist and 
analgesic activity^'^^ 35,61,85 106^ The benzomorphan
skeleton itself has been modified and its effect on
7 8activity determined . Analgesic activity has been
found in a number of homologues of 6,7-benzomorphan
7 8including the B-nor, C-nor and C-homobenzomorphan ' 
106,140,169^ May and his c o - w o r k e r s ^ h a v e  prepared
6.7-benzomorphan derivatives where the methano bridge
of benzomorphan has been omitted in order to determine
the role of the methano bridge for analgesic activity.
171Cavestri and Mokotoff have synthesized 2-azabicyclo 
(3.3.1) nonene derivatives, in order to test the neces­
sity of the aromatic ring for analgesic activity; no
significant activity was found for these compounds.
172Recently, Montzka and Matiskella have introduced a 
methylene group to connect the 3 and 8 positions of a
6.7-benzomorphan (161). This modification gave compounds 
with interesting narcotic antagonist and analgesic 
activity. Synthesis of other bridged benzomorphan deri­
vatives and their analgesic properties have been
reported106,173,174_
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In order to investigate further the structure- 
activity relationships in/benzomorphan series, we 
decided to introduce another bridging group 
connecting the ring nitrogen and the benzylic 
carbon, Cg, via an amino group (165). This modification 
creates a rigid bridged tetracyclic ring system and 
should affect the steric environment about the ring 
nitrogen and above the aromatic ring. Several workers 
have proposed that this steric environment may be 







In this chapter, the syntheses of 8-chloroacet- 
amido-6,7-benzomorphans (162 & 163), 8-chloroacetamido- 
methyl-6,7-benzomorphan (164) and 2,8-bridged benzo­
morphan derivative (165) are described. 8-Chloro- 
acetamido derivatives are potential long acting 
narcotic analgesics, which may be employed as receptor 
labels.
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These compounds were prepared by reacting/amine 
with chloroacetyl chloride in presence of triethyl- 
amine, under an atmosphere of nitrogen. Chloroacetyl 
chloride and triethylamine were freshly distilled 
prior to use. The neat acid chloride was added very 
slowly with a microlitre syringe to a cold stirred 
solution of amine in a dry acetone.
Treatment of 8£-amine (126) with.chloroace­
tyl chloride gave a mixture which proved difficult 
to separate. PMR and IR spectra of the product 
indicated that the mixture contained the desired 
8g^chloroacetamide (162). Thin layer chromatographic 
investigation on the product obtained after work-up 
demonstrated a mixture of two major components of 
very different Rf value. The more mobile component 
was identified as 8g-chloroacetamide by comparison 
with an authentic sample. Several attempts to 
isolate a pure sample of 8g-chloroacetamide (162) by 
crystallization of the hydrochloride or oxalate salt 
from various solvent mixtures, gave only a small 
amount of impure material. It was observed that 
excessive heating during crystallization or work up 
led rather easily to some further changes of the 
8^-chloroacetamide compound, partly into a polar 
substance (TLC) of unknown character. Attempted 
isolation of 8g-chloroacetamide by column
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chromatography on silica gel eluting with varying 
strengths of methanol/dichloromethane (1-10%) caused 
a chemical alteration in the nature of the reactive 
chloroacetamide.
It became clear subsequently that the desired 
8g-chloroacetamide derivative formed, underwent 
further reaction in presence of triethylamine in 
course of isolation to yield the intractable product.
To circumvent this reaction,/triethylamine hydro­
chloride precipitate was removed by filtration from 
the reaction mixture prior to work up. Work up gave 
a crude 8g-chloroacetamide which was converted into 
the hydrochloride salt and crystallized from ethanol- 
ether to give pure 162.
8c£-Chloroacetamido-6,7-benzomorphan (163) and 
the 8*rchloroacetamidomethyl-6,7-benzomorphan (164) 
were prepared by a similar procedure from the 
corresponding 8 ^ amino-6,7-benzomorphan (115) and 
8o[^aminomethy 1-6 ,7-benzomorphan (184; see chapter 5), 
respectively. It was necessary to separate the triethyl- 
amine hydrochloride prior to work up, to ensure that 
only the chloroacetamido derivatives were isolated. 
8o^Chloroacetamid>o-6,7-benzomorphan (163) was purified 
as its base by crystallisation from ethyl acetate.
The 8o^chloroacetamidomethyl derivative (164) was 
converted mto its hydrochloride salt and crystallized 
from ethanol-ether.
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The spectral characteristics of both chloroacet- 
amides were in accordance with the assigned structures. 
The infra-red spectra has a carbonyl absorption at 
1670 cm  ̂ and an amide NH band at 3330 cm ^. The PMR 
spectra of the 8 ^  and 8g-chloroacetamido derivatives 
(162 & 163) show several interesting features. The
y the.
amide proton o ^  ̂ -isomer is at lower field (8.0 ppm)
compared with that of o^isomer (6.6 ppm) presumably
due to the anisatropic effect of the aromatic ring.
i-bhê
The methylene singlet of/chloroacetamide group in 
^-isomer (162) also appeared at slightly lower field 
(4.18 ppm) compared to that o^oc-isomer (4.0 ppm).
The Cg proton in oç~ and g-isomers (162 & 163) 
appeared as a doublet (Jc6 Hz) and doublet of 
doublets (Jz6 Hz; 10-12 Hz) respectively. These 
couplings are consistent with the Cg proton in the 
e-isomer (163) being coupled to the N-H and the g- 
isomer (162) being coupled to both the N-H and the 
proton at C ^ .
The assigned structure of 8archloroacetamido- 
methyl-6,7-benzomorphan (164) is also consistent 
with its PMR data. The signal for the amide proton 
was found as a broad singlet centred at 6.8 ppm.
The methylene signal of the chloroacetyl function 
was observed os asinglet at 4.07 ppm. The complex 
multiplet in the 3.0-3.80 ppm region (3H) was assigned 















Mass spectra of both the and g-chloroacetamido 
derivatives (162 & 163) exhibited a molecular ion at 
M/Z 292 and fragmentation patterns gave eight major 
fragment ions above M/Z 50 with intensity greater 
than 20% of that of the base peak. The fragmentation 
patterns of both isomers were very similar. The 
possible fragmentation of/molecular ion are illustra­
ted in Figure 37. Interpretation of the spectra is 
based upon the assumption that upon electron impact 
one electron is removed either from the nitrogen 
atom (166) or from the aromatic nucleus (169). Some 
localization of charge on nitrogen in the molecular 
ion is expected to be followed by preferential 
cleavage of the carbon^-carbong bond g to the nitrogen 
to form radical ion (Figure 37; 167), and the frag­
mentations to all the major peaks can be ascribed 
to that ion. Ions at M/Z 277 and 256 are due to loss 





















Figure 37 H3C M/Z 57
M/Z 199 arises from the loss of the chloroacetyl unit 
and C^ methyl. The less intense ion (35% abundance) at 
M/Z 184 is derived from the loss of the C^-methyl and 
the chloroacetylamido group. At M/Z 110 (90% abundance) 
is a line attributed to the dihydropyridine ion (168). 
This ion may be formed by migration of a hydrogen 
from Cg to Cg, followed by the loss of the aromatic 
moiety as depicted in Figure 37. A retro Diels-Alder 
fragmentation of M^ gave rise to the base peak at M/Z 
70. Ions of M/Z 59 (C3HgN) and 57 (C3H^N) are presum­
ably due to nitrogen containing bridge with or without
134
additional hydrogen atoms^^^ ^ ( F i g u r e  37).
The mass spectral fragmentation pattern of 8oe~ 
(chloroacetamidomethyl)-6,7-benzomorphan showed 
at M/Z 306. Loss of the Cg-methyl from M^ afforded 
a radical ion at M/Z 291 (85% abundance). The
dihydropyridine ion at M/Z 110 constitutes the base 
peak.




R — C H ^  Cl  ► R - C H 2— NHR^+HCl
R^NH2
Scheme 9
Acyl halides are in general more reactive towards 
1^ and 2^ amines than are alkyl halides and the 
products of the reaction of 8-amino-6,7-benzomorphan 
with chloroacetyl chloride are as expected. The 
reaction of an acyl halide with a nucleophile differs 
from the SN2 reaction of an alkyl halide in that the 
former gives a discrete intermediate, whereas the 
latter does not (Scheme 9). The factors governing the 
ease of reaction are essentially the same in the two 
types of reaction. The acyl halide reaction involves 
the formation of a tetrahedral intermediate by addition
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of amine across the carbonyl double bond in an 
equilibrium step which then decomposer to products.
Compounds 162-164 possess a reactive halide 
and thus have the potential for alkylating nucleo­
philic centres such as SH,SMe,NH2#0H on or near 
receptors with which the principal pharmacophores 
interact. They may therefore be useful as long 
acting pharmacological probes, also revealing 
valuable information on the location of nucleophilic 
sites on the receptor.
Radiolabelled opiates are used extensively as 
pharmacological tools for the investigation of narcotic 
receptors but their reversible interactions sets a 
limit to their value. Groups capable of forming 
covalent bonds at opiate receptor sites, therefore, 
would prove to be of considerable value as pharmacolo­
gical probes. The strict structural features necessary 
to maintain opiate activity markedly limit the location 
and size of potential reactive substituents. There have 
been a number of a t t e m p t s ^ t o  develop such agents^ 
and the first two receptor site-directed alkylating 
agents ( 170a & 170b, R2=N(CH2CH2CI)2 ) that are 
effective both in vitro and in vivo have been reported 
only recently. These ligands are derivatives of g- 
naltrexamine (170a, R2=NH2) and g-oxymorphamine
(170b, R2=NH2) in which an alkylating function is
185attached to the 6g-amino group . Subsequently, 
different, long acting hydrazone derivatives (Figure 
38,171) of naloxone, oxymorphone and naltrexone have
136
187also been described . The mechanism through which 
these hydrazone derivatives produce their long acting 
effect in vivo and in vitro is not known. There is 
no conclusive evidence of covalent linkage between 






a. R^= CH2“C“C 2H^ Naloxazone R =-CH2“CH=CH2
b. R^= CH^ Oxymorphazone R = CH^
Naltrexazone R = -CH2-C-C2H2
Figure 38
Portoghese e_t ^  have recently used the derivatives 
of oxymorphone and naltrexone containing an. i(kv»tical 
alkylating moiety (172a & 172b) and have provided
186support for the multiple modality receptor concept 
Only the N-cyclopropyl compound (172b) was found to 
bind covalently to opiate receptors although both 
compounds form a receptor complex. This suggests that 
either they interact differently with identical 
receptors or that they associate with different recep­
tors. This assumes that the N-methyl compound (172a)
137
interacts with receptors in an identical fashion 
but differs in its mode of interaction from the 





NHCO  = CHCOOMe
a. R = Me
b. R = -CHg-c-CgH^
4.2 Synthesis of a novel tetracyclic benzomorphan;
2,8-bridged benzomorphan derivative (165).
The synthesis of 16 5 was achieved by the 
sequence of reactions outlined in Figure 39. The 
additional ring was constructed via the intermediate 
8p-chloroacetamido-6,7-benzomorphan (162).
Examination of Dreiding molecular models of 
8 ^  and 8^-chloroacetamido derivatives (162 & 163) 
indicated that the g-isomer is favourably disposed 
sterically for cyclization by intramolecular displace­
ment of halogen by the tertiary ring nitrogen, ie. 
intramolecular quaternisation. Attempted ring 
closure of 162 by heating in boiling acetone was
138
unsuccessful and starting material was recovered.
When the ring closure was attempted in higher boiling 
diisopropyl ketone, decomposition of the 8g-chloro- 
acetamido-6,7-benzomorphan resulted. Failure may have 



















The mechanism of amines reaction with.alkyl halides
and particularly of quaternisation reactions have been
189 188reviewed by Streitwieser and Ingold . Reactions
generally proceed via an uncomplicated SN^ process,
and usually follow a second-order rate law. The rate
depends upon the nucleophilicity of the amine, the
139.
solvent polarity and the leaving characteristics of 
the displaced group.
The most notable structural features of the 
SN^ mechanism is derived from the fact that it 
requires a new bond to be formed at the same time 
as the old bond is broken in order to facilitate 
the latter process. The accommodation of five 
groups around carbon, two of them being partly 
bonded to the centre by four electrons, results in 
<x highly congested transition state. A consequence 
of the crowded nature of the transition state is 
that the introduction of bulky groups at the reaction 
centre is generally associated with a decrease in 
reaction rate. Bimolecular nucleophilic substitution 
is usually accomplished by inversion of configura- 
tion^^O.
Theoretically, one would expect that electron- 
release towards the centre at which replacement was 
occurring could increase the ease of separation of 
the departing halogen, but could at the same time 
reduce the ease of attack by the nucleophile. In 
fact the transition states for SN^ substitution are 
often very closely balanced in their response to polar 
effects; the rate can be enhanced by either electron- 
releasing or electron-withdrawing conjugative effects, 
and it can be diminished by either electron-withdrawing 
or electron-releasing inductive effects. The failure 
of the 8g-chloroacetamido-6,7-benzomorphan (162) to 
form a bridged quaternary compound (165) may be
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explained in terms of a polar effect. The amide group, 
which is powerful Y  electron-withdrawing by the inductive 
effect but a weaicly electron-releasing by the conjuga­
tive effect, will reduce the ease of separation of the 
departing halogen.
The ease of replacement of halogen amongst the
alkyl halides parallels the relative leaving group
ability of the anion in an SN2 reaction, ie. Cl .
High polarisability makes I both good entering and
a good leaving group, and it is thus often used as
a catalyst to promote an otherwise slow displacement
reaction. The presence of iodide ion generates the
1 90organic iodide ^  situ by halogen exchange
The conversion of p-chloroacetamidobenzomorphan 
(162) into tKe corresponding iodoacetamido derivative 
(173) may be accomplished by treatment with sodium 
iodide. A cold solution of 8^-chloroacetamide (162) 
in acetone added to a stirred ice-cold solution of 
sodium iodide in acetone resulted in the precipitation 
of sodium chloride which was removed and evaporation 
of the solvent gave the required 2,8-bridged quaternary 
compound (165). No intermediate 8g-iodoacetamide (173) 
was isolated; intramolecular nucleophilic displacement 
of halogen ion by the ring nitrogen and ring closure 
had occured situ.
This type of intramolecular attack of the nitrogen
atom on the halogenated carbon to form 3-,4-,5-,6- and
7 membered cyclic ammonium ions has been studied by 
191Solomon . The ease of formation of products as it
141
192relates to ring-size was reviewed by Bennett . The 
stereochemical course of these intramolecular reac­
tions has been found to be similar to that of an 
intermolecular SN^ process, and proceeds with 
formal inversion of configuration of the centre of 
displacement. In the intramolecular process, only 
one molecule is formally involved in the rate- 
determining step, and thus it could be described as 
an SN^ process.
The interchange of one halogen with another 
is an equilibrium process but iodides may be prepared 
from chlorides because of the fact that sodium iodide 
is soluble in acetone whereas sodium chloride is not. 
When an alkyl chloride is treated with a solution 
of sodium iodide in acetone, the equilibrium is 
shifted by the precipitation of sodium chloride.
RCl + Nal ^ = ± r  RI + NaCl
An examination of the NMR and mass spectra of 
8j5-chloroacetamide (162) and the quaternary compound 
(165) indicated that the desired cyclisation had 
occurred. The proton, protons and N-Me protons 
of 162 occurring at 3.1, 2.0 and 2.6 ppm respectively 
are shifted to lowerfield in the cyclic quaternary 
salt (165) due to the strong deshielding effect of 
the cationic nitrogen. The signal of the proton 
was seen as a multiplet at 4.33 ppm, N-Me protons as 
a singlet (3H) at 3.32 ppm and protons as a
142
quartet (Jc5 Hz) centred at 4.30 ppm. The benzylic 
proton and C ^2 protons of the quaternary compound 
appeared as a multiplet centred at 5.18 ppm and a 
singlet at 3.41 ppm respectively. The chemical 
shifts of these protons would be expected to be 
similar to the corresponding signals in the 8p- 
chloroacetamido compound (162).
Many significant differences were observed 
between the mass spectra of 8p-chloroacetamide (162) 
and the cyclic quaternary salt (165). The mass 
spectrum of 165 gave a weak M^ at M/Z 256, correspon­
ding to a molecular formula 5^22^2^* The peak at 
M/Z 24 2 due to loss of methyl «ocLi de. is strong (60%) 
relative to that in the 8p-chloroacetamido derivative 
(162). The base peak in the spectrum of 165 is at 
M/Z 59 as oppose to M/Z 70 in the spectrum of 162.
The stereochemistry of 8p-chloroacetamide (162) 
is confirmed by its successful cyclization to the 
bridged compound 165. All attempts to cyclize the 
8û^chloroacetamide (163) under similar conditions 
proved to be impossible as anticipated on steric 
grounds. The reaction of Sarchloroacetamide (163) 
with sodium iodide in acetone yielded a very polar 
product which could not be extracted into ether or 
dichloromethane. A mass spectrum of the product 
crystallized from ethanol gave M^ at M/Z 305. The PMR 
spectrum was complex and the compound could not be 
identified.
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Several different hypotheses have been advanced 
to explain the roles of N-substituents in conferring
agonist or antagonist activity on opiate analgesics.
55Snyder et ^  have proposed a receptor model to 
explain agonist and antagonist properties on the 
orientation of N-substituents, and suggested that the 
N-substituent was confined to axial positions in the 
active conformation of antagonists. However, both 
axially and equatorially confined substituents have 
been identified in a number of homobenzomorphan 
agonists^^'^^. Kolb^^ has postulated that the primary 
action on a receptor by an opiate is through its lone 
pair and that the direction of the N-non bonding 
electron lobe is responsible for agonist or antagonist 
activity. The novel tetracyclic benzomorphan derivative 
(165) has a rigid conformation and fixed N-substituent 
and thus could be useful tool for the analysis of the 
opiate and its receptor interaction.
While this work was in progress, Shiotani and 
Kometani^^^ described the synthesis of two 2,8-bridged 
benzomorphan derivatives (Figure 22; 92. & 95). These 
compounds displayed no significant analgesic activity.
173Earlier, Kimura e_t a_l had reported that 
cyclization of the tetrahydro compound (174) with a 
Lewis acid gave a novel tetracyclic benzomorphan (175). 
Such compounds were found to be potent analgesics 
with low toxicity in mice. Recently, Nozaki et al^ 
investigating chemical features necessary for opiate
144.
agonist and antagonist activity synthesised the 
tetracyclic benzomorphans 176 and 177. No experimental 
details or biological data were reported.




















The search for effective centrally acting analgesic 
agents devoid of dependence and respiratory depressant 
properties has led to an unusually rich selection of 
compounds upon which to base proposals for the struc­
tural requirements for opiate activity. Most structures 
exhibiting such activity fit a common pattern in posses­
sing a basic nitrogen atom separated by a two carbon 
unit from an aromatic ring3'G"11'21'50,53,54,61,64^
Analgesic activity has been demonstrated in simple
amines like p-phenylethylamines and their rigid analogues,
19 32-aminoindane derivatives . Some 2-aminoindanes (
eg. 178) exhibited high activity and proved effective
up to the clinical evaluation stage, but the occurrence
of stimulation and hypertension precluded their use
in therapy^^^. N ,N-Dimethyl-1,2-diphenylethylamine (179)
has been reported to be approximately half as active
194as morphine as an analgesic , and analgesic activity
has been reported in tetralins and bridged tetralins
195(eg. 180) possessing an excocyclic amino function 
The possible structural similarity of met^-enkephalin 
to morphine by virtue of their phenylethylamine unit 
has been pointed out ; however it has been recently 
demonstrated that the conformation of this moiety in 
receptor-bound conformation of the peptide is different







The presence of a ^-phenylethylamine moiety is an
essential feature of molecules with high analgesic
activity. It has been postulated that this moiety is
important for stereochemically controlled binding of
138analgesics at the receptor site . The importance of 
the nitrogen to phenyl distance in structure-analgesic 
activity relationships has been described recently^
If it is assumed that a cationic nitrogen binds with 
an anionic site of opiate receptors and that the 
aromatic ring interacts with the lipophilic site to 
form a drug-receptor complex then the binding affinity 
would be greatly affected by the nitrogen to phenyl 
distance within the analgesics. It is noteworthy that 
structural modification of 6,7-benzomorphans made by
148.
changing the position of nitrogen decreases the anal- 
137-140gesic activity
Several compounds possessing interesting analgesic 
and narcotic antagonist activity have evolved from 
studies on the 6,7-benzomorphan .nucleus. Early work 
on structure-activity relationships have been addressed 
mainly to the effect of oxygen, hydroxyl, alkyl or aryl 
substituents in various positions of the molecule and 
variation of ,N-substituents^'^^'^^.
In order to investigate further structure-activity 
relationships in the 6,7-benzomorphan series we decided 
to explore the effect of introducing an aminomethyl 
group at the 8 position. This modification creates a 
second phenylethylamine moiety and may effect binding 
at an analgesic receptor. In this chapter the synthesis 
of 8-aminomethyl-6,7-benzomorphan (184) and its deriva­
tives is described.
5. 1 The oxidative décyanation of 8eç-cyano-2 , 5-dimethyl- 
6,7-benzomorphan; an attempt to prepare 8p-cyano- 
2,5-dimethyl-6,7-benzomorphan.
Cyano groups rank highly in their utility among
the many synthetically useful functional groups of
128organic chemistry . Their reactivity makes possible
transformation into carbon-oxygen functional groups
at both ends of the oxidation scale. Nitriles are
129readily obtained by a variety of reactions . The 
dehydration of carboxylic acid amides or aldoximes 
are among general methods of formation of nitriles.
149.
Other general methods of ■sy'n-fcHe.sij involve the substitu­
tion of a suitable leaving group in an organic compound
128 129by a cyano group ' . The conversion of ketones
into nitriles by base induced decomposition of methyl
dialkylcyanodiazone carboxylate has been reported by 
198Ziegler et al (as shown below).
Cat-HOAc 









19 9Recently, Biere £t al reported the synthesis 
of nitriles from hydrocarbons but no experimental data 
were given. The procedure involved the condensation 
of the aromatic compound possessing an activated 
methylene group with dialkyl formamide acetal or aminal 
esters to give the enamines which on treatment with 











The 8oj-cyano-2, 5-dimethyl-6,7-benzomorphan (121) 
was prepared by reaction of ketone (100) with a freshly 
prepared solution of tosylmethyl isocyanide (TOSMIC) 
in dimethyl sulphoxide containing potassium tertiary 
butoxide as described earlier (Section 2.4). The conver­
sion was completely stereoselectivèly giving 8oc-cyano- 
benzomorphan (121) as the only epimer detected. This 
fact may be explained in terms of attack of the large 
TOSMIC anion occurring only at the more accessible ssr 
face of the 6,7-benzomorphan. The g-face of the 6,7- 
benzomorphan is sterically hindered due mainly to the 
iminoethane bridge between carbons C^ and C^.
The use of TOSMIC in the conversion of ketones
131to nitriles is reported to afford both isomers ;
for example 2-norboranone gave both endo- and exo-2-
cyanonorborane. The ratio of isomers was suggested to
reflect thermodynamic control through the carbanion 
131intermediate (Section 2.4, Scheme 4,9). In view of 
this the exclusive formation of Soj-isomer (121) was 
rather surprising. The absence of the g-isomer may be 
explained in terms of the steric hindrance caused by 
the long length of the cyano group in the 8g-cyano- 
benzomorphan.
The stereochemistry of the 8arcyanobenzomorphan 
(121) was determined from the NMR chemical shift 
and coupling constant between C^-Cg protons. The cyano 
group is a strong electron withdrawing substituent, and 
its inductive effect is considerably enhanced by
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resonance interactions. The benzylic proton, ,P
appears as a singlet at 4.16 ppm with J=2 Hz. The
proton of thejx-cyano compound appears at lowfield 
(3.42 ppm) relative to that of amine (127, 2.90 ppm). 
This paramagnetic shift may be due to C^-H being held 
in the deshielding zone of the anisotropic nitrile.
It is reasonable to assume that the other methods 
will also give 8arcyanobenzomorphan (121) instead of 
Jg^-cyano derivative (182). In this study an attempt 
was made to prepare 182 by racémisation of the fit
nitrile (121) via a carbanion. The benzylic proton of 
the 121 is relatively acidic and may be removed by 
treatment with base. The acidity of the Cg-H bond is 
attributed to a combination of the inductive electron- 
withdrawing ability of the cyano substituent and the 
ability of this substituent to delocalize the negative 
charge remaining when the proton has been removed. The 
aryl ring provides considerable additional stabiliza­
tion for the carbanion. Nitrile (eg. 121) can be conver­
ted to its anion by treatment either with relatively 
strong bases in aprotic solvent or with anhydrous 
alcoholic solution of a metal alkoxide^^^.
In theory, a carbanion could assume a pyramidal
3 2Sp or a planar Sp configuration depending on substi­
tuents. The pyramidal configuration with the unshared 
electron pair occupying the fourth Sp^ orbital would 
resemble the amine with which they are isoelectronic. 
Since carbanion (181) has substituents capable of 
conjugative delocalization of the electron pair it will
152.
2probably be planar Sp , in order to allow the maximum
jtha
orbital overlap of the p orbital with those of^substi- 
201tuents . Proton from the solvent may now come to 
either face of the flat carbanion producing both oe- 
and g^-nitriles.
The Sgrnitrile (121) was treated with potassium- 
t-butoxide in dry tertiary butanol^^^ at room temperature 
for a few hours and the resulting mixture was poured 
into ice water and extracted with dichloromethane.
This surprisingly afforded 8-oxobenzomorphan (100), 
identified by IR, NMR, RF and GLPC peak enhancement 
with an authentic sample.
MeCN
Me












In order to investigate the mechanism of this 
transformation the reaction was repeated with sodium 
hydride in an aprotic solvent (THF) and this too 
yielded 8-oxo compound (100). However, when the 
reaction was carried out in a strict nitrogen 
atmosphere and progress was monitored by TLC, no 
8-oxobenzomorphan (100) was formed for up to four 
hours. This clearly suggested the role played by 
atmospheric oxygen.
The formation of 8-oxo-6,7-benzomorphan may 
be explained by the mechanism in Scheme 10. This 
mechanism involves the formation of a nitrile anion 
(181) by the tertiary-butoxy anion, which is followed 
by the attack of oxygen on the carbanion to afford 
Of-cyanohydroperoxide (183). Subsequent exposure of 

















The potassium-t-butoxide in tertiary butanol has
been used for autoxidation of ketones, aldehydes and 
202 203esters ' . The reactions were assumed to proceed
via «-hydroperoxide intermediates although these
intermediates were not isolated. However oç-hydroperoxides
of 20-keto steroids have recently been isolated from
the product of autoxidation in potassium-t-butoxide 
204and _t-butanol
The procedure described above allows direct 
introduction of an oxygen substituent to a nitrile. 
Previous procedures which accomplish this transforma­
tion effect the oxidation of nitriles to cyanohydrin 
via intermediate oc-iodo^^^ and oe-thiophenoxynitriles^^^ 
and subsequent conversion of the cyanohydrins to 
ketones. Few procedures allow for the direct introduction
of an oxygen substituent onto a nitrile. However,
207Watt and Selikson have recently reported general 
oxidative décyanation for the synthesis of ketones 
from secondary nitriles.
5 . 2 Preparation of 8of-aminomethyl-2 , 5-dimethyl-6 , 7- 
benzomorphan. Reduction of 8#rcyano-6,7- 
benzomorphan (121).
The lithium aluminium hydride reduction of 121 
was complicated in that it tended to undergo other 
reactions and gave a low yield of the required 8of- 
aminomethyl-2,5-dimethyl-6,7-benzomorphan (184). 
Thin layer chromatography of the resulting crude
155
product indicated a mixture consisting of five or six
components, two of which gave ninhydrin positive
reactions..The infra-red spectrum had a distinct
— 1carbonyl absorption band at 1675cm , and amine bands
-1 -1at 3480cm and at 1603cm . PMR examination indicated
the presence of two major components in 1:1 ratios. 
These components were identified as 8 ^ aminomethyl- 
benzomorphan (184) and 8or-aldehyde (185). Attempted 
column chromatographic separation was unsuccessful 







The reducing action of LAH has been extensively
143-145.209-212 studied . The mechanism of lithium
aluminium hydride reduction involves the transfer of
hydride ion from the aluminohydride ion to the nitrile
carbon atom, and it is known to proceed via oy\ aldimine
stage (Scheme 11). There is considerable evidence
indicating that each successive hydrogen ion transfer
takes place more slowly than the one b e f o r e ^ O n
hydrolysis the aluminium atom is replaced by hydrogen
1 56
supplied by the hydrolysing agent.
a






In the usual reaction conditions intermediate
imines are further reduced to amines, but they have
been hydrolysed ijn situ to the aldehyde. The selective
hydride reduction to the imine stage has been achieved
by variation of the reaction conditions, the indirect
synthesis and variation of the reducing hydride 
213reagent . Hindered nitrile groups for example in 
angular positions in steroids are reduced by LAH 
either to aldehydes of to the corresponding amines
214depending on the stereochemistry of the nitrile group
LAH reduction usually reduces a nitrile to the 
primary amine probably due to the ease of the reduction 
of the intermediate imine. In this work it appears that 
reduction proceeds as far as the imine but is halted
157.
.the.
perhaps partly because of formation of/insoluble 
lithium aluminium salt of the imine. This salt is 
then hydrolysed to the aldehyde in the course of 
isolation. The steric and electronic characteristics 
of the phenyl group will stabilize the initial imine 
derivative permitting the isolation of the aldehyde. 
The inductive influence of the neighbouring carbon 
centres and the large steric requirement of the 8of- 
cyanobenzomorphan (121) will also reduce the rate of 
nucleophilic attack at the imine carbon. Thus the 
first hydride addition will be favoured over the 
second, resulting in aldehyde formation. It has been 
suggested that lithium ion may become coordinated to 
the nitrogen atom of the imine intermediate and this 
would further assist in protecting the double bond 
from a second hydride addition.
Many nitriles are reduced satisfactory with LAH 
to primary amines and the reaction has been adequately 
r e v i e w e d ^ ^ . The effective reducing agent is 
AlH^ which acts as powerful hydride ion donor; such 
being the case it also preferentially abstracts proton 
from compounds with active hydrogen. Thus, LAH is
a very strong base in addition of being a powerful 
reducing agent. Hydrogen evolution representing attack 
by the nucleophilic reagent on the active hydrogen of 
the QC position has been described in a number of 
reactions with LAH^^^'^^^. This is believed to be 
responsible for the decreased yields encountered in
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this reduction of 8 ^ c y a n o - 6 ,7-benzomorphan. The 
carbanion (186) formed may undergo further abnormal 
changes involving possibly rearrangements, ring 
opening and condensation leading to a multicomponent 
mixture.
R H -, - R -
^ C - C = N  4 C-C=NA1H- + rearrangement etc
Rl '
(186)
It has been reported that the undesirable side
reaction in the reduction of nitriles can be diminished
by carrying out the reaction in tetrahydrofuran instead
of in ether, by employing lithium trimethoxyalumino- 
213hydride or by the use of a mixture of aluminium
209chloride and LAH . The general effect of the addition
of aluminium chloride is to lower the reducing power
of LAH and in consequence to produce reagents which
are more specific for particular reactions. The use
of this 'acidic hydride' is known to reduce nitriles
containing active hydrogen completely in good yields
209without liberation of hydrogen
Reduction of Scrcyanobenzomorphan (121) with the 
mixture of aluminium chloride and LAH gave a multi- 
component mixture containing some of the desired amine. 
PMR and IR spectra were similar to those of the product 
obtained from LAH reduction and the reaction was not 
examined further.
Nitriles have been reduced to amines by sodium and
1 59
alcohol but extensive reductive cleavage of the 
cyano group occurs especially with phenyl or benzyl 
derivatives . It was predicted that the presence 
of active o< hydrogen in the nitrile (121) would 
further complicate the reaction, as was evident from 
the earlier attempt at racemization under related 
conditions. Consequently no attempt was made to 
employ this method.
The catalytic hydrogenation of nitriles to primary
amines has been the subject of many investigations
because good yields are frequently difficult to obtain.
The difficulty apparently arises because the reduction
proceeds stepwise through the imine, some of which
condenses with the primary amine already formed and
218 219ultimately leads to secondary amines ' (Scheme 12). 
Further, the imine products are catalyst poisons as 
they bind with active surface via the unshared nitrogen 
electron.
^2 ^2 R-C==N __:______ ». R-CH==NH  R-CH.-NH.
catalyst
R-CHg-NHg + R-CH==NH ^ T RCHgNH-CH -R
NHg
^2R-CH_N==CH-R + NH. —  ------ ^ R-CH.NH-CH.-R
catalyst  ̂ ^
Scheme 12
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128Rosenmund has suggested carrying out the
hydrogenation in acetic anhydride solvent in order
to trap the primary amines as their acetamides. The
yield of primary amine is also increased at the
expense of side products by using as solvent ethanol
128containing some hydrochloric acid .' Hydrogenation
in acetic anhydride in the presence of Raney nickel
catalyst and a basic cocatalyst is reported to be
very effective for reduction of a variety of nitriles
2 20to primary amines . Recently Freitelder has described
the catalytic hydrogenation of a nitrile under mild
221conditions with rhodium catalyst
We prepared the 8-aminomethylbenzomorphan (184) 
in good yields by the hydrogenation of the nitrile 
(121) in ethanol containing a small amount of chloro­
form over a platinum oxide catalyst. The reduction was 
carried out at room temperature and low pressure (3 atm) 
The hydrogenolysis of the chloroform produces small 
quantities of hydrogen chloride which combines immedi­
ately with the amine as it forms by reduction and leads
217directly to the corresponding amine hydrochloride 
An important advantage of the procedure used in this 
work lies in the fact that it provides a method for 
the preparation of amine hydrochloride from 8orcyano- 
benzomorphan which might be unstable in acidic,mediae 
It also eliminates the acylation and the subsequent 
required hydrolysis is avoided.
Thin layer chromatographic analysis (silica gel)
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of the reduced product (184) showed only one spot.
That the reduction had occurred was indicated by 
absence of a nitrile band and the presence of a 
typical N-H stretching band at 3380cm ^. The ^H NMR 
spectrum of the free base of the reduced product was 
consistent with the expected amine (184). The spectrum 
showed the benzylic proton signal at 3.16 ppm, a 
triplet for/C. proton at 2.87 ppm (J^4Hz) and a 
multiplet centred at 2.85 ppm for^C^^ protons. It is 
noteworthy that the C^ proton of Boc-cyano derivative 
(121) which appeared at 3.4 2 ppm was shifted to 2.87ppm 
in the amine (184).
5. 3 Some reactions of 8o<-aminomethyl-6 , 7-benzomorphan.
5.3.1 Preparation of 8 - (acetoamidomethyl)-, 8-(cyclo- 
propionamidomethyl)- and 8 - (phenylacetamido- 
methyl)-2,5-dimethyl-6,7-benzomorphan.
The synthesis of the title compounds from
Boc-aminomethylbenzomorphan is outlined in Figure 40.
Target amides (187, 188 & .189) were prepared essentially
in the same manner as that described for 8-amino-2,5-
dimethyl-6,7-benzomorphan (Section 3.2.1), namely by
I the,
reacting the amine with/required acid chloride in the 
presence of a base. Thus, the reaction of the amine 
(184) with acetyl chloride and cyclopropanecarbonyl chlo­
ride in dichloromethane containing a mole of triethyl- 
amine gave acetamidomethyl- and cyclopropionamidomethyl
162
derivatives (187 & 189) respectively, as amorphous 
products. These compounds were crystallized from 













The acylation of the amine (184) with phenylacetyl 
chloride was carried out in aqueous methanol in the 
presence of potassium carbonate. The use of aqueous 
methanol is effective because the rate of solvolysis 
of phenylacetyl chloride is extremely slow in aqueous
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methanol. Organic solvents such as ether or THF with 
a tertiary amine such as triethylamine have been used 
for this reaction. The phenylacetamidomethyl deriva­
tive (189) was purified by crystallisation from 
ethylacetate-petroleum ether.
These amides (187, 188 & 189) were identified 
by their NMR and infra-red spectra. Infra-red spectra
displayed characteristic ^C=0 and N-H stretching
-1 -1bands at 1640cm and 3360cm respectively. The N-H
^ 1bending deformations of amides occurred at 1550cm
The ^C=0 stretching band in 8ar(chloroacetamido-
methyl)-6,7-benzomorphan (164) was displayed at a
** 1higher frequency (1670cm ) due to the presence of
the electron withdrawing chlorine atom (Section 3.2).
The 100-MHz proton NMR of amides (187, 188 & 189) 
revealed complex but well resolved splitting patterns 
for the Cg» and protons, and this was similar in all
three derivatives. The protons appeared as a
double doublet instead of the expected doublet after 
D^O exchange of the amide proton. This is possibly 
due to these protons being adjacent to an asymmetric 
carbon centre (Cg). A molecule in which a methylene 
group is adjacent to an asymmetric carbon centre
233forms an AB-system, a phenomenon which is well known.
The N-methyl protons in phenylacetamide (189) is 
shifted 0.18 ppm (2.18 ppm) compared with its normal 
position (2.36 ppm) in acetamido- and cyclopropionamido 
derivatives (187 & 188). Several other differences in
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the NMR of the amides were noted. The C^ bridgehead 
proton, N-H proton and,Cg benzylic and protons
of 187 and 188 all absorb at lower field (3.0, 6.36 
and 3.04-3.8 ppm respectively) compared with that 
of 189 (2.7, 6.0 and 2.90-3.5 ppm respectively).
The diamagnetic shift of these protons is probably 
due to the anisotropic effect of the aromatic ring 
of/phenylacetamido derivative. The aromatic region 
of 8oraminomethylbenzomorphan (184) was observed as 
an apparent singlet whereas this region appears as 
a broad multiplet in the amides (187, 188 & 189) 
possibly due to the anisotropic effect of the carbonyl 
group on aromatic protons.
A number of basic amides, for example fentanyl
(190), dextromoramide (191), are active analgesics and
are in common clinical use. Fentanyl is a highly
potent narcotic analgesic agent which is widely used
39 222in anesthesiology ' . Iji vitro receptor binding
studies have shown that this derivative .-possesses
a very high opiate receptor affinity with values
223in the subnanomolar range. Lobbezzo et ^  have
.the.reported that/replacement of the amide nitrogen in 
fentanyl by a carbon atom causes a complete loss of 
analgesic activity. It is generally acknowledged that 
oxygen function at in 4-phenylpipiridine serves as on 
additional binding site for drug receptor association.
The rationale behind preparation of the amides 
(187, 188 & 189) described here was because of their 
rigidity which may provide valuable information
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regarding the location of binding site(s), and may 
furnish compounds of therapeutic importance.
In this connection it should be noted that a ser­
ies of N-(aminoacid)— substituted benzomorphan deriva­
tives (eg. 192) hcxve been reported, recently, to possess
224opiate receptor binding activity . The basic centre 
I-the.
of/^benzomorphan in these compounds was neutralized by
-the
an amide linkage and the new basic centre of/amino acid 
function was considerably displaced in space relative 
to the original basic centre. Based on classical 
structure-activity relationships in the 6,7-benzomorphans 
such a displacement produces a considerable reduction 













5.3.2 Synthesis of 8or(ethylaminomethyl)-,8or (cyclo- 
propylmethylaminomethyl ) - and 8of-(phenylethyl- 
aminomethy1)-2,5-dimethy1-6,7-benzomorphan.
Nitrogen substituents on opiates play a central
role in determining the relative agonist/antagonist
potencies of these molecules. For example, a narcotic
antagonist component of action may be incorporated
into a morphine derived narcotic agent by replacement
of the N-methyl group with moieties such as allyl,
cycloalkyl methyl^^'^^ or tetrahydrofur/’aryl^^ The
potency raising effect of the N-phenylethyl group is
well established. The phenylethyl normetazocine (17,
R=CH2CH2Ph) is about 10 X more potent than metazocine
13 8(17, R=CH^) and has high affinity for the receptor
With the desired amine (184) at hand, the various
8oc-alkylaminomethyl-6,7-benzomorphans (Figure 41) were
prepared for pharmacological evaluation. These compounds
(193, 194 & 195) were synthesized followm^4M established
literature procedure for the acylation of the amine
and the subsequent reduction of the amide^^'^^^. Thus,
amine (184) was treated with the appropiate acid
chloride in the presence of a hydrogen acceptor to
afford amides and the intermediate amides were reduced
with LAH in ether or THF. The reduction proceeded
smoothly to yield/corresponding N-alkylated 8ar(amino-
methyl)-6,7-benzomorphans(193, 194 & 195) in poor to
good yields. The absence n. PMR signal for the amide
«the,proton and the loss of/ carbonyl stretching band in the
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infra-red spectra indicated that reduction had occurred.
All amine hydrochlorides were prepared by treating 
ether solution of the free amine with ethereal hydro­





(193) R = -CHgCH]
(194) R =
Figure 41 (195) r = -C H 2 C H 2  \ /
The direct alkylation on the nitrogen with alkyl 
2 6halides is inapplicable as the reaction will lead
to mixtures of amines and quaternary ammonium salts.
Alkylation of amines by the carboxylic acid-sodium
227borohydride method of Marchini al is also 
inapplicable as it is likely to be complicated by 
the formation of tertiary amines.
The reduction of amides to amines is believed to
proceed by an initial reduction to a geminal amine
alcohol derivative (196), following by elimination .
219and subsequently reduction of the resulting imine
225(Scheme 13). Newman ejt ^  have presented evidence 
indicating that the reduction of unsubstituted amides
168
with LAH proceeds by the initial dehydration of the 
amide to a nitrile.
LAH
O „ OAIH-







It is suggested that during the reduction of an
amide by LAH, there is a competition between the
cleavage of the carbon-oxygen bonding leading to an
amine and the rupture of the carbon-nitrogen bond
leading to an a l c o h o l ^ ^ . This competition is
markedly influenced by both the steric and electronic
character of the amide group, and the conditions of
14 6reaction as well as by the amount of hydride
The structure of the amines (193, 194 & 195) 
were clear from their spectral properties. IR spectra 
of the free amines exhibited typical N-H stretching 
absorption bands at 3340cm ^. PMR spectrum of the 
Sgrethylaminomethyl derivative (193) in CDCl^ exhibited 
a typical triplet (1.10 ppm, J-^SHz) for the methyl 
of the ethylamino group. The spectrum of Soecyclo- 
propylmethylaminomethyl derivative (194) exhibited
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a broad multiplet in the 0-0.7 ppm region for the 
cyclopropyl group, A multiplet centred at 0.5 ppm 
was assigned to the proton at the tertiary carbon 
atom of this group and a doublet at 2.56 ppm was 
assigned to the methylene to cyclopropyl group.
The methylene located oc and g  to the 2° amino 
function (PhCH^CH^NH) in 195 appeared as a complex 
multiplet in the 2.6-3.00 ppm region. Chemical shifts 
of these protons are, as expected, influenced by the 
inductive effect of the phenyl ring. The vicinal 
couplings between the amine proton (N-rH) and the 
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NMR spectroscopy has been extensively used in
the field of medicinal chemistry both from analytical
and structural aspects. Its great value lies in the
detailed structural information it can provide, not
only that concerning gross features but also fine
228 229points of molecular geometry ' . Such information
is of importance because it may lead to better under­
standing of the way in which molecules interact with 
their receptors.
There have been several reports upon the PMR 
features of benzomorphan and its derivatives^^ 24,33,40 
The original assignment of oç-cis and g-trans 5,9-.
2 2dimethyl-6,7-benzomorphan was based on the PMR data ,
109and was confirmed by x-ray crystallography . The Cg- 
methyl in the ^-isomer is about 0.5 ppm higher field 
than the g-isomer because it lies within the aromatic 
screening zone. It has been suggested that the proximity 
of the nitrogen lone-pair to the 9-Me group in the g- 
isomer may also, in part, be responsible for the 
9-Me shift difference
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A quaternization study of o<- and g-metazocine 
has been investigated by PMR spectroscopy^^' .
It has been proposed that skewboat populations are 
probably high in g-derivatives when protonated
in vivo and that such conformers favorably influence
230 231drug receptor interaction . X-ray analysis of
the -allyl-5,9-dimethy1-6,7-benzomorphan has shown
that ring B has a slightly distorted half chair
conformation and that ring C possess approximately
a chair form with the two methyl groups and the N-
substituent in equatorial positions with respect to
this ring.
The ^H NMR characteristics of a series of 4- and
5-methyl-substituted benzomorphans were determined by
40Parfitt and Walters in their study of the effects 
of steric crowding of nitrogen on analgesic activity. 
The 4-methyl appears strongly shielded at 0.6 ppm in 
contrast to the 3-methyl. This was rationalized by 
noting that when the piperidine ring is in the favour­
able chair conformation and the 4-methyl is equatorial, 
the latter lies in the shielding region of the fused 
benzene ring. It has been pointed out that since the 
3-methyl has a normal field position at ^ 1 . 0  ppm, 
it also must be equatorial.
This chapter presents NMR data for a series of
6,7-benzomorphan derivatives. Although these data are 
of importance for identification and differentiation 
purposes, their great value lies in the evidence they 
provide of the configuration and conformation of the
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various derivatives. The crucial influence of molecular 
geometry upon the activity of benzomorphan derivatives 
is well known, hence it is important that the stereo­
chemistry of novel derivatives of potential activity 
in this respect is established.
6.0.2 Proton chemical shifts.
The proton chemical shift of 8-substituted-
6.7-benzomorphans are shown in Table 11. 2,5-Dimethyl-
6.7-benzomorphan (1,compound numbers 1-39 used through­
out this discussion refer to.the numbers in Table 11) 
is first discussed. The %-benzylie proton of 2 h&s a 
higher PMR chemical shift than the g-proton. This 
difference can be interpreted in terms of differential 
aromatic screening, the g-proton being deshielded
because it lies within the aromatic deshielding zone.
232Yamaguchi et al have attributed the downfield shift 
of the g-proton relative to the o<-proton in dehydro- 
deoxycodeine-D to a shielding by the nitrogen atom.
They claim that the benzylic protons are symmetrically 
disposed with respect to the aromatic nucleus. It 
deserves to be noted that the greater deshielding influ­
ence of the lone pair orbital upon axial than upon
equatorial 3-Me substituents in trans quinolizidlnes
2 28(197) has been demonstrated
A distinctive feature of the PMR spectrum of 
8 - O X O - 6,7-benzomorphan (2) is the lowfield position
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0  Me H
(197)
N __ Me
a-Me downfield by 0.27 ppm 
than e-Me signal.
of the ' aromatic proton (8.03 ppm) and the 
bridgehead proton (3.28 ppm). The lowfield absorption 
indicates the deshielding effect of the carbonyl 
function on neighbouring protons which lie in the 
nodal region of the ^ = 0  bond. All aromatic protons 
in the 8-oxo compound (2) are deshielded in comparison 
to the resonance of the aromatic protons of unsubsti­
tuted 6 f7-benzomorphan. The chemical shift difference 
between the aromatic protons result in a more complex 
aromatic signal than that of the benzomorphan (1).
The ' proton and proton signal for the 
oxime (3) appeared at 8.00 ppm and 4.41 ppm respecti­
vely. The particulary lowfield absorption of the 
proton even in comparison to the 8-oxobenzomorphan 
(2) is apparently due to the anisotropic effect of the
hydroxyl group. The chemical shift of the proton
120 121indicates that it is syn to the hydroxyl group ' '.
The geometry of the magnetic anisotropy associated with 
the oximino group is not known with certainty, although 
there have been several studies on this subject^
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It has been suggested that the main deshielding effect
on the Of hydrogens arises from the proximity of the
hydroxyl group or/and from the proximity of the
unshared pair of electrons on nitrogen. The hydroxyl
y th e
proton resonance of/oxime appears at 11.33 ppm.
The stereochemical assignment of the diastereo- 
isomers (4 & 5) of aminobenzomorphan, obtained by 
reduction of the oxime, were deduced from the NMR 
evidence. The relative configuration of the amine 
was assigned from the vicinal coupling constants 
between^Cg- and protons. The dependence of vicinal 
coupling constants on the dihedral angle was first 
theoretically predicted by Karplus^^^. In the oc-amine
(4) the dihedral angle, measured in Dreiding models, 
between the Cg^ proton and proton is about 90^C 
while in the g-amine (5) the dihedral angle between 
the Cg^ proton and vicinal proton (C^-H) is about 30^C 
(Figure 32). Thus, according to the Karplus Cos^ ̂ / J 
relationship, JMg^H^ would be expected to be larger 
than JHg^H.j . This was observed in the spectra of oc- 
and g-amines. The Cg proton in the g a m i n e  (4) appears 
as a singlet at 4.06 ppm (J=1-2Hz) as opposed to CL 
doublet at 4,00 ppm (J=6Hz) in the g-amino isomer (5). 
The downfield shift of the benzylic proton in the amines 
compared to the unsubstituted benzomorphan is due to 
the inductive effect of the amino group. The proton 
signals in the amines are moved upfield to 2.96 ppm 
with respect to proton at 4.28 ppm in its precur­
sor. This upfield shift is as expected with removal
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of the inductive and anisotropic effect of the oxime 
group.
Close inspection of the NMR spectra of amines 
(4 & 5) revealed other relationships which appeared 
to be consistent with the assigned configuration of 
these diastereoisomers. Models of the 8g-amino-6,7- 
benzomorphan (5), indicate that the amine moiety lies 
close to the C^ * aromatic proton and its resonance 
should be different from other aromatic protons. This 
is confirmed experimently/ the g-C^' proton appeared 
at downfield (7.60 ppm) relative to other aromatic 
protons (7.20 ppm). In the amine (4) the C ^ * proton 
is further removed from the amino group and hence its 
chemical shift is closer to those of the other aryl 
hydrogens. Chemical shift differences among the aromatic 
protons are expected to be more pronounced in the g- 
amino isomer (5) with the result that the g aromatic 
signal was observed to be more complex than that of 
the corresponding amine.
There are other differences. For example the NHg 
singlet in the g-amine appeared at 2.04 ppm compared 
with 2.80 ppm in the amine. The downfield shift of 
N-H protons in the g-isomer may be due to their falling 
within the deshielding zone of the aromatic region.
The other main spectral difference between the oç- and 
g-amines was found in the chemical shift of the C^ proton 
The of-c^ proton resonance is close to that of unsubsti­
tuted benzomorphan but the C^ proton in the g-amine 
appeared at an unusually highfield (0.90 ppm). This
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signal is almost coincident with oç-9-methyl of 5,9- 
dimethyl-6,7-benzomorphan. The piperidine moiety in 
the g-amine is likely to be in a non-chair conformation 
The marked upfield shift of the proton is probably 
caused by this slight difference in molecular geometry 
which could place the proton within the shielding 
zone of the aromatic ring.
The NMR spectrum of the 8or-cyano derivative (22) 
showed a number of general features similar to that 
described for the 8«-amine (4). The chemical shift 
and the coupling constant of the benzylic proton (Cg) 
indicated that the compound was the o<-isomer.
The Cg proton singlet was located at 4.12 ppm, slightly 
downfield from this signal in the y-amine, because of 
the increased inductive effect of the nitrile group.
The bridgehead proton resonance in the «-nitrile (22) 
at 3.44 ppm is considerably downfield (a <T= -0.48 ppm) 
from its position in the spectrum of the «-amine (24) 
(2.96 ppm). This change can be ascribed to the 
anisotropic effect of the cyano group which is in 
proximity to the C.j proton. Triple bonds such as C=N 
have axial symmetry; a circulation is induced in the 
cylindrical shell of TT-electrons by an external magne­
tic field so that a resultant field is developed.
Nuclei along the axis of the triple bond will be 
shielded whereas nuclei in the area above and below 
will be deshielded relative to their normal position. 
The C.̂ proton lies along the side of the triple bond 
and is thus deshielded.
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The amide derivatives (6-13) obtained from 
amines (4,5) are compounds in which basicity of the 
nitrogen is diminished. The general characteristics 
of the amides' PMR spectra were similar to those of 
their precursors (4,5). The proton on the nitrogen 
atom of amides exchanges at slow rate and as a result 
it couples to the benzylic proton. The benzylic and 
the amide protons in «^acetamide (6) appeared as a 
doublet (J '^10 Hz) at 5.20 ppm and 5.90 ppm respecti­
vely. Deuterium oxide (D^O) exchange of the amide 
proton reduces the doublet of the benzylic proton to 
the expected singlet. On the other hand, the g-acet- 
amide (7) benzylic proton appeared as a doublet of 
doublet centred at 5.24 ppm with J%8 and 6 Hz. DgO 
exchange of the amide proton at 7.0 ppm changes the 
multiplicity of the Cg absorption to the expected 
doublet. The difference in chemical shift for amide 
protons in the isomeric acetamidts may be due to the 
anisotropic effect of the phenyl ring in the g-amide 
proton.
The ' aromatic proton in the spectrum of the 
g-acetamide (6) was located at 7.4 ppm, slightly up­
field (A<f= 0.20 ppm) from this pattern in the g-amine 
(5); probably because of the reduced basicity of the 
nitrogen. It is significant that the proton signal 
did not change from its position in the spectrum of 
the g-amine. This clearly suggests that the highfield 
position of this proton is possibly due to shielding 
by the aromatic ring rather than the nitrogen. All other
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proton absorptions of the acetamides (6 & 7) maintain 
their position (+ 0.05 ppm) compared with the amines.
Compounds (8-13 & 21) are additional Cg diastereo- 
isomeric amides whose PMR spectra show the general 
patterns just discussed. Chemical shift data from 
these spectra are included in Table 11. Of particular 
interest is the spectrum of the diacylated compound 
(21). The benzylic proton resonance of this compound 
at 6.04 ppm, is downfield (a  rf= -0.80 ppm) from that 
in the monoacylated derivative (9), because of the 
inductive effect of the extra acyl group. Interestingly 
the aromatic region in the diacylated compound, in 
contrast to the monoacylated derivative and the g-amine
(5), was observed as an apparent singlet.
The PMR spectrum of the 2,8-bridged quaternary 
salt (20) shows several interesting features. N-methyl, 
C.j bridgehead and Cg methylene proton absorptions 
moved downfield in the cyclic quaternary salt as 
expected due to the strong deshielding influence of 
the cationic nitrogen. The large downfield shift of 
Cg methylene protons compared with that of the N-methyl 
protons is somewhat surprising. A deshielding effect 
from the carbonyl group which is rigidly held in 
proximity to the Cg protons by the ring system may 
be responsible for their unusual downfield shift. The 
upfield position of C.j2 methylene resonance (3.42 ppm) 
in the cyclic quaternary salt compared with its precur­
sor, 8g-chloroacetamide (13), demonstrates the weak
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inductive effect of a positive nitrogen compared to 
that of a chlorine atom. The absorption by the C.j2 
methylene protons of 1_2. is at a lower field (4.16 ppm) 
compared with that of 8g-phenylacetamide (11) (3.47
ppm), indicating the difference in the deshielding 
effect between a chlorine atom and a phenyl ring.
Reduction of/«/g-amides with LAH gave the corre­
sponding alkylamines (14-19). The PMR spectra of 
these amines were similar to those of «/g-amines(4,5).
The 8oc-aminomethy 1-6,7-benzomorphan (23) formed by 
reduction of the 8oç-nitrile (22) was also investigated. 
The PMR of this compound revealed complex splitting 
patterns for the Cg, and protons in the 2.6-3.2
ppm region which integrated for 4H. Because of the 
overlapping lines of these protons it was difficult to 
determine the chemical shift and coupling pattern of 
the individual resonances. Deut^v-ium oxide exchange of 
the amine protons at 1.54 ppm reduced the multiplicity 
of this absorption. Careful examination of the spectrum 
revealed a single triplet at 2.95 ppm (J*^4Hz) which 
was assigned to the C.̂  bridgehead proton. This assign­
ment was confirmed by examining the spectra of the 
amides (24-27). Acylation of the 8graminomethyl deriva­
tive (23) produced a downfield shift of the C.^^ methy­
lene protons and a benzylic proton as expected whereas 
the C^ proton signal did not change from its position 
in the spectrum of the amine (23).
A molecule in which a methylene group is adjacent
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to an asymmetric carbon centre forms an AB-system,
233a phenomenon which is well known . The methylenes.acŷ ctTnt
of amides (24-27) have an/asymmetric environment and 
thus give rise to an AB quartet, each component of 
which is coupled to the amide and benzylic proton (Cg-H) 
resulting in a complex methylene signal. Although 
D^O exchange of the amide proton at 6.4 ppm reduces 
the multiplicity of this absorption, owing to resonance 
from the benzylic proton in this region, identification 
of the individual resonance lines was not possible.
The aromatic signal of the amides (24-27) is 
markedly broader than the corresponding amine (23).
This change could be ascribed to the deshielding effect 
of the carbonyl group of the amide. The aromatic signal 
of So^alkylamines (28-30), formed by reduction of amides 
(24-26), is similar to that of 8oc-aminomethyl-6,7- 
benzomorphan. This result lends support to the assump­
tion that the difference in the aromatic protons 
chemical shift is due to the anisotropic effect of the 
carbonyl group.
Compounds (34-39) are additional examples of 8a^ 
amino derivatives whose PMR spectra also show the 
general patterns discussed above. Chemical shift data 
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Carbon-13-NMR spectra used in combination with
spectra give unparalleled insight into the details
1 3of organic molecular structures. Application of C NMR
spectroscopy to the determination of structure and
stereochemical features of molecules is well established
and is routinely exploited. The tremendous strides
1 3taken in the advancement of C NMR techniques and
1 3instrumentation have rendered C spectroscopy^a routine
chemical tool offering powerful new approaches to the
234-237solution of a wide range of problems
Carbon resonances of organic compounds are found
over a chemical range of 220 ppm compared with the
<^20 ppm range for proton nuclei. The large chemical
shift range enormously increases the effective resolu- 
1 3tion. Since C spectra are routinely recorded with 
complete proton decoupling, they consist entirely of 
singlet signals and frequently separate resolved 
signals are seen for each individual carbon atom in 
molecules. Additional advantages of carbon-13-NMR is 
that it allows direct observation of molecular back­
bones and of quaternary carbon containing functional
groups. The dependence of chemical shifts on molecular
13geometry and substitution makes C NMR spectroscopy
237a powerful structural and stereochemical tool .
1 3In general, trends of C shielding are similar 
to these found for protons, with Sp^ hybridized carbon
187.
2atoms absorbing at highfield, Sp carbon at lower field 
and Sp hybridized carbon at intermediate field. The 
effects of electronegative shift to lower field follow 
the expected pattern with increasing shift to lower field 
caused by more polar groups. For example, the carbonyl 
carbons appear in the range of 160-220 ppm. In an 
unsaturated system, substituents can affect the shield­
ing of remote carbon centres by withdrawing or donating
electrons. Increasing electron density generally shifts
237the resonances towards higher field
1 3The striking feature of C shielding data is
the remarkable consistency of substituent effects in
closely related systems, with the general finding that
a simple additivity relation correlates the shielding
data within various families of compounds with good
precision. An early example was described by Grant and 
238Paul for acyclic hydrocarbons.
The effect of a substituent in ^ s h i f t  is not 
confined tô the nearest atom as in proton chemical 
shift but 6, positions are also affected. In
general a substituent in the oc- and p positions deshields 
the carbon nucleus but one in the y  position is shielding 
In acyclic alkanes the effect of substituents in the 
y  or further positions are very small but in cyclic 
compounds these long range effects may be quite signi­
ficant.
Thej^effect is of particular interest in 
conformational studies as it is subjective to relative
188.
stereochemistry. A semitheoretical rationalization of
239origin of/y effect was presented by Grant and Cheney 
in terms of a model for non-bonded steric interaction 
between closely neighbouring atoms in hydrocarbons. 
However it is now recognized that this cannot be the 
sole source of this effect because such shielding is 
often observed even when no such interaction is possible. 
A more compelling argument against a steric origin for 
these effects is the deshielding arising from a geometri­
cally proximate(^substituent. Although the mechanistic 
origin of this effect remaivis unclear, it is of great 
value for stereochemical studies^^* 237^
A wide range of techniques is available for the
assignment of NMR signals. Most widely used are
1 13those based on particular types of H decoupling. C
resonances in an off resonance decoupling experiment 
show first order multiplicity and thus primary, secon­
dary, tertiary and quaternary carbon atoms can be 
distinguished. Other decoupling experiments employed 
are selective ^H decoupling and off-resonance decoupling 
with variable-frequency off set^^^'^^^.
Among chemical methods employed for the assignment
13of C NMR signals, there are shifts induced by the 
addition of shift reagents, by changing the pH of the 
solution causing protonation or deprotonation or by 
solvent effects. In addition chemical modification such 
as simple derivatization or selective deuterium 
incorporation are also of diagnostic value. Finally, 
in the case of complicated structures such as those
189
of natural products, relaxation times (T^) measurements
13are increasingly used to assign different C resonan­
ces ,
1 36.1.2 C NMR spectral characteristics and 
stereochemical investigation.
13The C NMR chemical shifts of a series of 8-
substituted-6,7-benzomorphans prepared are listed in
Table 12. The structural and stereochemical information
from the NMR studies described above was considered
along with the application of established chemical
shift parameters^^^ , off-resonance decoupled (OFR)
spectra, and comparisons with structurally related
1 3compounds to arrive at the complete C NMR chemical
shift assignments of these compounds. Carbon-13-NMR
240-241studies of morphine alkaloids are of special
relevance in this respect.
The 2,5-dimethyl-6,7-benzomorphan (1) is employed
as the parent member and model for the series because
the stereochemistry of derivatives related to it is
109 228well established ' . The unprotonated aromatic
carbons, Cg and were easily differentiated from
other aromatic carbons by their low position and the 
fact that they appeared as a singlet in OFR spectra. 
They were also, as expected, of reduced intensity 
because of their longer relaxation times (T^). The Cg 
singlet was shifted downfield 7 ppm compared with the 
Cj due to the strong deshielding imposed on it by the
190.
attached quaternary centre; is bonded to a primary 
centre. The signal is also broader than that of Cg 
owing to long range coupling to the methylene protons 
of Cg. The ^ c h e m i c a l  shift values for the other 
aromatic carbons were obtained from the substituent 
additivity rule for a benzene ring and by comparing 
the shifts of tetralin . The highfield aromatic 
methine signal was assigned to * as it is shielded 
by interaction with the C^-methyl. Carbon^' doublet 
appeared at lower field compared with C 2 ' and ' 
presumably due to an ortho effect from the substitu­
ent. It was not possible to assign the two lines 
arising from C2 ' and C^' as they are separated by only 
0.3 ppm, a value which barely exceeds the experimental 
error.
The N-methyl is assigned to the lower field quartet
of the OFR spectrum and is easily distinguished from
the Cg-methyl (q) not attached to a heteroatom. Carbon^
methylene is at unusually highfield in accord with its
antiperiplanar relationship to the nitrogen lone
orbital. Lone-pair shielding of this type has been
24 2discussed by Eliel and Pietrusiewicz in the case 
of some N , 2oç- and N,2g-dimethyl decahydroquinolines 
(198) and the phenomenon is also evident in data on 
the mobile systems N,t-2,6-, N,t-2,3- and N,t-2,4- 
trimethylpiperidine^*^ where axial contributions move 
the C 2 ' chemical shifts upfield relative to the corre­
sponding shifts of the 6^-2-Me analogues. Other examples 
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It is of interest that a similar upfield shift of an









Carbon^ (d) and carbon^ (t) resonances were down­
field due to nitrogen substitution and easily distin­
guished from the carbons not attached to a heteroatom. 
Carbon^ was distinguished by its consistency throughout 
the series. The small chemical shifts difference between 
the two remaining methylenes (C^ & Cg) made completely 
unambiguous assignment difficult. However differentia­
tion of the and Cg triplets was accomplished by
comparing 6,7-benzomorphan to 8oc-amino-6 ,7-benzomorphan
.•the.
(4). The amino group should shift/Cg resonance upfield 
due to its ^  effect while that of C^ should remain 
unchanged. This type of shift was noted in going from
6,7-benzomorphan (1) to So^aminobenzomorphan (4). The 
C^ singlet was, as expected, of reduced intensity 
compared to other carbon signals and was easily identi­
fied by its consistency throughout the series.
Introduction of an electronegative oxygen at C^
196
appreciably changes the local charge density of the 
adjacent carbon atoms. The carbon^ shifted downfield
12.0 ppm in the 8-oxo compound (2) compared with
6,7-benzomorphan (1). This downfield shift is similar 
to that noted at the <x-carbon in cyclohexanone 
(13.6 ppm) compared with cyclohexane^*^. The carbonyl 
substituent caused a large downfield shift of the C 2 * 
and Cg resonance a'Yidl an upfield shift of and C^*. 
Carbon shift analyses of these aromatic carbons were 
made on the basis of the shifts of ^-tetralone (200) 










The assignment of the carbonyl carbon, Cg, is 
straightforward since it appears as a singlet at the 
lowest field position. The carbonyl shift (194 ppm) 
is similar to that noted for ortho substituted 
acetophenones. It is known that an important factor 
contributing to the carbonyl chemical shift is 
conjugation^^^. The carbonyl carbon of a conjugated 
system appears at a significantly higher field 
compared with an analogous saturated derivative. This
197.
shielding effect indicates that the electron density 
about a conjugated carbonyl carbon nucleus may be 
substantially greater than that about a saturated 
carbonyl carbon nucleus. Studies of proton spectra 
also indicate a greater electron density at the 
conjugated carbonyl carbon. If the conjugated inter­
action of the aromatic nucleus with the carbonyl group 
is diminished, the carbonyl peak appears towards lower
field relative to an electronically similar, but
247unhindered derivative
The carbong resonance of oxime (3) appeared in
the region 150 ppm; it is some 50 ppm higher relative
The.
to corresponding carbonyl resonance.I highfield chemical
shift of carbon (49.02 ppm) suggested the N-OH group
236is facing the group 
1 3The C NMR spectra of 8oc- and 8g^-aminobenzomorphan 
(4 & 5) showed several interesting differences and 
demonstrated the effect of substituent geometry on 
chemical shifts. The Cg of o^/B-amines was easily iden­
tified by examining the spectra of the amines and the 
unsubstituted benzomorphan (1). The Cg triplet of -the 
benzomorphan was replaced by a downfield doublet in 
the spectra of amines (4 & 5). This shift is due to a 
change in the electron density caused by the electro­
negative amino group. This substituent also caused a 
downfield shift of g-carbon atoms, C^ and C^. Carbon^ 
triplet appeared at higher field than that of 6,7-
benzomorphan (1) owing to the ̂  effect of the amino
24 8substituent. Eliel et al have discussed shielding
198
influences of nitrogen when gauche or antiperiplanar
to a ^-carbon, and have concluded that both influences
generally move the carbon resonance upfield. The
origin of this effect is not clear but it has been
postulated that it is due in|main not to the substir
tuent but to the removal of the hydrogen atom it 
249replaces
Comparison of and g-amine (4 & 5) spectra shows 
that the oc-amino isomer has a smaller downfield shift 
at Cg and but a larger downfield g  effect at C.j .
The Cg in the cjc-amine appeared at 46.00 ppm, upfield 
by 7 ppm from that in the g-amine (5). The o(-C.y singlet 
is also -2.0 ppm upfield from its position in/g-amine 
spectrum. The doublet at 62.3 ppm is 3.5 ppm
downfield relative to the g-amine.
There were significant differences in the chemical 
shifts for C g , Cg and C g ; these carbon resonances are 
upfield in the g-amine (5) compared to thoit in the 
oe-amine (4). The g-amino substituent causes upfield 
Shifts (-1 ppm) of Cg and Cg even though the groups are 
well separated. The other main spectral difference 
between the arid g-amino isomers was found in the 
shift of the C^. The or-C^ resonance is close to that 
of C^ in the unsubstituted benzomorphan (1) while in 
the g-amino isomer it is shifted upfield ̂ 7 . ppm. These 
differences in shifts are not fully understood at 
present but are probably due, in part, to differences
in conformation of the isomers. The amino group in the
g-amine (5) is orientated to the more hindered position.
199.
The severe nonbonded repulsion between the g-amino 
nitrogen and the ring nitrogen present when the 
piperidine ring moiety is in the chair form may be 
substantially relieved in the non-chair form. An 
unusually highfield proton shift (near 0.9 ppm) 
of the g-amine also suggests some deformation of the 
ring C.
The epimeric acetamides (6 & 7) synthesized from the.
OÇ- and g-amines respectively were also studied.
Carbon-13-NMR spectra of these compounds showed the.
general patterns discussed for the isomeric amines.
Introduction of an acetyl group modifies the shift of
the Cg as well as those of its immediate neighbours
C.̂  and The Cg, and C.̂ resonances of the amides
were shifted upfield relative to their position in the
amines. These upfield shifts are as expected with change
in the electronegativity of the nitrogen and g  and ^
effects from the acetyl groups. The acetyl group produces
a larger chemical shift on and Cg buta smaller shift
on C^ in the jg-acetamide (7) compared to ^acetamide
(6). An explanation for these differential effects is
not readily apparent. The chemical shift of all other 
/■the.
carbons of^ amides were similar,,within a narrow range 
of +0.5 ppm, to the corresponding amines.
The acetamides' (6 & 7) carbonyl carboTvs were 
easily identified as the lowest field resonances in 
the spectra. The carbonyl of g-acetamide at 170.7 was 
slightly lowfield from that of «-acetamide. The acetyl
200.
methyl gave a quartet in OFS spectra which appeared 
in the region (23.0 ppm) expected for a methyl next 
to a carbonyl group.
Compounds (8-13) are additional examples of
isomeric amides whose NMR spectra were entirely
analogous to those just discussed. A comparison of
shifts for the acetyl methyl of Sohacetamide with the
corresponding 8oç-chloroacetamide methylene shows the
effect of replacement of hydrogen by a chlorine of
20 ppm is somewhat less than that observed in other
systems for a similar substitution (entry 6 and 12).
For example, chlorine substitution in aliphatic hydro-
234carbons deshields atm by '^30 ppm . It would appear
i-thc
that^carbonyl group interacts with the chlorine in 
some way to produce an effect which opposes the chlorine 
effect. Phenyl ring substitution at the acetyl methyl 
of acetamide deshields the carbon by an essentially 
identical value, ^ 2 0  ppm (entry 6 and 10). This down^ielcL 
shift is similar to that noted at the «-carbon in 
aliphatic compounds^^*'^^^.
The carbonyl chemical shift for o^cyclopropionamide, 
«-phenylacetamide and «-chloroacetamide (8,10 & 12) 
were at 171.9, 169.4 and 164.5 ppm respectively. The 
carbonyl carbon of chloroacetamide (12) absorbed furthest 
upfield of all carbonyls. Carbonyl atoms of g-amides 
(7,9 &11) followed a similar pattern although these 
carbonyls appeared at a slightly lower field that those 
of the corresponding «-amides.
201 .
The chemical shift for the cyclopropyl group in 
«/g-cyclopropionamide (8 & 9) appeared at a very high­
field. The cyclopropyl methine (d) came at 15 ppm and 
cyclopropyl methylene (t) appeared at ppm. The 
assignments for carbons of the N-phenylacetyl group 
of «/g-phenylacetamido derivatives were made with/aid 
of chemical shift parameters of monosubstituted 
benzene^^*'^^^. For a monosubstituted phenyl group; 
the carbon "a" appeared to be the most deshielded 
whereas the para carbon "d" was slightly shielded. 
Carbons at the ortho position (Cb) occurred upfield 
of those at meta (Cc).
1 3The C NMR spectrum of 8g-dicyclopropionamide 
(21) was of particular interest. Introduction of a 
second acyl group has a striking effect on the benzylic 
carbon (Cg). This carbon signal was located at 60.7 ppm, 
downfield (û <î = 10.5 ppm) from its position in the 
spectrum of monoacylated derivative (9). The cyclopropyl 
groups in the diacylated compound (21) also appeared 
at a lower field relative to the monoacylated deriva­
tive (9). The cyclopropyl methylene signal was not 
well resolved and appeared at ^11.0 ppm as a broad 
peak. The cyclopropyl methine appeared at ~21-23 ppm 
as two separate doublets. The spectrum showed two 
separate carbonyl singlets at 178.6 and 176.0 ppm. 
Environmental features may be responsible for the slight 
differences in the carbonyl absorption.
Reduction of «/g-acetamides (6 & 7) resulted in
202.
a large downfield shift of Cg ùT= 6.8 ppm) because 
of the larger g  effect of the alkyl substituents. The 
Y  effect of a N-ethyl group, as expected, shifted C.j 
to a higher field. In contrast, aromatic C^ which is 
also y  to the N-alkyl, was shifted downfield *̂ 3 ppm 
relative to the amides (6 & 7), but surprisingly its 
chemical shift differs little from that of a primary 
amine (4 or 5). The magnitude of the change in the 
chemical shift of Cg, C^ and were similar in both 
cy- and g-alkylamines (14 & 15).
A comparison of the shifts for isomeric primary 
amines (4 & 5) with the corresponding secondary alkyl- 
amines (14 & 15) shows the effect of replacement of 
the proton in nitrogen with an alkyl group. Introduc­
tion of an alkyl group on the nitrogen produces g , y  
and £ effects on the carbons respectively of very similar 
magnitude to those observed for alkyl substitution in 
cyclohexane^^* 240,246^ amide carbonyl singlet on
reduction of the amide was replaced by a new triplet 
which appeared in the expected lowfield region for a 
methylene next to a nitrogen. The methyl of the N-ethyl 
group in ethylamines (14 & 15) appeared at 16.0 ppm.
Compounds (16-19) are additional derivatives in 
which the amino group bears an alkyl substituent; these 
spectra were similar to the spectra of and g-ethyl- 
amino-benzomorphans(14 & 15). The chemical shifts of 
Cg, and C.̂  were affected very slightly by larger 
N-alkyl substituents in these compounds. The cyclo-
203.
propyl group in the alkylamines (16 & 17) was shifted 
upfield owing to the expected smaller oc and g  effect 
of the methylene function compared to the carbonyl 
group in the amides (8 & 9). In the phenylethylamino- 
6,7-benzomorphans (18 & 19), methylene groups «  and g  to 
2° amino function (PhCH^ and PhCH^CH^) appeared at
37.1 ppm and 50.2 ppm respectively.
The general  ̂ NMR features of the 8oç-nitrile (22)
synthesized from 8-oxobenzomorphan (2), are close to
that of 8cy-aminobenzomorphan (4). The substituent
effects of the cyano group parallel that of the amino
group, although the effects are smaller. The polar
cyano group would be expected to give a larger «  effect
if inductive polarization dominates and it is clear
that other factors contribute substantially in the 
«■the.
case of^triple bonded grouping. The magnetic anisotropy 
of the nitrile triple bond has, on occasion , been 
invoked to explain its very much reduced deshielding
influence234-236_
The C q and resonances were at a lower field in 
the spectrum compared with those of the benzomorphan 
(1) as anticipated from the çt and g deshielding influ­
ences of the cyano substituent. The Cg triplet was 
shifted upfield due the ^  effect of the cyano group.
The aromatic C^, which is g to the cyano moiety, 
exhibited a somewhat surprising upfield shift of 
5.4 ppm relative to 6,7-benzomorphan. This behaviour 
is opposite to that found for the aliphatic C.j, which
204
is also g  to the cyano substituent. Replacement of the 
methyl hydrogen of toluene by a nitrile group is 
reported to produce a similar upfield g  effect on the 
aromatic carbon. The nitrile carbon gave a singlet 
which appeared in the region expected for the carbon 
multiply bonded to nitrogen (121.4 ppm). The shielding 
for most of the remaining carbons was relatively little 
affected by the cyano group.
The spectrum of 8«raminomethyl-6,7-benzomorphan 
(23) obtained by reduction of the nitrile (22) showed 
general characteristics similar to that of the nitrile. 
The chemical shift of Cg was lowfield 12.0 ppm relative 
to the nitrile owing to the «  and g  effect of the 
aminomethyl substituent. Aromatic was shifted down­
field (8.6 ppm) as expected with the removal of 
shielding g  effect of the cyano group. In contrast, 
was shifted upfield relative to its position in 
the nitrile. The downfield shift due to the g effect 
from the methylene (C^g) must be offset by a larger 
shielding influence of the nitrogen. Shifts of other 
carbon atoms further removed from the site of substi­
tution were small.
The general trends exhibited by the acyl and 
alkyl substituent effects in the 8ot-aminobenzomorphan 
were also observed in the spectra of a corresponding 









Infra-red spectra were recorded on a Pye Unicam 
SP.200 instrument and were obtained on liquid films 
or nujol mulls for solids.
^H NMR spectra were recorded on a J.E.O.L. PS. 100
instrument operating at 100 MHz and 2.349 Tesla, or
a Varian A60, 60 MHz spectrometer. PMR data are
quoted to two decimal places unless the last number
is zero.
1 3C NMR spectra were recorded on a J.E.O.L. FX 90Q 
Fourier Transform NMR spectrometer operating at 
22.9 MHz. TMS was used as internal standard.
Mass spectra were obtained on an AEI MS 50 mass 
spectrometer at Reckitt and Colman.
Elemental analysis were carried out at the micro- 
analytical laboratories in Reckitt and Colman (Hull). 
and London University.
Melting points were recorded on a Townson and Mercer 
apparatus. All melting points are uncorrected.
Thin layer chromatography (TLC) was carried out on 
silica gel (60) plates. Unless otherwise specified the. 
solvent system employed for elution was methanol: 
dichloromethane :acetic acid (12:4:1). The plates 
were developed by immersion in an atmosphere satu­
rated with iodine vapour for a few minutes.
Small-scale distillations were carried out with a
207
Kugelaohr microdistillation apparatus.
Light petroleum-ether had bp. 60-80° unless stated 
otherwise.
I n  nmocss spe.ctra s ijn  - f  =  .
208
7.O 2,5-Dimethyl-6,7-benzomorphan (40), 2 'hydroxy-
2,5-dimethyl-6,7-benzomorphan (111) and 2,5/9- 
trimethyl-6,7-benzomorphan (99).
These compounds were prepared according to the 
93method of May . Thus 2'hydroxy-2,5-dimethyl-6,7- 
benzomorphan (111) and the non-phenolic 2,5-dimethyl-
6,7-benzomorphan (40) were synthesized in a three 
step process from 4-picoline methiodide and p-methoxy- 
benzylmagnesium chloride, and 4-picoline and benzyl- 
magnesium chloride, respectively. 2,5,9-Trimethyl-6,7* 
benzomorphan (99) was obtained from 3,4-lutidine 
methiodide and benzylmagnesium chloride.
2,5-dimethyl-6,7-benzomorphan•HCl mp 193-195°(from 
ethanol-ether), (Lit. mp 193-195°).
nmr<fçp2i »t>ase 1 . 35 (3H, s ,Cg-Me) , 2 . 36 (3H,s ,NMe) ,
2.5-2.75(1H,m,HgqJ, 3.0-3.3(2H,m, 
Hgp + Hi), 7.0-7.4(4H,m,Ar-H).
2'hydroxy-2,5-dimethyl-6,7-benzomorphan. mp 208-211° 
(from acetone). (Lit. mp 209-214°).
^H nmr j^ocl 1.32(3H,s,CgMe), 2.40(3H,s,NMe),
2.7-3.4(3H,m,H^ + Hg), 6.5-7.0(5H, 
m,Ar-H + OH, exchangeable).
209
2, 5, 9^trimethy 1-6 , 7-benzomorphan • HCl mp 203-204°
(from ethanol-ether), (Lit, mp 203-205°) .
^H nmr #base O, 85 (3H,d ,Cg-Me) , 1 . 35 (3H,s ,C^-Me) ,




A 10% solution of chromium trioxide was prepared 
by dissolving chromium trioxide (21g) in acetic acid 
(190ml) and water 10ml). The chromium trioxide solution 
(80ml, 84mM) was added dropwise to a vigorously stirred 
mixture of 2,5-dimethyl-6,7-benzomorphan (5g, 25mM) in 
acetic acid (300ml). After addition was completed, the 
reaction mixture was stirred at room temperature for 
additional 20 hours. The solution was then poured into 
ice cold water, cautiously basified with ammonia solu­
tion and extracted with ether (4 x 100ml). The combined 
ethereal layers were extracted three times with 2N hydro­
chloric acid (100ml) and basified with ammonia solution.
The liberated base was dried in ether. Removal of ether 
under reduced pressure afforded a dark brown oil, to 
which was added petroleum ether (~100ml). The insoluble 
material was separated and dissolved in ether to give, 
after cooling, 2,5-dimethyl-3,4,8-trioxo-6,7-benzomorphan 
(12%), Evaporation of the petroleum ether left a yellow oil 
which was chromatographed on silica. Methanol;dichloro-
210
methane : acetic acid (12:4:1) eluted two components 
which were identified as unreacted starting material 
(9.0%) and 2,5-dimethyl-8-oxo-6,7-benzomorphan (68%).
2,5-dimethyl-8-oxo-6,7-benzomorphan, mp 55-56° ( from 
petroleum ether bp. 30-40°), (Lit. 54-57°),
"'̂ max 1680cm  ̂ (CO . )str.
nmr ^^OCl 1.45(3H,s,Cg-Me), 2.4(3H,s,NMe),
3.25(1H,t,C^-H), 7,2-7.65(3H,m,Ar-H),
8.04(1H,m,C^'-H).
Mass Spec. M/Z 215(M+), 200(M+fCg-Me),
172(M+fCg-MefC0), 57 ( M e N ^  ) 
base peak.
Elemental analysis:
Found C, 78.1 ; H, 8.0 ; N, 6.4%
C^^H^^NO requires C, 78.1 ; H, 8.0 ; N, 6.5%
2,5-dimethyl-3,4,8-trioxo-6,7-benzomorphan
^max 1730cm \  1680cm \
211 .




Mass Spec. M/Z 243(M^).
7.1.2 2,5,9-Trimethyl-8-oxo-6,7-benzomorphan (115).
2,5,9-Trimethyl-6,7-benzomorphan was oxidized 
with chromic acid in the same manner as described in 
section 7.1.1 to give 2,5,9-trimethvl-8-oxo-6 « 7- 
benzomorphan (46%) and 2,5,9-trimethyl-3,4,8- 
trioxo-6,7-benzomorphan (18%).
2,5,9-trimethyl-8-oxo-6,7-benzomorphan. mp 64-66° 
(from petroleum ether bp. 30-40°).
^ a x  16 70cm  ̂ (CO^^^ ).
nmr ^^ocig O.8 5 (3H,d,Cg-Me), 1.4(3H,s,Cg-Me),
2.35(3H,s,NMe), 3.1(1H,d,C^-H), 
7.2-7.7(3H,m,Ar-H), 8.0 (1H,m,C^ *-H)
Mass Spec. M/Z 229(M+), 214(M+fCg-Me),
4-/CH




Found C, 78.3 ; H, 8.0 ; N , 6.1%
C 15H 14NO requires C, 78.6 ; H, 8.3 ; N , 6.1%
2 ,5 ,9-trimethyl-3,4,8-trioxo-6 ,7-benzomorphan 
(impure, from ether).
%iax 1730cm \  1670cm  ̂.
nmr J^Qci 1.04(3H,d,Cg-Me), 1.67(3H,s,Cg-Me) ,
3.2(3H,s,NMe) , 4.0(1H,d,C.,-H) , 7.4-
7.8(3H,m,Ar-H), 8 .02(1H,m,C^*-H)
Mass Spec. M/Z 257(M*).
7.1.3 Attempted oxidation of 2,5-dimethyl-6,7- 
benzomorphan.
7.1.3.1 Cerium (IV) ammonium sulphate dihydrate.
A solution of cerium (IV) ammonium sulphate 
(25.Og, 40mM) in 3.5M-nitric acid (100ml) was added 
dropwise, with stirring, to a solution of 2 ,5-dimethyl-
6 ,7-benzomorphan (2.0g, 1OmM) in 3.5M-nitric acid (50ml) 
The solution was heated at 60° for 10 hours, cooled, 
diluted with water (150ml) and basified with ammonia 
solution. Extraction with ether gave only starting 
material.
7.1.3.2 With chromyl acetate.
Concentrated sulphuric acid (2.0ml) was added
213.
to a stirred cold solution of 2 ,5-dimethyl-6,7- 
benzomorphan (2.0g, lOmM) in acetic anhydride (10ml). 
When the mixture had cooled to 0°C, chromium trioxide 
(2.5g, 25mM) in acetic anhydride (12ml) was added 
slowly with stirring at such a rate that the tempera­
ture did not exceed 10°C. The resulting mixture was 
stirred for further 2 hours, poured on ice, basified 
with ammonia solution and extracted with ether (3x 100ml) 
The ethereal extracts were dried (MgSO^) and evaporated 
to give an oil (1.97g) which was shown to be a mixture 
(tic). IR and PMR spectra of this crude product 
indicated the presence of 8 , 8-diacet L— 6 , 7-benzomorphan 
(107). The diacetate (107) was hydrolyzed by refluxing 
in conc. sulphuric acid (0.45ml) in 50% ethanol (10ml) 
for 30 minutes. The solution was cooled, basified with 
ammonia solution and extracted with dichloromethane 
to give 2,5-dimethyl-8-oxo-6,7-benzomorphan (7%).
7.1.3.3 Chromium trioxide in sulphuric acid.
Concentrated sulphuric acid (9ml) was added 
to sufficient ice to make up a 100ml solution. 2,5- 
Dimethy1-6,7-benzomorphan (2.0g, lOmM) was added to 
half of this solution which was then heated under 
reflux. Chromium trioxide (2.5g, 25mM) was added to 
the remainder and the resulting solution added 
dropwise to the stirred mixture heated under reflux.
The mixture was cooled, basified with ammonia solution 
and extracted with ether (3 x 100ml). The ethereal 
extracts were washed with water, dried (MgSO^) and
214
evaporated to give a yellow oil, which was distilled 
at O.OSmmHg. This was shown to consist of two major 
components (tic). The IR and nmr of the mixture 
indicated it was mainly starting material and 2,5- 
dimethyl-8-oxo-6 ,7-benzomorphan (<^0 %).
7.1.3.4 Silver nitrate/ammonium persulphate.
A mixture of 2,5-dimethyl-6,7-benzomorphan 
(O.Sg, 2.5mM), ammonium persulphate (1.5g,6.6mM) and 
silver nitrate (0.2g) was stirred in water for 3.5 
hours at 60°C.. The mixture was cooled, basified with 
ammonia solution and extracted with ether. The solvent 
was removed under vacuum leaving a oily residue which 
was identified as starting material with some impurity.
7.1.3.5 With 2,3-dichloro-5,6-dicyanobenzoquinone.
Dichlorodicyanobenzoquinor>e (1.04g, 4.6mM) 
was added, with stirring, to a solution of 2 'hydroxy- 
2, 5-dimethyl-6 , 7-benzomorphan (0.5g, 2.3mM) in methanol 
(30ml) and the solution refluxed for 3 hours. The 
methanol was removed and the residue extracted with 
warm toluene (3 x 50ml). The toluene extracts were 
washed with water, dried (MgSO^) and evaporated to give 
yellow solid. IR spectrum of the crude material did 
not show the presence of a carbonyl group. PMR spectrum 
indicated a mixture of starting material and 2 * hydroxy- 





nmr 1.83(3H,s ,C^-Me), 2.52(3H,s,NMe),
3.4 7 (SHfSfOCHg), 4.24 ( 1H,s,Cg-H),
6.5-7.0(3H,m,Ar-H),
8.70(1H,s,0H, exchangeable).
Mass Spec M/Z 247(M^).
7.2 Reactions of Ketones.
7.2.1 2,5-Dimethyl-8-oxo-6,7-benzomorphan oxime (117). 
Method a.
A mixture of 2,5-dimethyl-8-oxo-6 ,7-benzomorphan 
(2.0g, 9.3mM) , hydroxylamine hydrochloride (I.Og, 14 . 5mM) 
and sodium acetate trihydrate (2.1g, 15mM) in 95% ethanol 
was heated under reflux for 16 hours. The mixture was 
cooled, neutralized with aqueous sodium hydrogen carbo­
nate and extracted with dichloromethane (3 x 100ml).
The dichloromethane extracts were washed with water 
(100ml), dried (MgSO^) and evaporated to afford 2,5- 
dimethyl-8-oxo-6 ,7-benzomorphan oxime (l.lg, 51%), 




11.33(1H ,s,0H , exchangeable).






Found C, 73.6 ; H, 7.8 ; N, 12.0%
requires C, 73.0 ; H, 7.9 } N, 12.2%
Method b.
A solution of hydroxylamine was prepared by mixing 
hydroxylamine hydrochloride (1.4g, 20mM) and sodium 
acetate (1.7g, 20mM) in 70ml ethanol. After 1 hour the 
mixture was filtered and the filtrate was treated with 
2.8g (13mM) of 2,5-dimethyl-8-oxo-6,7-benzomorphan.
After 8 hours of reflux the solution was concentrated 
to 20ml and upon cooling and filtering 1.8g (60%) oxime 
was obtained.
Analytical data same as those given for Method a.
7,2.2 2,5,9-Trimethyl-8-oxo-6,7-benzomorphan oxime (119)
A mixture of 2,5,9-trimethyl-8-oxo-6,7-benzomorphan 
(2.3g, lOmM), hydroxylamine hydrochloride (I.Og, 14.5mM) 
and sodium acetate trihydrate (2.1g, 15mM) in 95% ethanol 
was heated under reflux for 16 hours, and the procedure 
from 7.2.1 a. was repeated. The oxime was crystallized 
from chloroform, mp 188-189°. Yield I.Og (41%).
nmr 0.72(3H,d,C^-Me), 1.35(3H,s,Cg-Me),
2.28(3H,s,NMe), 4.24(1H,d,C^-H), 7.0- 
7.4(3H,m,Ar-H), 8 .0(1H,d,C^'-H),
11.0(1H,s,N-OH, exchangeable).
Mass Spec. M/Z 244(M+), 227(M+40H)
+ ^Me




Found C, 74.1 ; H, 8.0 ; N, 11.1%
^15^20^2^ requires C, 73.7 ; H, 8.3 ; N, 11.5%
7.2.3 Beckmann Rearrangement of 8-oxo-2,5-dimethyl-
6 ,7-benzomorphan oxime.
2,5-Dimethyl-8-oxo-6,7-benzomorphan oxime 
(I.Og, 4.3mM) in polyphosphoric acid (20g) was stirred 
at 150°C for 2 hours. The brown reaction mixture was 
cooled, poured into water and basified with ammonia 
solution. Extraction with dichloromethane and removal 
of solvent yielde.ot a, semi-sol id residue, which was 
crystallized from ethyl acetate-petroleum ether to 
give 6 ,9-dimethyl-4 , 5-benzo-3 ,9-diazabicyclo [4.3.1] 
decen -2-one (0.6g, 40%), mp 169-72°.
Snax (nujol) 1665cm"^ ^^^str ^
nmr 1.6 (3H,s,Me), 2.55(3H,s,NMe),
3
9.5(1H,s,NH, exchangeable).
Mass Spec. M/Z 230(M^).
7.2.4 8o^Cyano-2,5-dimethyl-6,7-benzomorphan (121) .
Potassium-t-butoxide (4.5g, 40mM) was added, all 
at once, to an ice-cooled solution of tosylmethyl iso­
cyanide (3.0g, 15mM) in dry dimethyl sulphoxide (15ml). 
After stirring for 5 min. under nitrogen, methanol 
(0.25ml) was added and then 2,5-dimethyl-8-oxo-6,7- 
benzomorphan (I.Og, 4.6mM). The mixture was stirred
218
for 1 hour at room temperature under nitrogen and then 
for 70 hours at 45°C. The reaction mixture was diluted 
with water (200ml) and the solution extracted with 
hydrochloric acid (IN, 3 x 50ml). The combined acid 
extracts were washed with ether (100ml), basified with 
ammonia solution and extracted with ether (3 x 100ml). 
The ethereal extracts were dried (MgSO^) and evaporated 
to give 8o^cyano-2 ,5-dimethyl-6 ,7-benzomorphan (0 .8g, 
76%) as a white solid, mp 101-102° (from acetone).
max






226 (M^), 211 (M^-rCg-Me) base peak.
CH
110( J , dihydropyridine ion)
N 1+CH3
The hydrochloride was crystallized from ethanol and 
had mp 220-221°.
Elemental analysis:
Found C, 68.4 ; H, 7.3 % N, 10.6%
C^gH^gNgCl requires C, 68.8 ; H, 7.3 j N, 10.7%
219.
7.2.5 Attempted synthesis of 8g-cyano-2,5-dimethyl-




(0.5g, 2.5mM) was added to a solution of potassium 
(0.2g, S.OmM) in freshly distilled tertiary-butanol 
(100ml). The resulting mixture was stirred at room 
temperature for 3 hours, poured into ice water and 
extracted with dichloromethane (3 x 50ml). Removal of 
solvent under reduced pressure afforded 2 ,5-di'vn6thyl- 
8 - O X O - 6,7-benzomorphan (0.5g, 95%),indistinguishable 
(IR, NMR, MS, GLPC) from authentic sample.
7.2.5.2 Sodium hydride.
A mixture of 2,5-dimethyl-8orcyano-6,7- 
benzomorphan (0.5g, 2.5mM) and sodium hydride (0,12g, 
5mM) in freshly distilled tetrahydrofuran was stirred 
at room temperature for 2 hours. The solution was 
cooled, treated with cold water (100ml) and extracted 
with dichloromethane. The solvent was removed under 
vacuum leaving a pale yellow oil which was identified 
(IR, NMR, MS, GLPC) to be 2,5-dimethyl-8-oxo-6,7- 
benzomorphan.
The procedure above was repeated under strict 
nitrogen atmosphere, and the reaction followed by thin 
layer chromatography. No 2,5-dimethyl-8-oxo-6,7- 
benzomorphan was detected for up to 4 hours suggesting 
the role played by atmospheric oxygen.
220.
7.3 Primary Amines.
7.3.1 8or-Amino-2, 5-dimethyl-6 ,7-benzomorphan (127) .
a. Raney alloy (1.5g, 13mM) was added in small
portions to a magnetically stirred solution of 2,5- 
dimethyl-8-oxo-6 ,7-benzomorphan oxime (I.Og, 4.3mM) 
in ethanol (20ml) and sodium hydroxide (20ml). The 
mixture was stirred at ambient temperature for 5 hours 
and then filtered. The filtrate was extracted with 
dichloromethane (3 x 75ml), washed with water (50ml), 
dried (MgSO^) and evaporated to give 8y a m i n o - 2,5- 









Mass Spec. M/Z 216 (M+), ISj^M+TC.-MefNHg), 146(M+f70),
+/CH
70 (HÇ = C — N ) base peak.
H H
The dioxalate was crystallized from ethanol and had 
mp 202-203^.
Elemental analysis:
Found C, 54.7 I H, 5.5 i N, 7.2%
^18^22^2^8 requires C, 54.8 ; H, 5.6 ; N, 7.1
221 .
b. A mixture of the oxime (0.5g, 2.2mM) and platinum 
oxide (50mg, 0.2mM) in absolute ethanol (80ml) contai­
ning conc. hydrochloric acid (4ml) was hydrogenated at 
50 psi in a rocking Parr apparatus at room temperature 
for 3 hours. The catalyst was removed by filtration 
and the filtrate evaporated to give a white solid which 
was dissloved in water (50ml), The solution was^ made 
basic with ammonia solution, extracted with dichloro­
methane (3 X 150ml) and dried (MgSO^). Removal of solvent 
under reduced pressure afforded 8«-amino-2 ,5-dimethyl-
6 ,7-benzomorphan as a colourless oil (0.34g, 72%).




4.3mM) was added slowly, with stirring, to a mixture 
of lithium aluminium hydride (0.8g, 21mM) in dry ether 
(lOOml) under nitrogen. The mixture was stirred over­
night, cooled and water (3.2ml), sodium hydroxide 
(5N, 0.6ml) added dropwiSe with cooling and stirring.
The solid was removed via filtration and repeatedly 
washed with ether. The organic phase was washed with 
water (50ml), dried (MgSO^) and evaporated to give a 
colourless oil (0.60g, 64%).
^max 3475cm” \  3400cm"\ 1603cm"^




C^-H, 4.0(1H,d,Cg-Hp^>J=6Hz) , 7.08- 
7 .4(3H,m,Ar-H), 7.6 (1H,m,C^'-H),
0 . 9 (1H,m,C^-H).
2 16(M+), 184(M+fCg-MefNHg), 146(M+f70), 
+ /CH
7 0 (HC = C-N '̂) base peak.
H H CH.
Treatment of the oil with ethereal HCl and crystal­
lization afforded 8p-amino-2 ,5-dimethyl-6,7-benzomorphan 
dihydrochloride, mp 212-213°
Elemental analysis:
Found C, 58.0 ; H, 7.5 ; N, 9.7%
C 14H 22N 2CI2 requires C, 58.1 ; H, 7.7 ; N, 9.7%
7.3.3 8cx-Amino-2, 5,9-trimethyl -6 , 7-benzomorphan (132).
The procedure described in 7.3.1a was repeated 
using 2 ,5,9-trimethyl-8-oxo-6,7-benzomorphan oxime 
instead of 2 ,5-dimethyl-8-oxo-6,7-benzomorphan oxime 
to give 8o<-amino-2 ,5,9-trimethyl-6 ,7-benzomorphan as 
an oil (60% yield).
max
Mass spec. M/Z
3400cm"\ 3300cm"\ 1603cm“ ^
0.96(3H,d,Cg-Me), 1.35(3H,s,Cg-Me),
1.90(2H,s,NH2 / exchangeable), 2.45 ( 




84 ( '^C=C-N ) base peak.
H H ^CH
223.
The oil was converted mbo its dioxalate salt and 
crystallized from ethanol, mp 180°.
Elemental analysis:
Found C, 60.1 j H, 5.6 ; N, 7.0%
^19^24^2^8 requires C, 55.9 ; H, 5.9 j N , 6.9%
7.3.4 Attempted synthesis of 8p-amino-2,5,9- 
trimethyl-6,7-benzomorphan (133).
A mixture of 2,5,9-trimethyl-8-oxo-6,7- 
benzomorphan oxime (0.5g, 2.0mM) and lithium aluminium 
hydride (0.4g, lOmM) was stirred in ether and the 
procedure described for 7.3.2 was repeated.
After removal of solvent (ether) under reduced
pressure, the crude product was examined by and 
1 3C NMR, IR spectroscopy and mass spectrometry. Proton 
and carbon-13-nuclear magnetic resonance spectra 
indicated a mixture of 8o(- and 8g-amino-2,5,9- 
trimethyl-6 ,7-benzomorphan in a 40:60 ratio. Attempts 
to isolate pure gi-amine by fractional crystallization 
as hydrochloride, oxalate or hydrobromide from various 
solvent mixtures was unsuccessful.
^max 3400cm \  3300cm \  1 603cm  ̂.




Mass Spec. M/Z 230(M+), 146(M^4S4),
CH., +^CH. 
H H ^CH.
84( '^Ç=Ç-N^ ^) base peak.
224.
7.3.5 8o<-Aminomethyl-2 , 5-dimethyl-6 ,7-benzomorphan
(184).
8^Cyano-2 , 5-dimethyl-6 ,7-benzomorphan (O. 5g, 
2.2mM) was dissolved in absolute ethanol (50ml).
PlatinuYYi oxide (50mg) and chloroform (2ml) were 
added to the solution and the mixture hydrogenated 
at 50 psi in a rocking Parr apparatus at room tempera­
ture for 6 hours. The mixture was filtered and the 
filtrate was evaporated to give a white solid. Recrystal- 
lization from ethanol afforded 8oc- (aminomethyl) -6 ,7- 
benzomorphan dihydrochloride (0.54g, 81%) as needles,
mp 260^ (d).





geable), 2.40(3H,s,NMe), 2.6-3.0(3H, 
m,Cg-H + CHg-NHg), 3.13(1H,t,C^-H; 
J=4Hz), 7.0-7.2(4H,m,Ar-H).
230(M+), 200(M+fCH2NH2) base peak.
1 1 0 (
+ .CH.
), 70(HÇ=Ç-N^ ion b)
H H CH.
Elemental analysis;
Found C, 59.6 ; H, 7.8 ; N, 9.3%
C^5H24N 2Cl2 requires ^9.4 , H, 8.0 ; N, 9.2%
225.
7.3.6 Attempted synthesis of 8p(-aminomethyl-6 ,7-
benzomorphan by reduction of 8-cyanobenzomorphan
7.3.6.1 With lithium aluminium hydride.
8^Cyano-2 ,5-dime thy 1-6 ,7-benzomorphan (1 .Og, 
4.4mM) in dry ether (100ml) was added dropwise, with 
stirring, to a mixture of lithium aluminium hydride 
(0.8g, 21mM) in dry ether (100ml). The resulting 
mixture was refluxed for 5 hours, cooled and water 
(2.8ml) and sodium hydroxide (5Nj 0.6ml) added dropwise 
with cooling and stirring. The solid was removed by 
filtration and repeatedly washed with ether. The ether 
phase was washed with water (50ml), dried (MgSO^) and 
evaporated in vacuo to give an oil. Thin layer chromato­
graphy showed four to five major components, two of 
which gave positive ninhydrin reaction. Two compounds, 
8o^aminomethyl-2 ,5-dimethyl-6,7-benzomorphan and 
aldehyde of 2 ,5-dimethyl-6,7-benzomorphan, could be 
distinguished from spectroscopic analysis. The oil 
was chromatographed on silica gel column eluting with 
ethanol-dioxane-toluene-ammonia (10:40:45:5) and 
collecting 15ml fractions to give impure 8gramino- 
methy1-2,5-dimethy1-6,7-benzomorphan (5%). Spectro­
scopic data were the same as those given for 7 .3 .5 .
8grformyl-2 ,5-dimethyl-6 ,7-benzomorphan:
yj -1max 1675cm (CO^^^ ).
nmrj^Qci 1 . 32 (3H, s ,Me) , 2. 5 (3H,s ,NMe) , 3.1 (1H,
(cruae aldehyde)
226.
t,C.,-HjJ=4Hz) , 4.7 (1H,m,Cg-H) , 7.1- 
7 . 4 (4H ,m, Ar-H) .
7.3.6 .2 With mixture of lithium aluminium hydride and
aluminium chloride.
A mixture of 8a-cyano-2,5-dimethyl-6,7- 
benzomorphan (0.5g, 2.2mM), lithium aluminium hydride 
(0.2g, 4.4mM) and aluminium chloride (0.4g, 5.2mM) in 
dry ether was stirred for 2 hours. The usual lithium 
aluminium hydride work up gave an oil which showed a 
complex mixture on analysis by TLC. PMR and IR 
spectra were similar to those of the products 
obtained from lithium aluminium hydride reduction 





Acetyl chloride (0.30ml, 4.2mM) was added 
dropwise, with stirring, to a solution of 8o<-amino-
2,5-dimethyl-6,7-benzomorphan (0.50g, 2.3mM) and 
triethylamine (1,0ml) in dry ether (100ml). The 
solution was stirred for 6 hours, washed with water 
(2 X 50ml) and extracted with hydrochloric acid (0.5N, 
2 X 50ml). The acid extracts were basified with 
ammonia solution and extracted with ether (3 x 100m l ) .
227.
The ethereal phase was washed with water (50ml), dried 
(MgSO^) and evaporated to give 8^-acetamido-6 ,7- 
benzomorphan as a white solid (0.42g, 70%).
''tnax (nujol) 3300cm  ̂ (NH) , 1640cm  ̂ (CO^^^ ) .
nmr J^^ci 1.40(3H,s,CHj), 1.92(3H,s,CO-CHg),
2.60(3H,s,NMe), 3.04 (1H,t,C.|-H) , 5.2 ( 
1H,d,Cg-H;J with NH =8Hz on D^O d — »s) , 
5.9(1H,d,Ng), 7.0-7.4(4H,m,Ar-H).
Mass Spec. M/Z 258 (M+), 243 (M+TCg-Me), 199 (M'̂'tNH^-
COCHg), 11O(dihydropyridine ion),
7 0 (ion b) base peak.
The hydrochloride was crystallized from ethanol and 
had mp. 212-213°.
Elemental analysis;
Found C, 64.8 ; H, 7.8 ; N, 9.2%
^16^21^2^^^ requires C, 65.2,- t H, 7.9 j N, 9.5%
7.4.2 8cx-Cyclopropionamido-2,5-dimethyl-6 ,7- 
benzomorphan (138).
To a solution of 8oramino-2,5-dimethyl-6,7- 
benzomorphan (l.lg, 5.ImM) in a mixture of dichloro­
methane (100ml) and triethylamine (3.5ml) was added 
cyclopropane carboxylic acid chloride (1.3g, 15mM).
The mixture was refluxed for 12 hours and evaporated.
The oily residue was dissolved in ether (200ml), 
washed with water (2 x 75ml) and extracted with 
hydrochloric acid (0.5N, 3 x 50ml). The aqueous 
layer was basified with ammonia solution and extracted
228
with dichloromethane (3 x 100ml). The dichloromethane
layer was washed with water (50ml), dried (MgSO^) and
evaporated to give 8gc-cyclopropionamido-2 , 5-dimethyl-
6 ,7-benzomorphan as a white amorphous solid
(0.9g, 62%). Recrystallization from ethyl acetate/
.•fc-hox
petroleum ether gave/8«-cyclopropionamide as white 
needles, mp. 205°.






c-CgHg), 2.56(3H,s,NMe), 3.06(1H, 
t,C.,-Hj J=4Hz) , 5.2 (1H,d,Cg-H_;J=10Hz 




11 O(dihydropyridine ion), 70(ion b)
+
base peak, 59 (CHgCH^isiHCHg) .
C, 75.7 ; H, 8.5 j N, 9.5%
^18^24^2^ requires C, 76.0 ; H, 8.5 ; N, 9.8%
7.4.3 8a-Phenylacetamido-2 ,5-dimethyl-6,7-benzomorphan 
(136) .
Phenylacetyl chloride (0.5ml, 3.8m M ) was added 
dropwise to a stirred suspension of 8oç-amino-2 ,5- 
dimethy1-6,7-benzomorphan (0.5g, 2.3mM) in a mixture 
of potassium carbonate (0.5g, 3.6mM) and methanol
229.
(25ml) and water (3ml). The mixture was stirred for 
4 hours and evaporated. The residue was dissolved in 
ether (200ml), washed with water (3 x 50ml) and extrac­
ted with hydrochloric acid (0.3N, 3 x 50ml). The acid 
extracts were basified with ammonia solution and 
extracted with dichloromethane (3 x 100ml). The 
dichloromethane phase was washed with water, dried 
(MgSO^) and evaporated to give 8o(-phenylacetamido-
2,5-dimethyl-6 ,7-benzomorphan (0.55, 71%) as 
colourless plates, mp. 172-173° (from ethanol-ether).
Xaax (Nujol) 3290cm“  ̂ (NH), 1630cm“  ̂ ^^^str ^'
^H nmr 1.36(3H,s,Cg-Me), 2.6 (3H,s,NMe),
3.06 (1H,t,C.j-H;J=4Hz) , 3.5 (2H, 
s,-C0CH2Ph), 5.16 (1H,d,Cg-HpjJ=8Hzj 
on D 2O d — »s), 5.7(1H,d,NH^exchange- 
able), 7.0-7.4(9H,m,Ar-H).
Mass Spec. M/Z 334(M+), 319(M+4Cg-Me), 275(M+459),
184(M+4Cg-MefNH2C0CH2Ph), 110(dihydro­
pyridine ion), 70(ion b) base peak.
Elemental analysis:
Found C, 78.9 j H, 8.0 ; N, 8.2%
^22^26^2^ requires C, 79.0 5 H, 7.8 ; N, 8.4%
7.4.4 8o^Chloroacetamido-2,5-dimethyl-6,7-benzomorphan 
(163).
Chloroacetyl chloride (0.75ml, 9.4mM) was added 
dropwise with a microlitre syringe, with stirring, to
230.
a cold solution of 8oç-amino-2, 5“dimethyl-6 ,7- 
benzomorphan (0.5g, 2.3mM) and triethylamine (1ml) 
in dry acetone (50ml). The mixture was stirred at 
0° for 3 hours, filtered and the filtrate was 
evaporated. The residue was dissolved in ether 
(100ml) and extracted with hydrochloric acid (0.25N,
3 X 50ml). The aqueous layer was washed with ether 
(30ml), basified with ammonia solution and extracted 
with dichloromethane. The dichloromethane layer was 
dried (MgSO^) and evaporated to afford a white 
amorphous substance. Recrystallization from ethyl- 
acetate gave 8oc"Chloroacetamido-2, 5-dimethyl-6,7- 
benzomorphan (0.42g, 63%) as colourless needles, 
mp 214° (d).
"^max 3350cm"\ 1660cm"^ ^^^str  ̂'
nmr <^qdc1 1 .4 (3H,s,Cg-Me) , 2 . 6 (3H, s ,NMe) ,
3.08 (1H,t,C.,-H) , 4.0(2H,s ,“C0CH2C1) ,
5.2 (1H,d,Cg-HjJ=10Hz, on D^O d-»s),
6 .6 (1H,d,NHjJ=10Hz,exchangeable),
7.08-7.4(4H,m,Ar-H).
Mass Spec. M/Z 292(M+), 277(M+4Cg-Me), 256(M+4C1),
199 (M'̂ ’tNH^COCH^CI) ,
110(dihydropyridine ion),
70(ion b) base peak.
Elemental analysis;
Found C, 66.0 ; H, 7.5 ; N, 9.6%




acylated by the same procedure as described in 7.4.1 
to afford 8g-acetamido-2 ,5-dimethyl-6 ,7-benzomorphan 
as an oil in 68% yield. The hydrochloride recrystal­
lized from ethanol had mp 229-230°.
Xnax 3345cm“ ^(NH), 1660cm“  ̂ ^^^str ^'
^H nmr 4 :d C1 0.9(1H,m,C^-H), 1.37(3H,s,CgMe),
2.14 (3H,s,C0CH.^) , 2 . 62 (3H, s ,NMe) , 
5.3(1H,dd,Cg-H^;J=6Hz,10Hz, on D^O 
dd-» d) , 7 .0-7 . 35 (3H.,m, Ar-H) ,
7.4(1H,m,C^'-H).
Mass Spec. M/Z 258(M+), 243(M+fMe), 199(M*4NH2C0CHg),
110, 70 base peak.
Elemental analysis:
Found C, 61.5 -, H, 7.8 f N, 8.9%
^16^23^2^^^’^2^ requires C, 61.0 | H, 8.0 ; N, 8.9%
7.4.6 8g-Dicyclopropionamido-2,5-dimethyl-6 ,7- 
benzomorphan (140).
The procedure described in section 7.4.2 was 
repeated using 8£-amino-2 ,5-dimethyl-6,7-benzomorphan 
to give 8g-dicyclopropionamido-2 ,5-dimethyl-6,7- 
benzomorphan as an oil (67%).
Xnax (Nujol) 3300cm“\  1712cm”\  1660cm"\
1642cm”\  1380cm“\
232.
nmr O.7-1.2(8H,m,2 (c-C^Hg) ) , 1.32(3H,s,Cg
-Me), 2.52 (3H,s,NMe), 3.04(1H,m, 
C.^-H), 6.08(1H,d,Cg-H^;J-6Hz) ,
6.9-7.3(4H,m,Ar-H).
Mass Spec. M/Z 352(M+), 283(M+4C0-c-CgHg), 226,
198(2834NH2CO-c-CgHg) base peak, 184 
(M+fCg-Me-NH(C0-c-CgHg)2), 110, 70.
The hydrochloride was crystallized from isopropanol 
and had mp 141°.
Elemental analysis;
Found C, 67.5 ; H, 7.7 ; N, 6.9%
^22^28^2^2*^^^ requires C, 67.9 f H, 7.5 f N, 7.2%
7.4.7 8p-Phenylacetamido-2,5-dimethyl-6 ,7- 
benzomorphan (137).
In the manner described in 7.4.3 acylation of 
8g-amino-2,5-dimethyl-6,7-benzomorphan (I.Og, 4.6mM) 
gave 1.07g (69%) of an amorphous white solid. This 
crystallized from ethyl acetate as colourless needles, 
mp 78°.
''max 3330cm”  ̂ (NH) , 1640cm~^ (CO ^ ) .
’h nmr 1.32(3H,s,Cg-Me), 2.62(3H,s,NMe),
2.90(1H,m,C,,-H) , 3.68(2H,s,PhCH,CO) , 
5.17(1H,dd,Cg-g^J^6Hz, 8Hz, on D 2O 
dd-»d), 7.0-7.42(10H,m,Ar-H f NH
reduced to 9H on D^O).
Mass Spec. M/Z 334 (M+), 319, 275 (M'*'t 59) , 184,
233
9 1 (PhCHg), 70 base peak.
Elemental analysis:
Found C, 79.1 ; H, 8.0 ; N, 8.3%
^22^26^2^ requires: C, 79.0 ; H, 7.8 ; N, 8.4%
7.4.8 8g-Chloroacetamido-2,5-dimethy1-6,7-benzomorphan 
(162).
By the same method as described in 7.4.4, 8Ĵ - 
amino-2,5-dimethyl-6,7-benzomorphan (I.Og) afforded 
^g-chloroacetamido-2,5-dimethyl-6,7-benzomorphan as 
an oil (0.72g, 53%).
Snax 3330cm“  ̂ (NH), 1670cm“  ̂ (^^str ^"
^H nmr j^oci 1.37(3H,s,Cg-Me), 2.6(3H,s,NMe),
3.04(1H,m,C^-H), 4.15(2H,s ,000^^01), 
5.2(1H,dd,Cg-H>J with_C^-H=6Hz,J with 
NH=10Hz, on D^O dd-^d), 7.0-7.25(3H,m, 
Ar-H), 7.3(1H,m,C^'-H), 8.05(1H,d,NH, 
exchangeable), O.96(1H,m,C^-H).
Mass Spec. M/Z 294 (M+), 199 (M'^'-fMH^COCH^Cl) ,
70 base peak.
The hydrochloride recrystallized as colourless prisms, 
mp. 206-208°, from ethanol.
Elemental analysis;
Found C, 55.7 ; H, 6.8 ; N, 7.9%
^16^22^2^^^2*^2^ requires C, 55.3 j H, 7.0 ; N, 8.1%
234.
7.4.9 2,8-Bridqed-6/7-benzomorphan derivative (165).
A cold solution of 8g-chloroacetamido-2,5- 
dimethyl-6,7-benzomorphan (O.IOg, 0.34mM) in dry acetone 
(5ml) was added slowly to a stirred ice cold solution 
of sodium iodide (0.065g, 0.4mM) in dry acetone (10ml). 
The mixture was stirred at ambient temperature for 2 
hours and the sodium chloride precipitate was filtered 
off. The filtrate was evaporated to giVtawhite solid. 
Recrystallization from ethanol afforded 2,8-bridged
cyclic quaternary salt (0.09g, 51%), mp. 240°.
. +
H nmr <̂d m SO 1.47(3H,s,Cg-Me), 3.32(3H,s,NMe),
4 +
3.42(2H,s ,COCH2N), 4.30(3H,m,C^-H
+ Cg-H) , 5.16 (1H,d,Cg-HjJ^6Hz),
7.1-7.3(3H,m,Ar-H), 7.68(1H,m,C^-H),
9.84(1H,m,NH).
Mass Spec. M/Z 256(M^t 127), 242, 59 base peak.
Elemental analysis:
Found C, 49.7 ; H, 5.7 ; N, 7.2%
^16^21^2^^ requires C, 50.0 j H, 5.5 ; N, 7.3%
7.4.10 8 Of- ( Acetamidomethyl ) -2 , 5-dimethyl-6 ,7- 
benzomorphan (187).
8 ^ (Aminomethyl)-2,5-dimethy1-6,7-benzomorphan 
(0.8g, 3.4mM) was acetylated by the same procedure as 
described in section 7.4.1 to afford 8o(- (aeetamido- 
methyl)-2,5-dimethy1-6,7-benzomorphan as an oil
235.
(0.67g, 71%). The hydrochloride crystallized 
as colourless plates from ethanol, mp. 228-229°.
max 3350cm“ ^(NH), 1660cm"^ (CO ).
^H nmr 1.38(3H,s,C^-Me), 2.04(3H,s,COCH3) ,
0>a^«) 2.37(3H,s,NMe), 3.0 (1H,t,C,-H>
J'4Hz), 3.05-3.6(3H,m,Cg-H + CH^NH)
6.44(1H,m,NH, exchangeable), 7.0- 
7.5(4H,m,Ar-H).
Mass Spec. M/Z 272 (M+), 257 (M+4Me), 21 3 (M'*‘TNH2C0CHg) ,
110 base peak.
Elemental analysis:
Found C, 74.4 ; H, 9.3 ; N, 10.4%
C^^H24N20 requires C, 75.0 ; H, 8.9 ; N, 10.3%
7.4.11 8of- (Cyclopropionamidomethy1)-2,5-dimethy1-6,7- 
benzomorphan (188).
8oc- (Cyclopropionamidomethyl) -2, 5-dime thyl-6 ,7- 
benzomorphan (63%) was prepared from 8o^ (aminomethyl)-
2,5-dimethyl-6,7-benzomorphan by the same procedure 
as described in 7.4.2.
^max 3350cm“  ̂ (NH), 1665cm‘  ̂ ^^^str ^"
^H nmr <^^^01 O. 8-1 .1 (4H ,m,c-CgHg) , 1 .40 (3H, s ,Cg-Me) ,
C-̂ ûu5e) 2.36 (3H,s,NMe) , 3.0(1H,t,C^-H;J-4Hz),
3.04-3.8(3H,m,CHCH2NH), 6.36(1H,m,
NĤ , exchange.o.ble) , 7.0-7. 5 (4H,m,Ar-H) .
Mass Spec. M/Z 298 (M+), 283(M+4Me), 200 (M%CH2NHC0-
C-CgHg), 199 (M+Teg-Me4NH2C0-c-C2Hg).
236.
100, 70, 6 9 (CO-c-CgHg) base peak.
The hydrochloride was recrystallized from ethanol- 
ether and had mp. 209°.
Elemental analysis;
Found C, 65.0 ; H, 8.3 > N, 7.6%
C^gH2^N20Cl'H20 requires C, 64,6 ; H, 8.3 f N, 7.9%
7.4.12 8 Of- (Pheny lace tamidome thy 1) -2, 5-dimethy 1-6 , 7- 
benzomorphan (189).
The procedure described in section 7.4.3 was 
repeated using 8^aminomethyl-2,5-dimethyl-6,7- 
benzomorphan to give 8o<~ (phenylacetamidomethyl) -2 , 5- 
dimethyl-6,7-benzomorphan (81%) as white solid. 
Recrystallization from ether gave colourless plates, 
mp. 110-111°,
^max (Nujol) 3360cm \  164 2cm”  ̂(CO^^^ ).
nmr c5̂ .dc1 1 .34 (3H, s , C^-Me) , 2 .1 8 (3H,s ,NMe) ,
2.77(1H,t,C^-H;J^4Hz), 2.90-3.53( 
3H,m,Cg-H + CH2NH), 3.56(2H,s,PhCH2 
CO), 6.0(1H,d,NH) , 7.0-7(.4 (9H,m,Ar-H) .
Mass Spec. M/Z 348 (M+), 333 (M+fMe), 198(M+fMefNHC0CH='
Ph), 110 base peak, 91 (PhCH^), 70.
Elemental analysis;
Found C, 79.2 ; H, 8.2 ; N, 8.0%
^23^28^2^ requires C, 79.3 ; H, 8.1 ; N, 8.0%
237.
7.4.13 8 Of- (Chloroacetamidomethyl) -2,5-dimethyl-6 , 7- 
benzomorphan (164).
The procedure described in section 7.4.4 was 
repeated using 8«-aminomethyl-2,5-dimethyl-6,7- 
benzomorphan instead of 8oc-amino-2,5-dimethyl-6 ,7- 
benzomorphan to give 8og- (chloroacetamidomethyl)-2,5- 
dimethyl-6,7-benzomorphan (53%) as an oil.
The hydrochloride was recrystallized from ethanol.
and had mp. 212 (d).
max
 ̂H nmr CDCl,
(base)
3350cm"1 (NH), 1660cm“  ̂ ^^^str.^*
1.40(3H,s,Cg-Me), 2.36 (3H,s,NMe), 
2.95(1H,t,C^-H), 3.08-3.80(3H,m, 
CgHCH^NH), 4.7(2H,s,CH2C1), 6.84( 





306(M+), 291(M+4Me), 110 base peak,
70.
C, 59.4 ; H, 7.4 ; N, 7.9%
C17H24N2OCI2 requires C, 59.5 ; H, 7.1 j N, 8.2%
7.4.14 8orAcetamido-2,5,9-trimethyl-6,7-benzomorphan 
(145).
8og-Acetamido-2 , 5,9-tr imethyl-6 ,7-benzomorphan 
was obtained in 58% yield from 8o^amino-2,5,9-trimethyl
6,7-benzomorphan by the same procedure as that described 
in section 7.4.1. The hydrochloride was crystallized










2.95 (1H,d,C.,-HjJ-8Hz) , 5.25 (1H,d,
Cg-IJgj J^IOHz , on D^O d — >s) , 5.8 (1H, 
d,NH j J*^10Hz , D^O exchangeable),
7.0-7.4(4H,s,Ar-H).
272(M+), 257(M+4Me), 213(M+4NH2C0CHg), 
Me
124 ( ), 84 base peak.
Me
Elemental analysis; 
Found C, 64.6 ; H, 8.6 ; N, 9.2%
C.^2^22^2^’^^^ requires C, 65.1 ; H, 8.2 ; N, 9.1%
7.4.15 8<x-Cyclopropionamido-2 , 5,9-trime thyl-6 , 7- 
benzomorphan (146).
8o^Amino-2,5,9-trimethyl-6,7-benzomorphan was 
acylated in the same manner as described in section
7.4.2 to give 8o^-cyclopropionamido-2 , 5,9-tr imethyl-
6,7-benzomorphan in 61% yield (from ethyl acetate- 
petroleum ether).
max
 ̂H nmr ACDCl,
3295cm"1 (NH), 1670cm”  ̂ ^^^str ^'
0.6-1.1 (7H,m,C0-c-CgHg & Cg-Me),
1.4(3H,s,Cg-Me), 2.6(3H,s,NMe), 
2.96 (1H,d,C.j-HjJ-7HZ) , 5.28 (1H,d,
239.
C q -H^jJ^IOHz , on D^O d-+s), 5.85(1H, 
d,NH;J‘-10Hz) , 7.0-7.4 (4H,^s' ,Ar-H) .
Mass Spec. M/Z 298(M+), 283(M++Me), 198(M*TMeTNH2C0-
c-CgH^), 84 base peak.
Elemental analysis;
Found C, 76.2 ; H, 9.0 ; N, 9.3%




This compound was prepared in 64%/from 8«-amino- 
2, 5 , 9-trimethyl-6 , 7-benzomorphan by the same procedure 
as that described in section 7.4.3. The amide was 
crystallized from ethyl acetate-ether to give white








J'-IOHz, on D^O d-^s) , 5.6(1H,d,NH; 
J'^IOHz ,exchangeable) , 7.0-7. 5 (9H, 
m,Ar-H).
348(M+), 333(M+fMe), 289(M+f59), 
198(M+fMetNH2C0CH2Ph), 84 base peak.
Elemental analysis:
Found C, 79.2 ; H, 8.0 ; N, 8.0%
^23^28^2^ requires C, 79.3 ; H, 8.1 > N, 8.0%
240.
7.5 Secondary amines.
7.5.1 Attempt to synthesis alkylamines. Reductive 
alkamination of 2,5-dimethyl-8-oxo-6,7- 
benzomorphan with sodium cyanohydridoborate.
To a solution of anhydrous methylamine (2.3g, 
7.2mM) in absolute methanol (25ml) was added 5N HCl- 
methanol (4.8ml), followed by 2,5-dimethyl-8-oxo-
6,7-benzomorphan (2.6g, 12mM) and sodium cyanohydrido­
borate (450mg,7.ImM). The solution was stirred at 40^ 
for 72 hours. Concentrated hydrochloric acid was added 
until pH was 2, and the methanol removed ^  vacuo. The 
residue was taken up in water (50ml) and extracted 
with ether (2 x 30ml). The aqueous layer was basified 
with ammonia solution and extracted with dichloro- 
methane (3 x 50ml). The organic layer was dried 
(MgSO^) and evaporated to give an oil which was 
chromatographed on silica gel using varying strengths 
of methanol-chloroform (1-10%) to give starting 
material, 8£-methylamino-2,5-dimethyl-6,7-benzomorphan 
(149, 8%) and 8g-hydroxy-2,5-dimethyl-6,7-benzomorphan 
(150, 14%). Attempts to improve the yield of the amine 
and reduce the undesired product by modifying the 
reaction conditions, eg. varying the reaction time, 
temperature and the time of addition of sodium 
cyanohydridoborate, met with limited success.
8^-hydroxy-2,5-dimethy1-6,7-benzomorphan, mp. 89-91° 
(from acetone). (Lit. mp 88-90°).
Hnax 3350cm  ̂.
241 .
nmr ^cDCl 1.32(3H,s,C^-Me), 2.58(3H,s,NMe),
3. 90 (1H,s,0]i,exchangeable) , 4 . 70 ( 
1H,d,CH0HjJ-6Hz), 7.1-7.4(4H,m,Ar-H).
8g-methylamino-2,5-dimethyl-6,7-benzomorphan (impure). 
^max 3350cm \  1603cm ^
nmr ,60Hz 1-33 (3H,s,Cg-Me) , 2.05 (1H,s,NH.,
exchangeable), 2.53(3H,s,NMe), 
2.60(3H,s,NHMe) , 3 . 2 ( 1H ,m,C.̂ -ji) ,
3.65 (1H,d,Cg-HjJ-6Hz), 7.0-7 .35(3H, 
m,Ar-H), 7.7(1H,m,Ar-H).
Mass Spec. M/Z 230(M^).
7.5.2 Alkylation of primary amines.
General procedure.
Amides were prepared as in section 7.4 by treating 
appropriate acyl halide (20mM) with the primary amines 
(lOmM) in the presence of base (1OmM). A solution of the 
crude amide in freshly distilled tetrahydrofuran 
(50ml) was added dropwise with stirring during 20 min., 
at room temperature, to a suspension of LAH (30mM) in 
tetrahydrofuran or ether (100ml). After the addition 
was completed the solution was refluxed for 5-8 hours, 
cooled in an ice bath and water (4.2ml), 5N sodium 
hydroxide (0.75ml) added dropwise with caution. The 
solid was removed by filtration and repeatedly washed 
with ether. The organic phase was washed with water, 
dried (MgSO^) and evaporated. The resulting syrup was
242.
taken up in ether and converted to the hydrochloride 
with ethereal-HCl. The hydrochloride was recrystallized 
from ethanol-ether or isopropanol-ether and yields 















C^-H), 3.87(1H,s,Cg-Hp), 7.0-7.45( 
4H,m,Ar-H).
244(M+), 201(M+fMefCH_=CH_),
. +184(M fMeTNH2Et), 59(EtNHMe) base
peak.
Elemental analysis: 
Found C, 54.5 ; H, 8.3 ; N, 7.9%
^16^26^2^^2*^^2^ requires C, 54.4 ; H, 8.6 ; N, 7.9%
7.5.2.2 8arCyclopropylmethylamino-2,5-dimethyl-6 ,7- 
benzomorphan (155).
Yield 43%
mp 208-209 (from ethanol-ether),
max 3300cm"^ (NH).






CgHgiJ^VHz) , 3.05(1H,t,C.,-HjJ-4Hz) , 
3.8(1H,s,Cg-Hp), 7.1-7.5(4H, m ,Ar-H).
270(M+), 213(M+TMe4c-C2Hg), 200(M+f 
MefCH2-c-CgHg), 184(M+TMeTNH2CH2-c- 
CgHg), 70, 59 base peak.
Elemental analysis; 
Found C, 62.8 ; H, 8.4 ; N, 8.2%
^18^26^2’^^^^ requires C, 63.0 ; H, 8.2 ; N, 8.2%











186-187° (from isopropanol-ether) 
3368cm"^ (NH).
1.34(3H,s,Me), 2.47(3H,s,NMe),




184(M+fMefPhCH2CH2NH2), 59 base peak
C, 65.3 ; H, 7.8 ; N, 7.0%












3300cm”  ̂ (NH).
0.8-1.05(1H,m,C^-H), 1.1-1.3(3H,t, 
CH^CHg;, 1.4(3H,s,Cg-Me), 2.3(1H,s,NH, 
exchangeable), 2.6(3H,s,NMe),
2.68-3.04(2H,m,CH2CHg), 3.17(1H,m,
C.J-H), 3.74(1H,d,CgH*;J~6Hz), 7.0- 
7.4(3H, m ,Ar-H), 7.75(1H,m,C^*-H).
244(M+), 201, 184, 131, 59 base peak.
Elemental analysis:
Found C, 60.4 ; H, 8.5 ; N , 8 .8%










3300cm”  ̂ (NH) .
0-1.1(6H,m,c-CgHg and C^-HJ, 1.35( 
3H,s,Me), 2.6(3H,s,NMe), 2.68(2H,m, 




Mass Spec. M/Z 270(M+), 213, 184, 70, 59 base peak.
Elemental Analysis:
Found C, 63.4 ; H , 7.9 ; N, 8.4%
^18^28^2^^2 require C, 63.0 ; H, 8.2 j N, 8.2%
7.5.2.6 8p-Phenylethylamino-2,5-dimethyl-6 ,7- 
benzomorphan (158).
Yield 18%
mp. 171-173° (from ethanol-ether).
^max 3300cm ^(NH).
nmr d^DCl 0 . 8 (1H,m,C^-H), 1.33(3H,s.C^-Me),
(free base) 2.55(3H,s,NMe), 2.8-3.4(5H,m,
PhCH2CH2 + C.J-H), 3.75(1H,d,Cg-H*,; 
J^6Hz), 7.0-7.5(8H,m,Ar-H), 7.7(1H, 
m,C^*-H),
Mass Spec. M/Z 320(M^), 201, 184, 131, 59 base peak
Elemental analysis:
Found C, 64.9 ; H, 7.9 ; N, 6 .8%
^22^30^2^^2*^2^ requires C, 64.9 ; H, 7.8 ; N , 6 .8%
7. 5. 2. 7 8oc- (Ethylaminomethy 1 ) -2 , 5-dimethyl-6 , 7- 
benzomorphan (193).
Yield 28%
mp. 274° (from isopropanol-ether).






3H,s,Me), 2.40(3H,s,NMe), 2.4-3.25( 
6H,m,CH2NHCH2,C.j-H + Cg-H^) , 7.0-
7.4 (4H,m,Ar-H^) .
258(M+), 201(M+tCH2=NCH2CHg)
186(2017Me)., 58 base peak.
Elemental analysis:
Found C, 61.2 } H, 8.5 î N, 8.0%
C^^H2gN2Cl2 requires C, 61.7 j H, 8.5 ; N, 8.5%
7. 5. 2. 8 8oe- (Cyclopropylmethylaminomethyl) -2 , 5-dimethyl- 












CH^,Cg-H+ C.J-H), 7.0-7.4 (4H,m,
Ar-fl) .
284(M*), 201, 84 base peak, 59.
Elemental analysis:
Found C, 63.3 ; H, 8.6 : N, 7.5%
C 19H30N 2CI2 requires C, 63.9 ; H, 8.5 j N, 7.8%
247.









235-236° (from ethanol-ether). 
3340cm” 1 (NH).
1.4(3H,s,Me), 2.4(3H,s,NMe), 2.4- 
3.3(8H,m,CH2NHCH2CH2Ph,Cg-H + C^-H), 
7.0-7.5(9H,m,Ar-H).
334(M+), 201, 134 base peak, 59.
Elemental analysis;
Found C, 66.3 ; H, 7.9 > N, 6 .6%
^23^32^2^^2 requires C, 67.8 ; H, 7.9 ; N , 6.9%














J-8HZ), 1.3(3H,s,Cg-Me), 2.4(3H,s, 
NMe), 2.6-3.1 (3H,m,CH2CHg and C^-H), 
3.6(1H,s,Cg-Hg), 7.0-7.3 (3H,m,Ar-H), 
7.4(1H,m,C^'-H).
258(M+), 198(M+fCg-MeTNH2CH2CH2),
84, 59 base peak.
248
Elemental analysis:
Found C, 61.2 ; H, 8.1 ; N, 8.4%












192 (d)(from ethanol ether).
3300cm"1 (NH).
0.0-0.8(5H,m,c-CgHg), 0.90(3H,d, 
Cg-Me), 1.32(3H,s,Cg-Me), 2.4(3H, 
s,NMe), 2.8(1H,d,C^-HjJ=7Hz), 3.6( 
1H,s,Cg-Hp), 7.0-7.3(3H,m,Ar-H),
7.4(1H,m,C^’-H).
284 (M+), 227 (M+fMefc-C^Hg),198 (M+f
' 84 , 59 base peak
C, 65.5 i H, 8.1 ; N, 7.5%
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